CATH Search:   
       by CATH code, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: Mainly Beta (13760)
(-)
Architecture: Beta Barrel (4804)
(-)
Topology: Acetoacetate decarboxylase-like (5)
(-)
Homologous Superfamily: Acetoacetate decarboxylase-like (5)
(-)
Chromobacterium violaceum atcc 12472. Organism_taxid: 243365. Strain:dsm 30191 / ifo 12614 / jcm 1249 / ncib 9131. (1)
3BH3D:14-245; A:14-244; B:14-244; C:14-244CRYSTAL STRUCTURE OF ACETOACETATE DECARBOXYLASE FROM CHROMOBACTERIUM VIOLACEUM IN COMPLEX WITH ACETYL ACETONE SCHIFF BASE INTERMEDIATE
(-)
Chromobacterium violaceum. Organism_taxid: 536. (1)
3BGTD:14-245; A:14-244; B:14-244; C:14-244STRUCTURAL STUDIES OF ACETOACETATE DECARBOXYLASE
(-)
Clostridium acetobutylicum atcc 824. Organism_taxid: 272562. Strain: dsm 792 / jcm 1419 / lmg 5710 / vkm b-1787. (1)
3BH2A:13-244; B:13-244; C:13-244; D:13-244STRUCTURAL STUDIES OF ACETOACETATE DECARBOXYLASE
(-)
Methanoculleus marisnigri jr1. Organism_taxid: 368407. Strain: jr1 / dsm 1498. (1)
3CMBA:0-264; D:0-264; B:-1-264; C:-1-264CRYSTAL STRUCTURE OF ACETOACETATE DECARBOXYLASE (YP_001047042.1) FROM METHANOCULLEUS MARISNIGRI JR1 AT 1.60 A RESOLUTION
(-)
Pneumophila str (Legionella pneumophila subsp) (1)
3C8WA:23-254; B:23-254; C:23-254; D:23-254CRYSTAL STRUCTURE OF ACETOACETATE DECARBOXYLASE (ADC) (YP_094708.1) FROM LEGIONELLA PNEUMOPHILA SUBSP. PNEUMOPHILA STR. PHILADELPHIA 1 AT 1.60 A RESOLUTION
(-)
Topology: AOC barrel-like (2)
(-)
Homologous Superfamily: SO1590-like (2)
(-)
Shewanella denitrificans os217. Organism_taxid: 318161. Strain: os217,dsm 15013. (1)
2Q03B:5-135; A:5-137CRYSTAL STRUCTURE OF UNCHARACTERIZED PROTEIN (YP_563039.1) FROM SHEWANELLA DENITRIFICANS OS217 AT 1.80 A RESOLUTION
(-)
Shewanella oneidensis mr-1. Organism_taxid: 211586. Strain: mr-1. (1)
2OOJB:2-135; A:2-134CRYSTAL STRUCTURE OF A PROTEIN WITH UNKNOWN FUNCTION FROM DUF3224 FAMILY (SO_1590) FROM SHEWANELLA ONEIDENSIS MR-1 AT 1.84 A RESOLUTION
(-)
Topology: At1g16640 B3 domain (3)
(-)
Homologous Superfamily: At1g16640 B3 domain (3)
(-)
Escherichia coli. Organism_taxid: 562. (1)
1NA6A:4-177; B:4-177CRYSTAL STRUCTURE OF RESTRICTION ENDONUCLEASE ECORII MUTANT R88A
(-)
Thale cress (Arabidopsis thaliana) (2)
1WIDA:182-298SOLUTION STRUCTURE OF THE B3 DNA-BINDING DOMAIN OF RAV1
1YELA:1-102STRUCTURE OF THE HYPOTHETICAL ARABIDOPSIS THALIANA PROTEIN AT1G16640.1
(-)
Topology: AttH-like fold (1)
(-)
Homologous Superfamily: AttH-like domain (1)
(-)
Nitrosomonas europaea. Organism_taxid: 915. (1)
2ICHA:35-221; B:35-221; B:222-352; A:222-351CRYSTAL STRUCTURE OF A PUTATIVE ATTH (NE1406) FROM NITROSOMONAS EUROPAEA AT 2.00 A RESOLUTION
(-)
Topology: Barwin-like endoglucanases (75)
(-)
Homologous Superfamily: [code=2.40.40.20, no name defined] (63)
(-)
[unclassified] (2)
2C45A:1-114; B:1-114; C:1-114; D:1-114; E:1-114; F:1-114; G:1-114; H:1-114NATIVE PRECURSOR OF PYRUVOYL DEPENDENT ASPARTATE DECARBOXYLASE
2IV2X:572-688REINTERPRETATION OF REDUCED FORM OF FORMATE DEHYDROGENASE H FROM E. COLI
(-)
Alcaligenes faecalis. Organism_taxid: 511. Strain: ncib 8687. (2)
1G8JA:683-817; C:683-817CRYSTAL STRUCTURE ANALYSIS OF ARSENITE OXIDASE FROM ALCALIGENES FAECALIS
1G8KA:683-817; E:683-817; G:683-817; C:683-825CRYSTAL STRUCTURE ANALYSIS OF ARSENITE OXIDASE FROM ALCALIGENES FAECALIS
(-)
Baker's yeast (Saccharomyces cerevisiae) (2)
1CR5A:26-102; B:26-102; C:26-102N-TERMINAL DOMAIN OF SEC18P
1I50A:347-373,A:437-510RNA POLYMERASE II CRYSTAL FORM II AT 2.8 A RESOLUTION
(-)
Chinese hamster (Cricetulus griseus) (2)
1QCSA:2-83N-TERMINAL DOMAIN OF N-ETHYLMALEIMIDE SENSITIVE FACTOR (NSF)
1QDNA:1-83; B:1-83; C:1-83AMINO TERMINAL DOMAIN OF THE N-ETHYLMALEIMIDE SENSITIVE FUSION PROTEIN (NSF)
(-)
Desulfovibrio desulfuricans. Organism_taxid: 876. (8)
2JIMA:610-723A NEW CATALYTIC MECHANISM OF PERIPLASMIC NITRATE REDUCTASE FROM DESULFOVIBRIO DESULFURICANS ATCC 27774 FROM CRYSTALLOGRAPHIC AND EPR DATA AND BASED ON DETAILED ANALYSIS OF THE SIXTH LIGAND
2JIOA:610-723A NEW CATALYTIC MECHANISM OF PERIPLASMIC NITRATE REDUCTASE FROM DESULFOVIBRIO DESULFURICANS ATCC 27774 FROM CRYSTALLOGRAPHIC AND EPR DATA AND BASED ON DETAILED ANALYSIS OF THE SIXTH LIGAND
2JIPA:610-723A NEW CATALYTIC MECHANISM OF PERIPLASMIC NITRATE REDUCTASE FROM DESULFOVIBRIO DESULFURICANS ATCC 27774 FROM CRYSTALLOGRAPHIC AND EPR DATA AND BASED ON DETAILED ANALYSIS OF THE SIXTH LIGAND
2JIQA:610-723A NEW CATALYTIC MECHANISM OF PERIPLASMIC NITRATE REDUCTASE FROM DESULFOVIBRIO DESULFURICANS ATCC 27774 FROM CRYSTALLOGRAPHIC AND EPR DATA AND BASED ON DETAILED ANALYSIS OF THE SIXTH LIGAND
2JIRA:610-723A NEW CATALYTIC MECHANISM OF PERIPLASMIC NITRATE REDUCTASE FROM DESULFOVIBRIO DESULFURICANS ATCC 27774 FROM CRYSTALLOGRAPHIC AND EPR DATA AND BASED ON DETAILED ANALYSIS OF THE SIXTH LIGAND
2NAPA:610-723DISSIMILATORY NITRATE REDUCTASE (NAP) FROM DESULFOVIBRIO DESULFURICANS
2V3VA:610-723A NEW CATALYTIC MECHANISM OF PERIPLASMIC NITRATE REDUCTASE FROM DESULFOVIBRIO DESULFURICANS ATCC 27774 FROM CRYSTALLOGRAPHIC AND EPR DATA AND BASED ON DETAILED ANALYSIS OF THE SIXTH LIGAND
2V45A:610-723A NEW CATALYTIC MECHANISM OF PERIPLASMIC NITRATE REDUCTASE FROM DESULFOVIBRIO DESULFURICANS ATCC 27774 FROM CRYSTALLOGRAPHIC AND EPR DATA AND BASED ON DETAILED ANALYSIS OF THE SIXTH LIGAND
(-)
Desulfovibrio gigas. Organism_taxid: 879. Strain: ncib 9332. (1)
1H0HA:802-977; K:802-977TUNGSTEN CONTAINING FORMATE DEHYDROGENASE FROM DESULFOVIBRIO GIGAS
(-)
Escherichia coli k-12. Organism_taxid: 83333. Strain: k12. (1)
3IR7A:1067-1191,A:1220-1244CRYSTAL STRUCTURE OF NARGHI MUTANT NARG-R94S
(-)
Escherichia coli k12. Organism_taxid: 83333. Strain: k-12. (1)
2NYAA:668-791; F:668-791CRYSTAL STRUCTURE OF THE PERIPLASMIC NITRATE REDUCTASE (NAP) FROM ESCHERICHIA COLI
(-)
Escherichia coli. Organism_taxid: 562. (9)
1PPYA:1-118; B:1-115NATIVE PRECURSOR OF PYRUVOYL DEPENDENT ASPARTATE DECARBOXYLASE
1PQEA:1-117S25A MUTANT OF PYRUVOYL DEPENDENT ASPARTATE DECARBOXYLASE
1PQFA:-3-123; B:1-116GLYCINE 24 TO SERINE MUTATION OF ASPARTATE DECARBOXYLASE
1PQHA:-2-116; B:1-115SERINE 25 TO THREONINE MUTATION OF ASPARTATE DECARBOXYLASE
1PT0A:0-116; B:1-116UNPROCESSED PYRUVOYL DEPENDENT ASPARTATE DECARBOXYLASE WITH AN ALANINE INSERTION AT POSITION 26
1PT1A:-1-115; B:1-115UNPROCESSED PYRUVOYL DEPENDENT ASPARTATE DECARBOXYLASE WITH HISTIDINE 11 MUTATED TO ALANINE
1PYQA:-3-116; B:1-116UNPROCESSED ASPARTATE DECARBOXYLASE MUTANT, WITH ALANINE INSERTED AT POSITION 24
1PYUB:25-116; D:25-115PROCESSED ASPARTATE DECARBOXYLASE MUTANT WITH SER25 MUTATED TO CYS
1Q16A:1067-1191,A:1220-1244CRYSTAL STRUCTURE OF NITRATE REDUCTASE A, NARGHI, FROM ESCHERICHIA COLI
(-)
Escherichia coli. Organism_taxid: 562. (1)
1AW8B:25-115; E:26-115PYRUVOYL DEPENDENT ASPARTATE DECARBOXYLASE
(-)
Escherichia coli. Organism_taxid: 562. Strain: fm911. (3)
1AA6A:572-688REDUCED FORM OF FORMATE DEHYDROGENASE H FROM E. COLI
1FDIA:568-688OXIDIZED FORM OF FORMATE DEHYDROGENASE H FROM E. COLI COMPLEXED WITH THE INHIBITOR NITRITE
1FDOA:573-688OXIDIZED FORM OF FORMATE DEHYDROGENASE H FROM E. COLI
(-)
Escherichia coli. Organism_taxid: 562. Strain: gl101. Escherichia coli. Organism_taxid: 562. Strain: gl101. (2)
1KQFA:840-1015FORMATE DEHYDROGENASE N FROM E. COLI
1KQGA:840-1015FORMATE DEHYDROGENASE N FROM E. COLI
(-)
Helicobacter pylori. Organism_taxid: 210. (2)
1UHDA:26-120CRYSTAL STRUCTURE OF ASPARTATE DECARBOXYLASE, PYRUVOLY GROUP BOUND FORM
1UHEA:26-122CRYSTAL STRUCTURE OF ASPARTATE DECARBOXYLASE, ISOASPARGINE COMPLEX
(-)
House mouse (Mus musculus) (5)
1E32A:21-107STRUCTURE OF THE N-TERMINAL DOMAIN AND THE D1 AAA DOMAIN OF MEMBRANE FUSION ATPASE P97
1R7RA:17-108THE CRYSTAL STRUCTURE OF MURINE P97/VCP AT 3.6A
1S3SF:21-107; C:22-107; A:23-107; B:23-107; D:23-107; E:23-107CRYSTAL STRUCTURE OF AAA ATPASE P97/VCP ND1 IN COMPLEX WITH P47 C
1WLFA:13-99STRUCTURE OF THE N-TERMINAL DOMAIN OF PEX1 AAA-ATPASE: CHARACTERIZATION OF A PUTATIVE ADAPTOR-BINDING DOMAIN
3CF2A:21-108; B:21-108; C:21-108; D:21-108STRUCTURE OF P97/VCP IN COMPLEX WITH ADP/AMP-PNP
(-)
Pseudomonas aeruginosa. Organism_taxid: 287. (1)
1YLEA:274-340THE STRUCTURE OF ARGININE/ORNITHINE SUCCINYLTRANSFERASE SUBUNIT AI FROM PSEUDOMONAS AERUGINOSA.
(-)
Rhodobacter capsulatus. Organism_taxid: 1061. Strain: 37b4. (1)
1DMSA:612-774STRUCTURE OF DMSO REDUCTASE
(-)
Rhodobacter capsulatus. Organism_taxid: 1061. Strain: h123. (9)
1DMRA:612-774OXIDIZED DMSO REDUCTASE FROM RHODOBACTER CAPSULATUS
1E18A:612-774TUNGSTEN-SUSBSTITUTED DMSO REDUCTASE FROM RHODOBACTER CAPSULATUS
1E5VA:612-774; C:612-774OXIDIZED DMSO REDUCTASE EXPOSED TO HEPES BUFFER
1E60A:612-774; C:612-774OXIDIZED DMSO REDUCTASE EXPOSED TO HEPES - STRUCTURE II BUFFER
1E61A:612-774; C:612-774OXIDIZED DMSO REDUCTASE EXPOSED TO HEPES - STRUCTURE II BUFFER
1H5NA:612-774; C:612-774DMSO REDUCTASE MODIFIED BY THE PRESENCE OF DMS AND AIR
2DMRA:612-774DITHIONITE REDUCED DMSO REDUCTASE FROM RHODOBACTER CAPSULATUS
3DMRA:612-774STRUCTURE OF DMSO REDUCTASE FROM RHODOBACTER CAPSULATUS AT PH 7.0
4DMRA:612-774REDUCED DMSO REDUCTASE FROM RHODOBACTER CAPSULATUS WITH BOUND DMSO SUBSTRATE
(-)
Rhodobacter sphaeroides. Organism_taxid: 1063. (2)
1EU1A:612-774THE CRYSTAL STRUCTURE OF RHODOBACTER SPHAEROIDES DIMETHYLSULFOXIDE REDUCTASE REVEALS TWO DISTINCT MOLYBDENUM COORDINATION ENVIRONMENTS.
1OGYA:678-801; C:678-801; E:678-801; G:678-801; I:678-801; K:678-801; M:678-801; O:678-801CRYSTAL STRUCTURE OF THE HETERODIMERIC NITRATE REDUCTASE FROM RHODOBACTER SPHAEROIDES
(-)
Shewanella massilia. Organism_taxid: 76854. (1)
1TMOA:618-790TRIMETHYLAMINE N-OXIDE REDUCTASE FROM SHEWANELLA MASSILIA
(-)
Thermoplasma acidophilum. Organism_taxid: 2303. (2)
1CZ4A:1-92NMR STRUCTURE OF VAT-N: THE N-TERMINAL DOMAIN OF VAT (VCP-LIKE ATPASE OF THERMOPLASMA)
1CZ5A:1-92NMR STRUCTURE OF VAT-N: THE N-TERMINAL DOMAIN OF VAT (VCP-LIKE ATPASE OF THERMOPLASMA)
(-)
Thermus thermophilus hb8. Organism_taxid: 300852. Strain: hb8. (1)
2EEOB:26-120CRYSTAL STRUCTURE OF T.TH. HB8 L-ASPARTATE-ALPHA-DECARBOXYLASE COMPLEXED WITH FUMARATE
(-)
Thermus thermophilus. Organism_taxid: 262724. Strain: hb27. Thermus thermophilus. Organism_taxid: 262724. Strain: hb27. (4)
2VPWA:605-764; E:605-764POLYSULFIDE REDUCTASE WITH BOUND MENAQUINONE
2VPXA:605-764; E:605-764POLYSULFIDE REDUCTASE WITH BOUND QUINONE (UQ1)
2VPYA:605-764; E:605-764POLYSULFIDE REDUCTASE WITH BOUND QUINONE INHIBITOR, PENTACHLOROPHENOL (PCP)
2VPZA:605-764; E:605-764POLYSULFIDE REDUCTASE NATIVE STRUCTURE
(-)
Thermus thermophilus. Organism_taxid: 274. (1)
1VC3B:26-120CRYSTAL STRUCTURE OF L-ASPARTATE-ALPHA-DECARBOXYLASE
(-)
Homologous Superfamily: Barwin-like endoglucanases (12)
(-)
C58 (Agrobacterium tumefaciens str) (1)
2PNWA:5-101,A:270-369CRYSTAL STRUCTURE OF MEMBRANE-BOUND LYTIC MUREIN TRANSGLYCOSYLASE FROM AGROBACTERIUM TUMEFACIENS
(-)
Hordeum vulgare. Organism_taxid: 4513 (2)
1BW3A:1-125THREE-DIMENSIONAL STRUCTURE IN SOLUTION OF BARWIN, A PROTEIN FROM BARLEY SEED
1BW4A:1-125THREE-DIMENSIONAL STRUCTURE IN SOLUTION OF BARWIN, A PROTEIN FROM BARLEY SEED
(-)
Humicola insolens. Organism_taxid: 34413 (4)
1HD5A:1-211ENDOGLUCANASE FROM HUMICOLA INSOLENS AT 1.7A RESOLUTION
2ENGA:1-210ENDOGLUCANASE V
3ENGA:1-213STRUCTURE OF ENDOGLUCANASE V CELLOBIOSE COMPLEX
4ENGA:1-210STRUCTURE OF ENDOGLUCANASE V CELLOHEXAOSE COMPLEX
(-)
Melanocarpus albomyces. Organism_taxid: 204285 (3)
1L8FA:1-207STRUCTURE OF 20K-ENDOGLUCANASE FROM MELANOCARPUS ALBOMYCES AT 1.8 A
1OA7A:1-208STRUCTURE OF MELANOCARPUS ALBOMYCES ENDOGLUCANASE IN COMPLEX WITH CELLOBIOSE
1OA9A:1-208STRUCTURE OF MELANOCARPUS ALBOMYCES ENDOGLUCANASE
(-)
Timothy grass (Phleum pratense) (1)
1N10A:1015-1138; B:2015-2138CRYSTAL STRUCTURE OF PHL P 1, A MAJOR TIMOTHY GRASS POLLEN ALLERGEN
(-)
Zea mays. Organism_taxid: 4577. (1)
2HCZX:4-141CRYSTAL STRUCTURE OF EXPB1 (ZEA M 1), A BETA-EXPANSIN AND GROUP-1 POLLEN ALLERGEN FROM MAIZE
(-)
Topology: Beta-clip (16)
(-)
Homologous Superfamily: MoeA C-terminal domain-like (16)
(-)
Escherichia coli. Organism_taxid: 562 (2)
1G8LA:329-402; B:329-402CRYSTAL STRUCTURE OF ESCHERICHIA COLI MOEA
1G8RA:329-402; B:329-402MOEA
(-)
Escherichia coli. Organism_taxid: 562. (7)
2NQKA:329-402; B:329-402MOEA D59N MUTANT
2NQMB:329-402MOEA T100A MUTANT
2NQQA:329-402; B:329-402; C:329-402; D:329-402MOEA R137Q
2NQRB:329-402MOEA D142N
2NQSA:329-402; B:329-402MOEA E188A
2NQUA:329-402; B:329-402MOEA E188Q
2NQVA:329-402MOEA D228A
(-)
Escherichia coli. Organism_taxid: 562. (1)
1FC5A:329-401; B:329-401CRYSTAL STRUCTURE OF MOLYBDOPTERIN BIOSYNTHESIS MOEA PROTEIN
(-)
Norway rat (Rattus norvegicus) (3)
1T3EA:656-736; B:656-736STRUCTURAL BASIS OF DYNAMIC GLYCINE RECEPTOR CLUSTERING
2FTSA:656-736CRYSTAL STRUCTURE OF THE GLYCINE RECEPTOR-GEPHYRIN COMPLEX
2FU3A:656-736; B:656-736CRYSTAL STRUCTURE OF GEPHYRIN E-DOMAIN
(-)
Pyrococcus furiosus. Organism_taxid: 2261. (1)
1XI8A:320-396; B:320-396MOLYBDENUM COFACTOR BIOSYNTHESIS PROTEIN FROM PYROCOCCUS FURIOSUS PFU-1657500-001
(-)
Pyrococcus horikoshii. Organism_taxid: 53953. (1)
1WU2A:320-396; B:326-396CRYSTAL STRUCTURE OF MOLYBDOPTERIN BIOSYNTHESIS MOEA PROTEIN FROM PYROCOCCUS HORIKOSHII OT3
(-)
Pyrococcus horikoshii. Organism_taxid: 70601. Strain: ot3. (1)
1UZ5A:329-402THE CRYSTAL STRUCTURE OF MOLYBDOPTERIN BIOSYNTHESIS MOEA PROTEIN FROM PYROCOCCUS HORIKOSII
(-)
Topology: Butyryl-CoA Dehydrogenase, subunit A; domain 2 (35)
(-)
Homologous Superfamily: Butyryl-CoA Dehydrogenase, subunit A, domain 2 (35)
(-)
Clostridium aminobutyricum. Organism_taxid: 33953 (1)
1U8VA:144-276; C:144-276; D:144-276; B:144-277CRYSTAL STRUCTURE OF 4-HYDROXYBUTYRYL-COA DEHYDRATASE FROM CLOSTRIDIUM AMINOBUTYRICUM: RADICAL CATALYSIS INVOLVING A [4FE-4S] CLUSTER AND FLAVIN
(-)
Geobacillus kaustophilus hta426. Organism_taxid: 235909. Strain: hta426. (1)
2PG0A:125-233; B:125-233CRYSTAL STRUCTURE OF ACYL-COA DEHYDROGENASE FROM GEOBACILLUS KAUSTOPHILUS
(-)
Human (Homo sapiens) (14)
1EGCA:131-251; B:131-251; C:131-251; D:131-251STRUCTURE OF T255E, E376G MUTANT OF HUMAN MEDIUM CHAIN ACYL-COA DEHYDROGENASE COMPLEXED WITH OCTANOYL-COA
1EGDA:131-251; B:131-251; C:131-251; D:131-251STRUCTURE OF T255E, E376G MUTANT OF HUMAN MEDIUM CHAIN ACYL-COA DEHYDROGENASE
1EGEA:131-251; B:131-251; C:131-251; D:131-251STRUCTURE OF T255E, E376G MUTANT OF HUMAN MEDIUM CHAIN ACYL-COA DEHYDROGENASE
1IVHA:131-250; B:131-250; C:131-250; D:131-250STRUCTURE OF HUMAN ISOVALERYL-COA DEHYDROGENASE AT 2.6 ANGSTROMS RESOLUTION: STRUCTURAL BASIS FOR SUBSTRATE SPECIFICITY
1RX0A:134-238; B:134-238; C:134-238; D:134-238CRYSTAL STRUCTURE OF ISOBUTYRYL-COA DEHYDROGENASE COMPLEXED WITH SUBSTRATE/LIGAND.
1SIQA:131-237THE CRYSTAL STRUCTURE AND MECHANISM OF HUMAN GLUTARYL-COA DEHYDROGENASE
1SIRA:131-237THE CRYSTAL STRUCTURE AND MECHANISM OF HUMAN GLUTARYL-COA DEHYDROGENASE
1T9GA:131-251; B:131-251; C:131-251; D:131-251STRUCTURE OF THE HUMAN MCAD:ETF COMPLEX
2A1TA:131-251; B:131-251; C:131-251; D:131-251STRUCTURE OF THE HUMAN MCAD:ETF E165BETAA COMPLEX
2JIFA:170-278; B:170-278; C:170-278; D:170-278STRUCTURE OF HUMAN SHORT-BRANCHED CHAIN ACYL-COA DEHYDROGENASE (ACADSB)
2UXWA:212-326CRYSTAL STRUCTURE OF HUMAN VERY LONG CHAIN ACYL-COA DEHYDROGENASE (ACADVL)
2VIGG:150-267; D:150-267; A:150-267; E:150-267; C:150-267; F:150-267; H:150-267; B:150-267CRYSTAL STRUCTURE OF HUMAN SHORT-CHAIN ACYL COA DEHYDROGENASE
2WBIA:150-266; B:150-266CRYSTAL STRUCTURE OF HUMAN ACYL-COA DEHYDROGENASE 11
3B96A:172-286STRUCTURAL BASIS FOR SUBSTRATE FATTY-ACYL CHAIN SPECIFICITY: CRYSTAL STRUCTURE OF HUMAN VERY-LONG-CHAIN ACYL-COA DEHYDROGENASE
(-)
Megasphaera elsdenii. Organism_taxid: 907 (1)
1BUCA:124-242; B:124-242THREE-DIMENSIONAL STRUCTURE OF BUTYRYL-COA DEHYDROGENASE FROM MEGASPHAERA ELSDENII
(-)
Mouse-ear cress (Arabidopsis thaliana) (1)
1W07A:133-269; B:133-269ARABIDOPSIS THALIANA ACYL-COA OXIDASE 1
(-)
Mycobacterium tuberculosis. Organism_taxid: 1773. (2)
3AFEA:115-209; B:115-209; C:115-209; D:115-209CRYSTAL STRUCTURE OF THE HSAA MONOOXYGENASE FROM M.TUBERCULOSIS
3AFFA:115-209; B:115-209CRYSTAL STRUCTURE OF THE HSAA MONOOXYGENASE FROM M. TUBERCULOSIS
(-)
Norway rat (Rattus norvegicus) (3)
1IS2A:134-266; B:134-266CRYSTAL STRUCTURE OF PEROXISOMAL ACYL-COA OXIDASE-II FROM RAT LIVER
1JQIA:126-243; B:526-643CRYSTAL STRUCTURE OF RAT SHORT CHAIN ACYL-COA DEHYDROGENASE COMPLEXED WITH ACETOACETYL-COA
2DDHA:134-266CRYSTAL STRUCTURE OF ACYL-COA OXIDASE COMPLEXED WITH 3-OH-DODECANOATE
(-)
Pig (Sus scrofa) (3)
1UDYA:131-251; B:131-251; C:131-251; D:131-251MEDIUM-CHAIN ACYL-COA DEHYDROGENASE WITH 3-THIAOCTANOYL-COA
3MDDA:131-251; B:131-251CRYSTAL STRUCTURES OF MEDIUM CHAIN ACYL-COA DEHYDROGENASE FROM PIG LIVER MITOCHONDRIA WITH AND WITHOUT SUBSTRATE
3MDEA:131-251; B:131-251CRYSTAL STRUCTURES OF MEDIUM CHAIN ACYL-COA DEHYDROGENASE FROM PIG LIVER MITOCHONDRIA WITH AND WITHOUT SUBSTRATE
(-)
Rha1 (Rhodococcus sp) (2)
2OR0B:107-205; A:107-205STRUCTURAL GENOMICS, THE CRYSTAL STRUCTURE OF A PUTATIVE HYDROXYLASE FROM RHODOCOCCUS SP. RHA1
2RFQA:112-206; B:112-206; C:112-206; D:112-206CRYSTAL STRUCTURE OF 3-HSA HYDROXYLASE FROM RHODOCOCCUS SP. RHA1
(-)
Solanum lycopersicum. Organism_taxid: 4081. (1)
2FONA:133-269; B:133-269; C:133-269X-RAY CRYSTAL STRUCTURE OF LEACX1, AN ACYL-COA OXIDASE FROM LYCOPERSICON ESCULENTUM (TOMATO)
(-)
Streptomyces hygroscopicus. Organism_taxid: 1912. Strain: ascomyceticus. (1)
1R2JA:107-212FKBI FOR BIOSYNTHESIS OF METHOXYMALONYL EXTENDER UNIT OF FK520 POLYKETIDE IMMUNOSUPPRESANT
(-)
Thermus thermophilus hb8. Organism_taxid: 300852. Strain: hb8. (3)
1WS9A:123-233; B:123-233CRYSTAL STRUCTURE OF PROJECT ID TT0172 FROM THERMUS THERMOPHILUS HB8
2D29A:123-233; B:123-233STRUCTURAL STUDY ON PROJECT ID TT0172 FROM THERMUS THERMOPHILUS HB8
2DVLA:119-220; B:119-220CRYSTAL STRUCTURE OF PROJECT TT0160 FROM THERMUS THERMOPHILUS HB8
(-)
Thermus thermophilus. Organism_taxid: 274. (2)
1UKWA:148-257; B:148-257CRYSTAL STRUCTURE OF MEDIUM-CHAIN ACYL-COA DEHYDROGENASE FROM THERMUS THERMOPHILUS HB8
2CX9A:123-233; B:123-233; C:123-233; D:123-233CRYSTAL STRUCTURE OF ACYL-COA DEHYDROGENASE
(-)
Topology: Catalase HpII, Chain A, domain 1 (2)
(-)
Homologous Superfamily: Catalase HpII, Chain A, domain 1 (2)
(-)
Escherichia coli. Organism_taxid: 562. (1)
1IPHC:51-436; D:51-436STRUCTURE OF CATALASE HPII FROM ESCHERICHIA COLI
(-)
Plexaura homomalla. Organism_taxid: 47982. (1)
1U5UA:3-368; B:3-368THE STRUCTURE OF AN ALLENE OXIDE SYNTHASE REVEALS A NOVEL USE FOR A CATALASE FOLD
(-)
Topology: Cathepsin D, subunit A; domain 1 (745)
(-)
Homologous Superfamily: Acid Proteases (745)
(-)
[unclassified] (17)
1CPIA:1-99; B:1-99REGIOSELECTIVE STRUCTURAL AND FUNCTIONAL MIMICRY OF PEPTIDES. DESIGN OF HYDROLYTICALLY STABLE CYCLIC PEPTIDOMIMETIC INHIBITORS OF HIV-1 PROTEASE
1D4KA:1-99; B:1-99HIV-1 PROTEASE COMPLEXED WITH A MACROCYCLIC PEPTIDOMIMETIC INHIBITOR
1D4LA:1-99; B:1-99HIV-1 PROTEASE COMPLEXED WITH A MACROCYCLIC PEPTIDOMIMETIC INHIBITOR
1TSQA:1-99; B:1-99CRYSTAL STRUCTURE OF AP2V SUBSTRATE VARIANT OF NC-P1 DECAMER PEPTIDE IN COMPLEX WITH V82A/D25N HIV-1 PROTEASE MUTANT
1TSUA:1-99; B:1-99CRYSTAL STRUCTURE OF DECAMER NCP1 SUBSTRATE PEPTIDE IN COMPLEX WITH WILD-TYPE D25N HIV-1 PROTEASE VARIANT
1Z1HA:1-99; B:101-199HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 3
1Z1RA:1-99; B:101-199HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 2
2J9KA:1-99; B:1-99ATOMIC-RESOLUTION CRYSTAL STRUCTURE OF CHEMICALLY-SYNTHESIZED HIV-1 PROTEASE COMPLEXED WITH INHIBITOR MVT-101
2O40A:1-102; A:103-203CRYSTAL STRUCTURE OF A CHEMICALLY SYNTHESIZED 203 AMINO ACID 'COVALENT DIMER' HIV-1 PROTEASE MOLECULE
3BXRA:1-99; B:101-199CRYSTAL STRUCTURES OF HIGHLY CONSTRAINED SUBSTRATE AND HYDROLYSIS PRODUCTS BOUND TO HIV-1 PROTEASE. IMPLICATIONS FOR CATALYTIC MECHANISM
3BXSA:1-99; B:101-199CRYSTAL STRUCTURES OF HIGHLY CONSTRAINED SUBSTRATE AND HYDROLYSIS PRODUCTS BOUND TO HIV-1 PROTEASE. IMPLICATIONS FOR CATALYTIC MECHANISM
3DCKA:1-99; B:1-99X-RAY STRUCTURE OF D25N CHEMICAL ANALOGUE OF HIV-1 PROTEASE COMPLEXED WITH KETOMETHYLENE ISOSTERE INHIBITOR
3DCRA:1-99; B:1-99X-RAY STRUCTURE OF HIV-1 PROTEASE AND HYDRATED FORM OF KETOMETHYLENE ISOSTERE INHIBITOR
3FSMA:1-102; A:103-203CRYSTAL STRUCTURE OF A CHEMICALLY SYNTHESIZED 203 AMINO ACID 'COVALENT DIMER' [L-ALA51,D-ALA51'] HIV-1 PROTEASE MOLECULE
3HBOA:1-99; B:1-99CRYSTAL STRUCTURE OF CHEMICALLY SYNTHESIZED [D-ALA51/51']HIV-1 PROTEASE
3HDKA:1-99; B:1-99CRYSTAL STRUCTURE OF CHEMICALLY SYNTHESIZED [AIB51/51']HIV-1 PROTEASE
(-)
2_ (1)
1ER8E:171-326; E:2-170THE ACTIVE SITE OF ASPARTIC PROTEINASES
(-)
Aspergillus oryzae. Organism_taxid: 5062 (2)
1IZDA:171-322; A:6-170CRYSTAL STRUCTURE OF ASPERGILLUS ORYZAE ASPARTIC PROTEINASE
1IZEA:171-322; A:6-170CRYSTAL STRUCTURE OF ASPERGILLUS ORYZAE ASPARTIC PROTEINASE COMPLEXED WITH PEPSTATIN
(-)
Aspergillus phoenicis. Organism_taxid: 5063 (1)
1IBQA:170-324; B:170-324; A:5-169; B:5-169ASPERGILLOPEPSIN FROM ASPERGILLUS PHOENICIS
(-)
Atlantic cod (Gadus morhua) (1)
1AM5A:171-324; A:1-170THE CRYSTAL STRUCTURE AND PROPOSED AMINO ACID SEQUENCE OF A PEPSIN FROM ATLANTIC COD (GADUS MORHUA)
(-)
Avian myeloblastosis-associated virus. Organism_taxid: 11960 (1)
1MVPA:1-124; B:1-124STRUCTURAL STUDIES OF THE RETROVIRAL PROTEINASE FROM AVIAN MYELOBLASTOSIS ASSOCIATED VIRUS
(-)
Baker's yeast (Saccharomyces cerevisiae) (11)
1DP5A:171-325; A:0-170THE STRUCTURE OF PROTEINASE A COMPLEXED WITH A IA3 MUTANT INHIBITOR
1DPJA:171-325; A:0-170THE STRUCTURE OF PROTEINASE A COMPLEXED WITH IA3 PEPTIDE INHIBITOR
1FMUA:174-326; A:0-173STRUCTURE OF NATIVE PROTEINASE A IN P3221 SPACE GROUP.
1FMXA:175-328; A:1-174; B:1-174; B:175-328STRUCTURE OF NATIVE PROTEINASE A IN THE SPACE GROUP P21
1FQ4A:171-325; A:0-170CRYSTAL STRUCTURE OF A COMPLEX BETWEEN HYDROXYETHYLENE INHIBITOR CP-108,420 AND YEAST ASPARTIC PROTEINASE A
1FQ5A:171-325; A:0-170X-RAY STRUCTURE OF A CYCLIC STATINE INHIBITOR PD-129,541 BOUND TO YEAST PROTEINASE A
1FQ6A:171-325; A:0-170X-RAY STRUCTURE OF GLYCOL INHIBITOR PD-133,450 BOUND TO SACCHAROPEPSIN
1FQ7A:171-325; A:0-170X-RAY STRUCTURE OF INHIBITOR CP-72,647 BOUND TO SACCHAROPEPSIN
1FQ8A:171-325; A:0-170X-RAY STRUCTURE OF DIFLUOROSTATINE INHIBITOR CP81,198 BOUND TO SACCHAROPEPSIN
1G0VA:171-325; A:0-170THE STRUCTURE OF PROTEINASE A COMPLEXED WITH A IA3 MUTANT, MVV
2JXRA:171-325; A:0-170STRUCTURE OF YEAST PROTEINASE A
(-)
Bread mold (Rhizopus chinensis) (3)
4APRE:6-174; E:175-323STRUCTURES OF COMPLEXES OF RHIZOPUSPEPSIN WITH PEPSTATIN AND OTHER STATINE-CONTAINING INHIBITORS
5APRE:6-174; E:175-323STRUCTURES OF COMPLEXES OF RHIZOPUSPEPSIN WITH PEPSTATIN AND OTHER STATINE-CONTAINING INHIBITORS
6APRE:6-174; E:175-323STRUCTURES OF COMPLEXES OF RHIZOPUSPEPSIN WITH PEPSTATIN AND OTHER STATINE-CONTAINING INHIBITORS
(-)
Bread wheat (Triticum aestivum) (3)
1T6EX:1-180; X:181-381CRYSTAL STRUCTURE OF THE TRITICUM AESTIVUM XYLANASE INHIBITOR I
1T6GA:1-180; B:1-180; A:181-381; B:181-381CRYSTAL STRUCTURE OF THE TRITICUM AESTIVUM XYLANASE INHIBITOR-I IN COMPLEX WITH ASPERGILLUS NIGER XYLANASE-I
2B42A:1-180; A:181-381CRYSTAL STRUCTURE OF THE TRITICUM XYLANSE INHIBITOR-I IN COMPLEX WITH BACILLUS SUBTILIS XYLANASE
(-)
Candida albicans. Organism_taxid: 5476. (3)
1EAGA:173-342; A:1-172SECRETED ASPARTIC PROTEINASE (SAP2) FROM CANDIDA ALBICANS COMPLEXED WITH A70450
2H6SA:173-342; A:1-172SECRETED ASPARTIC PROTEINASE (SAP) 3 FROM CANDIDA ALBICANS
2H6TA:173-342; A:1-172SECRETED ASPARTIC PROTEINASE (SAP) 3 FROM CANDIDA ALBICANS COMPLEXED WITH PEPSTATIN A
(-)
Candida albicans. Organism_taxid: 5476. Strain: val-1. Variant: pathogenic clinical isolate from skin. (1)
1ZAPA:173-341; A:1-172SECRETED ASPARTIC PROTEASE FROM C. ALBICANS
(-)
Candida parapsilosis. Organism_taxid: 5480. Strain: p-69. (1)
3FV3A:176-339; B:176-339; B:1-175; C:1-175; E:1-175; F:1-175; G:1-175; H:1-175; C:176-339; D:176-339; E:176-339; F:176-339; G:176-339; H:176-339; D:1-175; A:1-175SECRETED ASPARTIC PROTEASE 1 FROM CANDIDA PARAPSILOSIS IN COMPLEX WITH PEPSTATIN A
(-)
Candida tropicalis. Organism_taxid: 5482. (1)
1J71A:174-334; A:1-173STRUCTURE OF THE EXTRACELLULAR ASPARTIC PROTEINASE FROM CANDIDA TROPICALIS YEAST.
(-)
Cattle (Bos taurus) (4)
1CMSA:172-323; A:3-171THE THREE-DIMENSIONAL STRUCTURE OF RECOMBINANT BOVINE CHYMOSIN AT 2.3 ANGSTROMS RESOLUTION
1CZIE:171-325; E:-1-170CHYMOSIN COMPLEX WITH THE INHIBITOR CP-113972
3CMSA:171-325; A:1-170ENGINEERING ENZYME SUB-SITE SPECIFICITY: PREPARATION, KINETIC CHARACTERIZATION AND X-RAY ANALYSIS AT 2.0-ANGSTROMS RESOLUTION OF VAL111PHE SITE-MUTATED CALF CHYMOSIN
4CMSA:171-325; A:1-170X-RAY ANALYSES OF ASPARTIC PROTEINASES IV. STRUCTURE AND REFINEMENT AT 2.2 ANGSTROMS RESOLUTION OF BOVINE CHYMOSIN
(-)
Chesnut blight fungus (Cryphonectria parasitica) (3)
1OD1A:175-330; A:5-174ENDOTHIAPEPSIN PD135,040 COMPLEX
2JJIA:175-329; A:5-174ENDOTHIAPEPSIN IN COMPLEX WITH A GEM-DIOL INHIBITOR.
2JJJA:175-329; A:5-174ENDOTHIAPEPSIN IN COMPLEX WITH A GEM-DIOL INHIBITOR.
(-)
Chestnut blight fungus (Cryphonectria parasitica) (20)
1EEDP:171-326; P:2-170X-RAY CRYSTALLOGRAPHIC ANALYSIS OF INHIBITION OF ENDOTHIAPEPSIN BY CYCLOHEXYL RENIN INHIBITORS
1ENTE:171-326; E:2-170X-RAY ANALYSES OF ASPARTIC PROTEINASES. THE THREE-DIMENSIONAL STRUCTURE AT 2.1 ANGSTROMS RESOLUTION OF ENDOTHIAPEPSIN
1EPNE:171-326; E:2-170A STRUCTURAL COMPARISON OF 21 INHIBITOR COMPLEXES OF THE ASPARTIC PROTEINASE FROM ENDOTHIA PARASITICA
1EPOE:171-326; E:2-170ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) COMPLEXED WITH CP-81,282 (MOR PHE NLE CHF NME)
1EPPE:171-326; E:2-170ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) COMPLEXED WITH PD-130, 693 (MAS PHE LYS+MTF STA MBA)
1EPQE:171-326; E:2-170ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) COMPLEXED WITH PD-133, 450 (SOT PHE GLY+SCC GCL)
1EPRE:171-326; E:2-170ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) COMPLEXED WITH PD-135, 040
1GKTA:175-329; A:5-174NEUTRON LAUE DIFFRACTION STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH TRANSITION STATE ANALOGUE INHIBITOR H261
1OEWA:174-328; A:5-173ATOMIC RESOLUTION STRUCTURE OF NATIVE ENDOTHIAPEPSIN
1OEXA:174-328; A:5-173ATOMIC RESOLUTION STRUCTURE OF ENDOTHIAPEPSIN IN COMPLEX WITH A HYDROXYETHYLENE TRANSITION STATE ANALOGUE INHIBITOR H261
2ER0E:171-326; E:2-170X-RAY STUDIES OF ASPARTIC PROTEINASE-STATINE INHIBITOR COMPLEXES
2ER7E:171-326; E:2-170X-RAY ANALYSES OF ASPARTIC PROTEINASES.III. THREE-DIMENSIONAL STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH A TRANSITION-STATE ISOSTERE INHIBITOR OF RENIN AT 1.6 ANGSTROMS RESOLUTION
2ER9E:171-326; E:2-170X-RAY STUDIES OF ASPARTIC PROTEINASE-STATINE INHIBITOR COMPLEXES.
2V00A:175-330; A:5-174X-RAY CRYSTAL STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH COMPOUND 1
2VS2A:175-329; A:5-174NEUTRON DIFFRACTION STRUCTURE OF ENDOTHIAPEPSIN IN COMPLEX WITH A GEM-DIOL INHIBITOR.
3ER3E:171-326; E:2-170THE ACTIVE SITE OF ASPARTIC PROTEINASES
4ER1E:171-326; E:2-170THE ACTIVE SITE OF ASPARTIC PROTEINASES
4ER2E:171-326; E:2-170THE ACTIVE SITE OF ASPARTIC PROTEINASES
5ER1E:171-326; E:2-170A RATIONAL APPROACH TO THE DESIGN OF ANTIHYPERTENSIVES. X-RAY STUDIES OF COMPLEXES BETWEEN ASPARTIC PROTEINASES AND AMINOALCOHOL RENIN INHIBITORS
5ER2E:171-326; E:2-170HIGH-RESOLUTION X-RAY DIFFRACTION STUDY OF THE COMPLEX BETWEEN ENDOTHIAPEPSIN AND AN OLIGOPEPTIDE INHIBITOR. THE ANALYSIS OF THE INHIBITOR BINDING AND DESCRIPTION OF THE RIGID BODY SHIFT IN THE ENZYME
(-)
Chestnut blight fungus (Endothia parasitica) (5)
1GVTA:175-329; A:5-174ENDOTHIAPEPSIN COMPLEX WITH CP-80,794
1GVUA:175-329; A:5-174ENDOTHIAPEPSIN COMPLEX WITH H189
1GVVA:175-329; A:5-174FIVE ATOMIC RESOLUTION STRUCTURES OF ENDOTHIAPEPSIN INHIBITOR COMPLEXES; IMPLICATIONS FOR THE ASPARTIC PROTEINASE MECHANISM
1GVWA:175-329; A:5-174ENDOTHIAPEPSIN COMPLEX WITH PD-130,328
1GVXA:175-329; A:5-174ENDOTHIAPEPSIN COMPLEXED WITH H256
(-)
Chinensis (Rhizopus microsporus var) (5)
1UH7A:6-174; A:175-323CRYSTAL STRUCTURE OF RHIZOPUSPEPSIN AT PH 4.6
1UH8A:6-174; A:175-323CRYSTAL STRUCTURE OF RHIZOPUSPEPSIN AT PH 8.0
1UH9A:6-174; A:175-323CRYSTAL STRUCTURE OF RHIZOPUSPEPSIN AT PH 7.0
2APRA:6-174; A:175-323STRUCTURE AND REFINEMENT AT 1.8 ANGSTROMS RESOLUTION OF THE ASPARTIC PROTEINASE FROM RHIZOPUS CHINENSIS
3APRE:6-174; E:175-323BINDING OF A REDUCED PEPTIDE INHIBITOR TO THE ASPARTIC PROTEINASE FROM RHIZOPUS CHINENSIS. IMPLICATIONS FOR A MECHANISM OF ACTION
(-)
Cryphonectria parasitica. Organism_taxid: 5116 (1)
4APEA:171-326; A:2-170THE ACTIVE SITE OF ASPARTIC PROTEINASES
(-)
Cryphonectria parasitica. Organism_taxid: 5116. (5)
1EPLE:171-326; E:2-170A STRUCTURAL COMPARISON OF 21 INHIBITOR COMPLEXES OF THE ASPARTIC PROTEINASE FROM ENDOTHIA PARASITICA
1EPME:171-326; E:2-170A STRUCTURAL COMPARISON OF 21 INHIBITOR COMPLEXES OF THE ASPARTIC PROTEINASE FROM ENDOTHIA PARASITICA
2ER6E:171-326; E:2-170THE STRUCTURE OF A SYNTHETIC PEPSIN INHIBITOR COMPLEXED WITH ENDOTHIAPEPSIN.
3ER5E:171-326; E:2-170THE ACTIVE SITE OF ASPARTIC PROTEINASES
4ER4E:171-326; E:2-170HIGH-RESOLUTION X-RAY ANALYSES OF RENIN INHIBITOR-ASPARTIC PROTEINASE COMPLEXES
(-)
Cynara cardunculus. Organism_taxid: 4265. (1)
1B5FB:243-326; D:243-326; C:1-238; A:0-238NATIVE CARDOSIN A FROM CYNARA CARDUNCULUS L.
(-)
Endothia parasitica. Organism_taxid: 5116 (2)
1E81E:171-326; E:2-170ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA-EMD61395
1E82E:171-326; E:2-170ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA-EMD59601
(-)
Endothia parasitica. Organism_taxid: 5116. (2)
1E5OE:171-326; E:2-170ENDOTHIAPEPSIN COMPLEX WITH INHIBITOR DB2
1E80E:171-326; E:2-170ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA-EMD56133
(-)
Equine infectious anemia virus. Organism_taxid: 11665. (2)
1FMBA:1-104EIAV PROTEASE COMPLEXED WITH THE INHIBITOR HBY-793
2FMBA:1-104EIAV PROTEASE COMPLEXED WITH AN INHIBITOR LP-130
(-)
Feline immunodeficiency virus (isolate petaluma). Organism_taxid: 11674. Strain: (isolate petaluma). (2)
5FIVA:5-116STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITH AN EFFICIENT INHIBITOR OF FIV PR
6FIVA:5-116STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITH AN EFFICIENT INHIBITOR OF FIV PR
(-)
Feline immunodeficiency virus (isolate petaluma). Organism_taxid: 11674. Strain: isolate petaluma. (1)
2HAHA:5-116THE STRUCTURE OF FIV 12S PROTEASE IN COMPLEX WITH TL-3
(-)
Feline immunodeficiency virus. Organism_taxid: 11673 (1)
1B11A:4-116STRUCTURE OF FELINE IMMUNODEFICIENCY VIRUS PROTEASE COMPLEXED WITH TL-3-093
(-)
Feline immunodeficiency virus. Organism_taxid: 11673. (2)
1FIVA:4-116STRUCTURE OF AN INHIBITOR COMPLEX OF PROTEINASE FROM FELINE IMMUNODEFICIENCY VIRUS
4FIVA:4-116FIV PROTEASE COMPLEXED WITH AN INHIBITOR LP-130
(-)
Feline immunodeficiency virus. Organism_taxid: 11673. Cell_line: bl21. (2)
2FIVA:4-116; B:4-116CRYSTAL STRUCTURE OF FELINE IMMUNODEFICIENCY VIRUS PROTEASE COMPLEXED WITH A SUBSTRATE
3FIVA:6-116; B:6-116CRYSTAL STRUCTURE OF FELINE IMMUNODEFICIENCY VIRUS PROTEASE COMPLEXED WITH A SUBSTRATE
(-)
Hiv-1 (Human immunodeficiency virus 1) (5)
2QAKA:1-99; B:1-99HIV-1 PR MUTANT IN COMPLEX WITH NELFINAVIR
2QHCA:1-99; B:1-99THE INFLUENCE OF I47A MUTATION ON REDUCED SUSCEPTIBILITY TO THE PROTEASE INHIBITOR LOPINAVIR
2RKFA:1-99; B:1-99HIV-1 PR RESISTANT MUTANT + LPV
2RKGA:1-100; B:1-100HIV-1 PR RESISTANT MUTANT + LPV
3I7EA:1-99; B:1-99CO-CRYSTAL STRUCTURE OF HIV-1 PROTEASE BOUND TO A MUTANT RESISTANT INHIBITOR UIC-98038
(-)
Hiv-1 (Human immunodeficiency virus type 1 (z2/cdc-z34 isolate)) (1)
2WL0A:1-99; B:101-199HIV-1 PROTEASE INHIBITORS CONTAINING A TERTIARY ALCOHOL IN THE TRANSITION-STATE MIMIC WITH IMPROVED CELL-BASED ANTIVIRAL ACTIVITY
(-)
Hiv-1 (Human immunodeficiency virus type 1 ( isolate z2/cdc-z34 group m subtype d)) (1)
2WKZA:1-99; B:101-199HIV-1 PROTEASE INHIBITORS CONTAINING A TERTIARY ALCOHOL IN THE TRANSITION-STATE MIMIC WITH IMPROVED CELL-BASED ANTIVIRAL ACTIVITY
(-)
Hiv-1 (Human immunodeficiency virus type 1 (bru isolate)) (6)
3GGT  [entry was replaced by entry 3U7S without any CATH domain information]
3H5BA:1-99; B:101-199CRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE WITH NOVEL P1'-LIGAND GRL-02031
3I6OA:1-99; B:101-199CRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE WITH MACROCYCLIC INHIBITOR GRL-0216A
3JVWA:1-99; B:101-199HIV-1 PROTEASE MUTANT G86A WITH SYMMETRIC INHIBITOR DMP323
3JVYA:1-99; B:101-199HIV-1 PROTEASE MUTANT G86A WITH DARUNAVIR
3JW2A:1-99; B:101-199HIV-1 PROTEASE MUTANT G86S WITH DARUNAVIR
(-)
Hiv-1 (Human immunodeficiency virus type 1) (14)
2Z54A:1-99; B:1-99THE INFLUENCE OF I47A MUTATION ON REDUCED SUSCEPTIBILITY TO THE PROTEASE INHIBITOR LOPINAVIR
2ZGAA:1-99HIV-1 PROTEASE IN COMPLEX WITH A DIMETHYLALLYL DECORATED PYRROLIDINE BASED INHIBITOR (HEXAGONAL SPACE GROUP)
3CKTA:1-99; B:1-99HIV-1 PROTEASE IN COMPLEX WITH A DIMETHYLALLYL DECORATED PYRROLIDINE BASED INHIBITOR (ORTHOROMBIC SPACE GROUP)
3D1YA:1-99; B:101-199CRYSTAL STRUCTURE OF HIV-1 MUTANT I54V AND INHIBITOR SAQUINA
3D1ZA:1-99; B:1-99CRYSTAL STRUCTURE OF HIV-1 MUTANT I54M AND INHIBITOR DARUNAVIR
3D20A:1-99; B:101-199CRYSTAL STRUCTURE OF HIV-1 MUTANT I54V AND INHIBITOR DARUNAVIA
3DJKA:1-99; B:101-199WILD TYPE HIV-1 PROTEASE WITH POTENT ANTIVIRAL INHIBITOR GRL-0255A
3DK1A:1-99; B:101-199WILD TYPE HIV-1 PROTEASE WITH POTENT ANTIVIRAL INHIBITOR GRL-0105A
3K4VA:1-99; B:1-99; C:1-99; D:1-99NEW CRYSTAL FORM OF HIV-1 PROTEASE/SAQUINAVIR STRUCTURE REVEALS CARBAMYLATION OF N-TERMINAL PROLINE
3KDBA:1-99; B:1-99CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K, L33I, L63I) IN COMPLEX WITH KNI-10006
3KDCA:1-99; B:1-99CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K, L33I, L63I) IN COMPLEX WITH KNI-10074
3KDDA:1-99; B:1-99CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K, L33I, L63I) IN COMPLEX WITH KNI-10265
3KT2A:1-99; A:1001-1099CRYSTAL STRUCTURE OF N88D MUTANT HIV-1 PROTEASE
3KT5A:1-99; A:1001-1099CRYSTAL STRUCTURE OF N88S MUTANT HIV-1 PROTEASE
(-)
Hiv-1 (Human immunodeficiency virus) (4)
1W5VA:1-99; B:1-99HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2-SYMMETRIC INHIBITOR
1W5WA:1-99; B:1-99HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2-SYMMETRIC INHIBITOR
1W5XA:1-99; B:1-99HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2-SYMMETRIC INHIBITOR
1W5YA:1-99; B:1-99HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2-SYMMETRIC INHIBITOR
(-)
Hiv-1 m:b_arv2/sf2. Hiv-1. Organism_taxid: 11685. (4)
3EKPA:1-99; C:1-99; D:1-99; B:1-99CRYSTAL STRUCTURE OF THE INHIBITOR AMPRENAVIR (APV) IN COMPLEX WITH A MULTI-DRUG RESISTANT HIV-1 PROTEASE VARIANT (L10I/G48V/I54V/V64I/V82A)REFER: FLAP+ IN CITATION
3EKTA:1-99; B:1-99; C:1-99; D:1-99CRYSTAL STRUCTURE OF THE INHIBITOR DARUNAVIR (DRV) IN COMPLEX WITH A MULTI-DRUG RESISTANT HIV-1 PROTEASE VARIANT (L10F/G48V/I54V/V64I/V82A) (REFER: FLAP+ IN CITATION.)
3EKWA:1-99; B:1-99CRYSTAL STRUCTURE OF THE INHIBITOR ATAZANAVIR (ATV) IN COMPLEX WITH A MULTI-DRUG RESISTANCE HIV-1 PROTEASE VARIANT (L10I/G48V/I54V/V64I/V82A) REFER: FLAP+ IN CITATION.
3EL0A:1-99; B:1-99CRYSTAL STRUCTURE OF THE INHIBITOR NELFINAVIR (NFV) IN COMPLEX WITH A MULTI-DRUG RESISTANT HIV-1 PROTEASE VARIANT (L10I/G48V/I54V/V64I/V82A) (REFER: FLAP+ IN CITATION)
(-)
Hiv-1 m:b_arv2/sf2. Hiv-1. Organism_taxid: 11685. Strain: hxb2. (11)
3EKQA:1-99; B:1-99CRYSTAL STRUCTURE OF INHIBITOR SAQUINAVIR (SQV) IN COMPLEX WITH MULTI-DRUG RESISTANT HIV-1 PROTEASE (L63P/V82T/I84V) (REFERRED TO AS ACT IN PAPER)
3EKVA:1-99; B:1-99CRYSTAL STRUCTURE OF THE WILD TYPE HIV-1 PROTEASE WITH THE INHIBITOR, AMPRENAVIR
3EKXA:1-99; B:1-99CRYSTAL STRUCTURE OF THE WILD-TYPE HIV-1 PROTEASE WITH THE INHIBITOR, NELFINAVIR
3EKYA:1-99; B:1-99CRYSTAL STRUCTURE OF WILD-TYPE HIV PROTEASE IN COMPLEX WITH THE INHIBITOR, ATAZANAVIR
3EL1A:1-99; B:1-99CRYSTAL STRUCTURE OF WILD-TYPE HIV PROTEASE IN COMPLEX WITH THE INHIBITOR, ATAZANAVIR
3EL4A:1-99; B:1-99CRYSTAL STRUCTURE OF INHIBITOR SAQUINAVIR (SQV) COMPLEXED WITH THE MULTIDRUG HIV-1 PROTEASE VARIANT L63P/V82T/I84V
3EL5A:1-99; B:1-99CRYSTAL STRUCTURE OF NELFINAVIR (NFV) COMPLEXED WITH A MULTIDRUG VARIANT (ACT) (V82T/I84V) OF HIV-1 PROTEASE
3EL9A:1-99; B:1-99CRYSTAL STRUCTURE OF ATAZANAVIR (ATV) IN COMPLEX WITH A MULTIDRUG HIV-1 PROTEASE (V82T/I84V)
3EM3A:1-99; B:1-99CRYSTAL STRUCTURE OF AMPRENAVIR (APV) IN COMPLEX WITH A DRUG RESISTANT HIV-1 PROTEASE VARIANT (I50L/A71V).
3EM4A:1-99; B:1-99; U:1-99; V:1-99CRYSTAL STRUCTURE OF ATAZANAVIR (ATV) IN COMPLEX WITH I50L/A71V DRUG-RESISTANT HIV-1 PROTEASE
3EM6A:1-99; B:1-99CRYSTAL STRUCTURE OF I50L/A71V MUTANT OF HIV-1 PROTEASE IN COMPLEX WITH INHIBITOR DARUNAVIR
(-)
Hiv-1 m:b_arv2/sf2. Organism_taxid: 11685. Strain: sf2. (3)
2NXDA:1-99; B:1-99STRUCTURE OF HIV-1 PROTEASE D25N COMPLEXED WITH RT-RH ANALOGUE PEPTIDE GLY-ALA-ASP-ILE-PHE*TYR-LEU-ASP-GLY-ALA
2NXLA:1-99; B:1-99STRUCTURE OF HIV-1 PROTEASE D25N COMPLEXED WITH THE RT-RH ANALOGUE PEPTIDE GLY-ALA-GLU-VAL-PHE*TYR-VAL-ASP-GLY-ALA
2NXMA:1-99; B:1-99STRUCTURE OF HIV-1 PROTEASE D25N COMPLEXED WITH THE RT-RH ANALOGUE PEPTIDE GLY-ALA-GLN-THR-PHE*TYR-VAL-ASP-GLY-ALA
(-)
Hiv-1 m:b_hxb2r. Organism_taxid: 11706. (1)
1ODYA:1-99; B:1-99HIV-1 PROTEASE COMPLEXED WITH AN INHIBITOR LP-130
(-)
Hiv-1 m:b_hxb2r. Organism_taxid: 11706. Cell_line: s2. (1)
3PHVA:1-99X-RAY ANALYSIS OF HIV-1 PROTEINASE AT 2.7 ANGSTROMS RESOLUTION CONFIRMS STRUCTURAL HOMOLOGY AMONG RETROVIRAL ENZYMES
(-)
Homo sapiens. Organism_taxid: 9606. (4)
2VA6A:14-146; A:147-386X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 24
3DUYA:14-146; B:14-146; A:147-385; B:147-385; C:147-385; C:14-146CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE IN COMPLEX WITH NVP-AFJ144
3DV1A:14-146; A:147-385; B:147-386; C:147-385; B:14-146; C:14-146CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE IN COMPLEX WITH NVP-ARV999
3DV5A:14-146; A:147-385; B:147-385; C:147-385; B:14-146; C:14-146CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE IN COMPLEX WITH NVP-BAV544
(-)
House mouse (Mus musculus) (1)
1SMRA:171-325; C:171-325; E:171-325; G:171-325; A:1-170; C:1-170; E:1-170; G:1-170THE 3-D STRUCTURE OF MOUSE SUBMAXILLARY RENIN COMPLEXED WITH A DECAPEPTIDE INHIBITOR CH-66 BASED ON THE 4-16 FRAGMENT OF RAT ANGIOTENSINOGEN
(-)
Human (Homo sapiens) (161)
1AVFA:172-327; J:172-328; A:2-171; J:2-171ACTIVATION INTERMEDIATE 2 OF HUMAN GASTRICSIN FROM HUMAN STOMACH
1BBSA:171-325; A:1-170X-RAY ANALYSES OF PEPTIDE INHIBITOR COMPLEXES DEFINE THE STRUCTURAL BASIS OF SPECIFICITY FOR HUMAN AND MOUSE RENINS
1BILA:171-325; B:171-325; B:1-170; A:1-170CRYSTALLOGRAPHIC STUDIES ON THE BINDING MODES OF P2-P3 BUTANEDIAMIDE RENIN INHIBITORS
1BIMA:171-325; B:171-325; B:1-170; A:1-170CRYSTALLOGRAPHIC STUDIES ON THE BINDING MODES OF P2-P3 BUTANEDIAMIDE RENIN INHIBITORS
1FKNA:14-146; B:14-146; A:147-385; B:147-385STRUCTURE OF BETA-SECRETASE COMPLEXED WITH INHIBITOR
1FLHA:171-325; A:1-170CRYSTAL STRUCTURE OF HUMAN UROPEPSIN AT 2.45 A RESOLUTION
1HRNA:171-325; B:171-325; B:1-170; A:1-170HIGH RESOLUTION CRYSTAL STRUCTURES OF RECOMBINANT HUMAN RENIN IN COMPLEX WITH POLYHYDROXYMONOAMIDE INHIBITORS
1HTRB:172-328; B:1-171CRYSTAL AND MOLECULAR STRUCTURES OF HUMAN PROGASTRICSIN AT 1.62 ANGSTROMS RESOLUTION
1LYAA:1-97; C:1-97; B:106-346; D:106-346CRYSTAL STRUCTURES OF NATIVE AND INHIBITED FORMS OF HUMAN CATHEPSIN D: IMPLICATIONS FOR LYSOSOMAL TARGETING AND DRUG DESIGN
1LYBA:1-97; C:1-97; B:106-346; D:106-346CRYSTAL STRUCTURES OF NATIVE AND INHIBITED FORMS OF HUMAN CATHEPSIN D: IMPLICATIONS FOR LYSOSOMAL TARGETING AND DRUG DESIGN
1LYWA:3-97; C:3-97; E:3-97; G:3-97; B:106-346; D:106-346; F:106-346; H:106-346CATHEPSIN D AT PH 7.5
1M4HA:14-146; A:147-385; B:147-385; B:14-146CRYSTAL STRUCTURE OF BETA-SECRETASE COMPLEXED WITH INHIBITOR OM00-3
1PSNA:171-325; A:1-170THE CRYSTAL STRUCTURE OF HUMAN PEPSIN AND ITS COMPLEX WITH PEPSTATIN
1PSOE:171-325; E:1-170THE CRYSTAL STRUCTURE OF HUMAN PEPSIN AND ITS COMPLEX WITH PEPSTATIN
1Q9PA:1-95SOLUTION STRUCTURE OF THE MATURE HIV-1 PROTEASE MONOMER
1QRPE:171-325; E:1-170HUMAN PEPSIN 3A IN COMPLEX WITH A PHOSPHONATE INHIBITOR IVA-VAL-VAL-LEU(P)-(O)PHE-ALA-ALA-OME
1RNEA:171-325; A:1-170THE CRYSTAL STRUCTURE OF RECOMBINANT GLYCOSYLATED HUMAN RENIN ALONE AND IN COMPLEX WITH A TRANSITION STATE ANALOG INHIBITOR
1SGZA:14-146; A:147-385; B:147-385; C:147-385; D:147-385; B:14-146; C:14-146; D:14-146CRYSTAL STRUCTURE OF UNBOUND BETA-SECRETASE CATALYTIC DOMAIN.
1TQFA:14-146; A:147-385CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR
1W50A:14-146; A:147-385APO STRUCTURE OF BACE (BETA SECRETASE)
1W51A:14-146; A:147-385BACE (BETA SECRETASE) IN COMPLEX WITH A NANOMOLAR NON-PEPTIDIC INHIBITOR
1XN2A:14-146; B:14-146; A:147-385; B:147-385; C:147-385; D:147-385; C:14-146; D:14-146NEW SUBSTRATE BINDING POCKETS FOR BETA-SECRETASE.
1XN3A:14-146; A:147-385; B:147-385; C:147-385; D:147-385; B:14-146; C:14-146; D:14-146CRYSTAL STRUCTURE OF BETA-SECRETASE BOUND TO A LONG INHIBITOR WITH ADDITIONAL UPSTREAM RESIDUES.
1XS7D:14-146; D:147-385CRYSTAL STRUCTURE OF A CYCLOAMIDE-URETHANE-DERIVED NOVEL INHIBITOR BOUND TO HUMAN BRAIN MEMAPSIN 2 (BETA-SECRETASE).
1YM2A:14-146; A:147-385; C:147-385; B:147-385; B:14-146; C:14-146CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH NVP-AUR200
1YM4A:14-146; B:14-146; C:14-146; B:147-385; A:147-385; C:147-385CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH NVP-AMK640
2B8LA:14-146; A:147-385CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR
2B8VA:14-146; A:147-385CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE COMPLEXED WITH L-L000430,469
2EWYA:30-162; B:30-162; C:30-162; D:30-162; A:163-398; B:163-398; C:163-398; D:163-398CRYSTAL STRUCTURE OF HUMAN BACE2 IN COMPLEX WITH A HYDROXYETHYLENAMINE TRANSITION-STATE INHIBITOR
2F3EA:14-146; A:147-385; B:147-385; C:147-385; B:14-146; C:14-146CRYSTAL STRUCTURE OF THE BACE COMPLEX WITH AXQ093, A MACROCYCLIC INHIBITOR
2F3FA:14-146; B:14-146; C:14-146; A:147-385; B:147-385; C:147-385CRYSTAL STRUCTURE OF THE BACE COMPLEX WITH BDF488, A MACROCYCLIC INHIBITOR
2FDPA:14-146; B:14-146; C:14-146; B:147-385; A:147-385; C:147-385CRYSTAL STRUCTURE OF BETA-SECRETASE COMPLEXED WITH AN AMINO-ETHYLENE INHIBITOR
2FS4A:175-332; B:175-332; A:3-174; B:3-174KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE C RING
2G1NA:177-334; B:177-334; A:3-176; B:3-176KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE "C" RING
2G1OA:177-334; B:177-334; A:3-176; B:3-176KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE "C" RING
2G1RA:177-334; B:177-334; A:3-176; B:3-176KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE C RING
2G1SA:177-334; B:177-334; A:3-176; B:3-176KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE C RING
2G1YA:177-334; B:177-334; A:3-176; B:3-176KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE "C" RING
2G20A:177-334; B:177-334; A:3-176; B:3-176KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE C RING
2G21A:175-332; B:175-332; A:3-174; B:3-174KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE "C" RING
2G22A:177-334; B:177-334; A:3-176; B:3-176KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE "C" RING
2G24A:175-332; B:175-332; A:3-174; B:3-174KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE "C" RING
2G26A:175-332; B:175-332; A:3-174; B:3-174KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE "C" RING
2G27A:175-332; B:175-332; A:3-174; B:3-174KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE "C" RING
2G94A:14-146; B:14-146; C:14-146; D:14-146; A:147-385; B:147-385; C:147-385; D:147-385CRYSTAL STRUCTURE OF BETA-SECRETASE BOUND TO A POTENT AND HIGHLY SELECTIVE INHIBITOR.
2HIZA:14-146; B:14-146; C:14-146; A:147-385; B:147-386; C:147-386CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE (BACE) IN THE PRESENCE OF AN INHIBITOR
2HM1A:14-146; A:147-386CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE (BACE) IN THE PRESENCE OF AN INHIBITOR (2)
2I4QA:177-335; B:177-335; A:0-176; B:0-176HUMAN RENIN/PF02342674 COMPLEX
2IQGA:14-146; A:147-386CRYSTAL STRUCTURE OF HYDROXYETHYL SECONDARY AMINE-BASED PEPTIDOMIMETIC INHIBITOR OF HUMAN BETA-SECRETASE (BACE)
2IRZA:14-146; A:147-385CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE COMPLEXED WITH INHIBITOR
2IS0A:14-146; A:147-385CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE COMPLEXED WITH INHIBITOR
2NTRA:14-146; A:147-385CRYSTAL STRUCTURE OF HUMAN BACE-1 BOUND TO INHIBITOR
2OAHA:14-146; A:147-385CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR
2OF0A:14-146; A:147-385X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 5
2OHKA:14-146; A:147-385X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH 1-AMINO-ISOQUINOLINE
2OHLA:14-146; A:147-385X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH 2-AMINOQUINOLINE
2OHMA:14-146; A:147-385X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH N~3~-BENZYLPYRIDINE-2,3-DIAMINE
2OHNA:14-146; A:147-385X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH 4-(4-FLUOROBENZYL)PIPERIDINE
2OHPA:14-146; A:147-385X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 3
2OHQA:14-146; A:147-385X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 4
2OHRA:14-146; A:147-385X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 6A
2OHSA:14-146; A:147-385X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 6B
2OHTA:14-146; A:147-385X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 7
2OHUA:14-146; A:147-385X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 8B
2P4JA:14-146; B:14-146; C:14-146; D:14-146; A:147-385; B:147-385; C:147-385; D:147-385CRYSTAL STRUCTURE OF BETA-SECRETASE BOND TO AN INHIBITOR WITH ISOPHTHALAMIDE DERIVATIVES AT P2-P3
2P83A:14-146; B:14-146; C:14-146; A:147-385; B:147-386; C:147-386POTENT AND SELECTIVE ISOPHTHALAMIDE S2 HYDROXYETHYLAMINE INHIBITOR OF BACE1
2P8HA:14-146; A:147-385CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR
2PH6A:14-146; A:147-385CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR
2PH8A:14-146; A:147-385CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR
2Q11A:14-146; B:14-146; C:14-146; A:147-385; B:147-385; C:147-385STRUCTURE OF BACE COMPLEXED TO COMPOUND 1
2Q15A:14-146; A:147-385STRUCTURE OF BACE COMPLEXED TO COMPOUND 3A
2QK5A:75-207; B:208-446; A:208-447; B:75-207STRUCTURE OF BACE1 BOUND TO SCH626485
2QMDA:75-207; B:208-446; A:208-447; B:75-207STRUCTURE OF BACE BOUND TO SCH722924
2QMFA:75-207; B:75-207; B:208-446; A:208-447STRUCTURE OF BACE BOUND TO SCH735310
2QMGA:75-207; B:75-207; B:208-446; A:208-447STRUCTURE OF BACE BOUND TO SCH745966
2QP8A:75-207; B:75-207; B:208-446; A:208-447STRUCTURE OF BACE BOUND TO SCH734723
2QU2A:76-208; A:209-445BACE1 WITH COMPOUND 1
2QU3A:76-208; A:209-445BACE1 WITH COMPOUND 2
2QZKA:14-146; A:147-385CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH I21
2QZLA:14-146; A:147-385CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH IXS
2RENA:182-337; A:7-181STRUCTURE OF RECOMBINANT HUMAN RENIN, A TARGET FOR CARDIOVASCULAR-ACTIVE DRUGS, AT 2.5 ANGSTROMS RESOLUTION
2VA5A:14-146; A:147-386X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 8C
2VA7A:14-146; A:147-386X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 27
2VIEA:75-207; A:208-447HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-1-BENZYL-2-HYDROXY-3-((1,1,5-TRIMETHYLHEXYL)AMINO)PROPYL)-3-(ETHYLAMINO)-5-(2-OXOPYRROLIDIN-1-YL)BENZAMIDE
2VIJA:75-207; A:208-447HUMAN BACE-1 IN COMPLEX WITH 3-(1,1-DIOXIDOTETRAHYDRO-2H-1, 2-THIAZIN-2-YL)-5-(ETHYLAMINO)-N-((1S,2R)-2-HYDROXY-1-( PHENYLMETHYL)-3-(1,2,3,4-TETRAHYDRO-1-NAPHTHALENYLAMINO) PROPYL)BENZAMIDE
2VIYA:75-207; A:208-447HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(((1S)-2-( CYCLOHEXYLAMINO)-1-METHYL-2-OXOETHYL)AMINO)-2-HYDROXY-1-( PHENYLMETHYL)PROPYL)-3-(PENTYLSULFONYL)BENZAMIDE
2VIZA:75-207; A:208-447HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(((1S)-2-( CYCLOHEXYLAMINO)-1-METHYL-2-OXOETHYL)AMINO)-2-HYDROXY-1-( PHENYLMETHYL)PROPYL)-3-(2-OXO-1-PYRROLIDINYL)-5-(PROPYLOXY) BENZAMIDE
2VJ6A:75-207; A:208-447HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(((1S)-2-( CYCLOHEXYLAMINO)-1-METHYL-2-OXOETHYL)AMINO)-2-HYDROXY-1-( PHENYLMETHYL)PROPYL)-3-(ETHYLAMINO)-5-(2-OXO-1-PYRROLIDINYL)BENZAMIDE
2VJ7A:75-207; A:208-447HUMAN BACE-1 IN COMPLEX WITH 3-(ETHYLAMINO)-N-((1S,2R)-2-HYDROXY-1-(PHENYLMETHYL)-3-(((3-(TRIFLUOROMETHYL)PHENYL) METHYL)AMINO)PROPYL)-5-(2-OXO-1-PYRROLIDINYL)BENZAMIDE
2VJ9A:75-207; A:208-451HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(CYCLOHEXYLAMINO)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-3-(ETHYLAMINO)-5-(2-OXO-1-PYRROLIDINYL)BENZAMIDE
2VKMA:14-146; A:147-385; B:147-385; C:147-385; D:147-385; B:14-146; C:14-146; D:14-146CRYSTAL STRUCTURE OF GRL-8234 BOUND TO BACE (BETA-SECRETASE)
2VNMA:75-207; A:208-447HUMAN BACE-1 IN COMPLEX WITH 3-(1,1-DIOXIDOTETRAHYDRO-2H-1, 2-THIAZIN-2-YL)-5-(ETHYLAMINO)-N-((1S,2R)-2-HYDROXY-1-( PHENYLMETHYL)-3-(((3-(TRIFLUOROMETHYL)PHENYL)METHYL)AMINO) PROPYL)BENZAMIDE
2VNNA:75-207; A:208-447HUMAN BACE-1 IN COMPLEX WITH 7-ETHYL-N-((1S,2R)-2-HYDROXY-1-(PHENYLMETHYL)-3-(((3-(TRIFLUOROMETHYL)PHENYL)METHYL)AMINO) PROPYL)-1-METHYL-3,4-DIHYDRO-1H-(1,2,5)THIADIAZEPINO(3,4,5-HI)INDOLE-9-CARBOXAMIDE 2,2-DIOXIDE
2WEZA:75-207; A:208-447HUMAN BACE-1 IN COMPLEX WITH 1-ETHYL-N-((1S,2R)-2-HYDROXY-3-(((3-(METHYLOXY)PHENYL)METHYL)AMINO)-1-(PHENYLMETHYL) PROPYL)-4-(2-OXO-1-PYRROLIDINYL)-1H-INDOLE-6-CARBOXAMIDE
2WF0A:75-207; A:208-447HUMAN BACE-1 IN COMPLEX WITH 4-ETHYL-N-((1S,2R)-2-HYDROXY-1-(PHENYLMETHYL)-3-(((3-(TRIFLUOROMETHYL)PHENYL)METHYL)AMINO) PROPYL)-8-(2-OXO-1-PYRROLIDINYL)-6-QUINOLINECARBOXAMIDE
2WF1A:75-207; A:208-447HUMAN BACE-1 IN COMPLEX WITH 7-ETHYL-N-((1S,2R)-2-HYDROXY-3-(((3-(METHYLOXY)PHENYL(METHYL)AMINO)-1-(PHENYLMETHYL) PROPYL)-1-METHYL-3,4-DIHYDRO-1H-(1,2,5)THIADIAZEPINO(3,4,5-HI)INDOLE-9-CARBOXAMIDE 2,2-DIOXIDE
2WF2A:75-207; A:208-447HUMAN BACE-1 IN COMPLEX WITH 8-ETHYL-N-((1S,2R)-2-HYDROXY-3-(((3-(METHYLOXY)PHENYL)METHYL)AMINO)-1-(PHENYLMETHYL) PROPYL)-1-METHYL-3,4,7,8-TETRAHYDRO-1H,6H-(1,2,5) THIADIAZEPINO(5,4,3-DE)QUINOXALINE-10-CARBOXAMIDE 2,2-DIOXIDE
2WF3A:75-207; A:208-447HUMAN BACE-1 IN COMPLEX WITH 6-(ETHYLAMINO)-N-((1S,2R)-2-HYDROXY-3-(((3-(METHYLOXY)PHENYL)METHYL)AMINO)-1-(PHENYLMETHYL)PROPYL)-1-METHYL-1, 3,4,5-TETRAHYDRO-2,1-BENZOTHIAZEPINE-8-CARBOXAMIDE 2,2-DIOXIDE
2WF4A:75-207; A:208-447HUMAN BACE-1 IN COMPLEX WITH 6-ETHYL-1-METHYL-N-((1S)-2-OXO-1-(PHENYLMETHYL)-3-(TETRAHYDRO-2H-PYRAN-4-YLAMINO)PROPYL)-1,3,4,6-TETRAHYDRO(1,2)THIAZEPINO(5,4,3-CD)INDOLE-8-CARBOXAMIDE 2,2-DIOXIDE
2WJOA:14-146; A:147-388HUMAN BACE (BETA SECRETASE) IN COMPLEX WITH CYCLOHEXANECARBOXYLIC ACID (2-(2-AM INO-6-PHENOXY-4H-QUINAZOLIN-3-YL)-2-CYCLOHEXYL-ETHYL)-AMIDE
2XFIA:75-207; A:208-447HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(((1S)-2-( CYCLOHEXYLAMINO)-1-METHYL-2-OXOETHYL)AMINO)-2-HYDROXY-1-( PHENYLMETHYL)PROPYL)-3-((METHYLSULFONYL)(PHENYL)AMINO) BENZAMIDE
2XFJA:75-207; A:208-447HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(((1S)-2-( CYCLOHEXYLAMINO)-1-METHYL-2-OXOETHYL)AMINO)-2-HYDROXY-1-( PHENYLMETHYL)PROPYL)-3-(ETHYLAMINO)-5-(2-OXO-1-PYRROLIDINYL)BENZAMIDE
2XFKA:75-207; A:208-447HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(((1S)-2-( CYCLOHEXYLAMINO)-1-METHYL-2-OXOETHYL)AMINO)-2-HYDROXY-1-( PHENYLMETHYL)PROPYL)-3-(ETHYLAMINO)-5-((METHYLSULFONYL)( PHENYL)AMINO)BENZAMIDE
2ZDZA:76-208; A:209-446X-RAY STRUCTURE OF BACE-1 IN COMPLEX WITH COMPOUND 3.B.10
2ZE1A:76-208; A:209-446X-RAY STRUCTURE OF BACE-1 IN COMPLEX WITH COMPOUND 6G
2ZHRA:14-146; B:14-146; B:147-385; A:147-385CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH OM99-2 AT PH 5.0
2ZHSA:14-146; A:147-385CRYSTAL STRUCTURE OF BACE1 AT PH 4.0
2ZHTA:14-146; A:147-385CRYSTAL STRUCTURE OF BACE1 AT PH 4.5
2ZHUA:14-146; A:147-385CRYSTAL STRUCTURE OF BACE1 AT PH 5.0
2ZHVA:14-146; A:147-385CRYSTAL STRUCTURE OF BACE1 AT PH 7.0
2ZJHA:14-146; A:147-385CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH N-(1-BENZYL-PIPERIDIN-4-YL)-4-MERCAPTO-BUTYRAMIDE
2ZJIA:14-146; A:147-385CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH N-[1-(2,6-DIMETHOXY-BENZYL)-PIPERIDIN-4-YL]-4-MERCAPTO-BUTYRAMIDE
2ZJJA:14-146; A:147-385CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH 4-(4-FLUORO-BENZYL)-PIPERAZINE-2-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE
2ZJKA:14-146; B:14-146; C:14-146; B:147-385; A:147-385; C:147-385CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH 4-(4-FLUORO-BENZYL)-PIPERAZINE-2-CARBOXYLIC ACID(3-MERCAPTO-PROPYL)-AMIDE
2ZJLA:14-146; A:147-385CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH N-[1-(5-BROMO-2,3-DIMETHOXY-BENZYL)-PIPERIDIN-4-YL]-4-MERCAPTO-BUTYRAMIDE
2ZJMA:14-146; A:147-385CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH N-[1-(5-CHLORO-2-ISOPROPOXY-3-METHOXY-BENZYL)-PIPERIDIN-4-YL]-2-(4-SULFAMOYL-PHENOXY)-ACETAMIDE
2ZJNA:14-146; A:147-385CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH N-[1-(5-CHLORO-2-ISOPROPOXY-3-METHOXY-BENZYL)-PIPERIDIN-4-YL]-2-(2-METHYL-4-SULFAMOYL-PHENOXY)-ACETAMIDE
3BRAA:14-146; A:147-386BACE-1 COMPLEXED WITH COMPOUND 1
3BUFA:14-146; A:147-386BACE-1 COMPLEXED WITH COMPOUND 2
3BUGA:14-146; A:147-386BACE-1 COMPLEXED WITH COMPOUND 3
3BUHA:14-146; A:147-386BACE-1 COMPLEXED WITH COMPOUND 4
3CIBA:75-207; B:75-207; B:208-446; A:208-447STRUCTURE OF BACE BOUND TO SCH727596
3CICA:75-207; B:75-207; B:208-446; A:208-447STRUCTURE OF BACE BOUND TO SCH709583
3CIDA:75-207; B:75-207; B:208-446; A:208-447STRUCTURE OF BACE BOUND TO SCH726222
3CKPA:14-146; B:14-146; C:14-146; C:147-386; A:147-386; B:147-386CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH INHIBITOR
3CKRA:14-146; B:14-146; C:14-146; C:147-386; A:147-386; B:147-386CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH INHIBITOR
3DM6A:14-146; B:14-146; C:14-146; C:147-385; B:147-385; A:147-385BETA-SECRETASE 1 COMPLEXED WITH STATINE-BASED INHIBITOR
3EXOA:14-146; A:147-385CRYSTAL STRUCTURE OF BACE1 BOUND TO INHIBITOR
3FKTA:34-166; A:167-403CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH SPIROPIPERDINE IMINOHYDANTOIN INHIBITOR
3GW5A:182-339; B:182-339; B:7-181; A:7-181CRYSTAL STRUCTURE OF HUMAN RENIN COMPLEXED WITH A NOVEL INHIBITOR
3H0BA:14-146; B:14-146; C:14-146; A:147-385; B:147-385; C:147-385DISCOVERY OF AMINOHETEROCYCLES AS A NOVEL BETA-SECRETASE INHIBITOR CLASS
3HVGA:14-146; B:14-146; C:14-146; B:147-385; C:147-385; A:147-385STRUCTURE OF BACE (BETA SECRETASE) IN COMPLEX WITH EV0
3HW1A:14-146; C:14-146; B:14-146; A:147-385; B:147-385; C:147-385STRUCTURE OF BACE (BETA SECRETASE) IN COMPLEX WITH LIGAND EV2
3I25A:14-146; A:147-385; B:147-385; C:147-385; B:14-146; C:14-146POTENT BETA-SECRETASE 1 HYDROXYETHYLENE INHIBITOR
3IGBA:76-208; A:209-447BACE-1 WITH COMPOUND 3
3IN3A:76-208; A:209-446BACE1 WITH COMPOUND 30
3IN4A:76-208; A:209-446BACE1 WITH COMPOUND 38
3INDA:76-208; A:209-448BACE1 WITH THE AMINOHYDANTOIN COMPOUND 29
3INEA:76-208; A:209-447BACE1 WITH THE AMINOHYDANTOIN COMPOUND S-34
3INFA:76-208; A:209-448BACE1 WITH THE AMINOHYDANTOIN COMPOUND 37
3INHA:76-208; A:209-448BACE1 WITH THE AMINOHYDANTOIN COMPOUND R-58
3IVHA:75-207; A:208-447DESIGN AND SYNTHESIS OF POTENT BACE-1 INHIBITORS WITH CELLULAR ACTIVITY: STRUCTURE-ACTIVITY RELATIONSHIP OF P1 SUBSTITUENTS
3IVIA:75-207; C:208-447; B:208-447; A:208-447; B:75-207; C:75-207DESIGN AND SYNTHESIS OF POTENT BACE-1 INHIBITORS WITH CELLULAR ACTIVITY: STRUCTURE-ACTIVITY RELATIONSHIP OF P1 SUBSTITUENTS
3IXJA:62-194; C:195-433; A:195-433; B:195-433; B:62-194; C:62-194CRYSTAL STRUCTURE OF BETA-SECRETASE 1 IN COMPLEX WITH SELECTIVE BETA-SECRETASE 1 INHIBITOR
3K5CA:14-146; A:147-385; B:147-385; C:147-385; B:14-146; C:14-146HUMAN BACE-1 COMPLEX WITH NB-216
3K5DA:14-146; B:14-146; C:14-146; A:147-385; B:147-385; C:147-386CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH AHM178
3K5FA:14-146; B:14-146; C:14-146; A:147-385; B:147-385; C:147-385HUMAN BACE-1 COMPLEX WITH AYH011
3K5GA:14-146; A:147-385; B:147-385; C:147-385; B:14-146; C:14-146HUMAN BACE-1 COMPLEX WITH BJC060
3KM4A:182-339; B:182-339; B:7-181; A:7-181OPTIMIZATION OF ORALLY BIOAVAILABLE ALKYL AMINE RENIN INHIBITORS
3KMXA:75-207; B:208-446; A:208-447; B:75-207STRUCTURE OF BACE BOUND TO SCH346572
3KMYA:75-207; B:208-446; A:208-447; B:75-207STRUCTURE OF BACE BOUND TO SCH12472
3KN0B:75-207; B:208-446; A:208-447; A:75-207STRUCTURE OF BACE BOUND TO SCH708236
3L38A:76-208; A:209-445BACE1 IN COMPLEX WITH THE AMINOPYRIDINE COMPOUND 44
3L3AA:76-208; A:209-446BACE-1 WITH THE AMINOPYRIDINE COMPOUND 32
3L58A:75-207; B:75-207; B:208-446; A:208-447STRUCTURE OF BACE BOUND TO SCH589432
3L59A:75-207; B:208-446; A:208-447; B:75-207STRUCTURE OF BACE BOUND TO SCH710413
3L5BA:75-207; B:75-207; B:208-446; A:208-447STRUCTURE OF BACE BOUND TO SCH713601
3L5CB:75-207; A:75-207; B:208-446; A:208-447STRUCTURE OF BACE BOUND TO SCH723871
3L5DB:75-207; A:75-207; B:208-446; A:208-447STRUCTURE OF BACE BOUND TO SCH723873
3L5EA:75-207; B:75-207; B:208-446; A:208-447STRUCTURE OF BACE BOUND TO SCH736062
3L5FA:75-207; B:75-207; B:208-446; A:208-447STRUCTURE OF BACE BOUND TO SCH736201
(-)
Human immunodeficiency virus 1 (1)
2QMPA:1-99; B:1-99CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH PL-100
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. (1)
2JE4A:1-99; B:1-99ATOMIC-RESOLUTION CRYSTAL STRUCTURE OF CHEMICALLY-SYNTHESIZED HIV-1 PROTEASE IN COMPLEX WITH JG-365
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. (92)
1B6JA:1-99; B:101-199HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 1
1B6KA:1-99; B:101-199HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 5
1B6LA:1-99; B:101-199HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 4
1B6MA:1-99; B:101-199HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 6
1B6PA:1-99; B:101-199HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 7
1C6XA:1-99; B:201-299ALTERNATE BINDING SITE FOR THE P1-P3 GROUP OF A CLASS OF POTENT HIV-1 PROTEASE INHIBITORS AS A RESULT OF CONCERTED STRUCTURAL CHANGE IN 80'S LOOP.
1C6YA:1-99; B:201-299ALTERNATE BINDING SITE FOR THE P1-P3 GROUP OF A CLASS OF POTENT HIV-1 PROTEASE INHIBITORS AS A RESULT OF CONCERTED STRUCTURAL CHANGE IN 80'S LOOP.
1C6ZA:1-99; B:201-299ALTERNATE BINDING SITE FOR THE P1-P3 GROUP OF A CLASS OF POTENT HIV-1 PROTEASE INHIBITORS AS A RESULT OF CONCERTED STRUCTURAL CHANGE IN 80'S LOOP.
1C70A:1-99; B:201-299ALTERNATE BINDING SITE FOR THE P1-P3 GROUP OF A CLASS OF POTENT HIV-1 PROTEASE INHIBITORS AS A RESULT OF CONCERTED STRUCTURAL CHANGE IN 80'S LOOP.
1HBVA:1-99; B:1-99A CHECK ON RATIONAL DRUG DESIGN. CRYSTAL STRUCTURE OF A COMPLEX OF HIV-1 PROTEASE WITH A NOVEL GAMMA-TURN MIMETIC
1HSGA:1-99; B:1-99CRYSTAL STRUCTURE AT 1.9 ANGSTROMS RESOLUTION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) II PROTEASE COMPLEXED WITH L-735,524, AN ORALLY BIOAVAILABLE INHIBITOR OF THE HIV PROTEASES
1HSHA:1-99; B:1-99; C:1-99; D:1-99CRYSTAL STRUCTURE AT 1.9 ANGSTROMS RESOLUTION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) II PROTEASE COMPLEXED WITH L-735,524, AN ORALLY BIOAVAILABLE INHIBITOR OF THE HIV PROTEASES
1HVCA:1A-99A; A:1B-99BCRYSTAL STRUCTURE OF A TETHERED DIMER OF HIV-1 PROTEASE COMPLEXED WITH AN INHIBITOR
1K6CA:1-99; B:1-99LACK OF SYNERGY FOR INHIBITORS TARGETING A MULTI-DRUG RESISTANT HIV-1 PROTEASE
1K6PA:1-99; B:1-99LACK OF SYNERGY FOR INHIBITORS TARGETING A MULTI-DRUG RESISTANT HIV-1 PROTEASE
1K6TA:1-99; B:1-99LACK OF SYNERGY FOR INHIBITORS TARGETING A MULTI-DRUG RESISTANT HIV-1 PROTEASE
1K6VA:1-99; B:1-99LACK OF SYNERGY FOR INHIBITORS TARGETING A MULTI-DRUG RESISTANT HIV-1 PROTEASE
1KJ4A:1-99; B:1-99; C:1-99; D:1-99SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES
1KJ7A:1-99; B:1-99SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES
1KJFA:1-99; B:1-99SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES
1KJGA:1-99; B:1-99SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES
1KJHA:1-99; B:1-99SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES
1N49A:1-99; B:1-99; C:1-99; D:1-99VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE VARIANT: STRUCTURAL INSIGHTS FOR BETTER ANTI-VIRAL THERAPY
1NPAA:1-99; B:1-99CRYSTAL STRUCTURE OF HIV-1 PROTEASE-HUP
1NPVA:1-99; B:201-299CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH LDC271
1NPWA:1-99; B:201-299CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITH LGZ479
1ODWA:1-99; B:1-99NATIVE HIV-1 PROTEINASE
1ODXA:1-99; B:1-99HIV-1 PROTEINASE MUTANT A71T, V82A
1RL8A:1-99; B:1-99CRYSTAL STRUCTURE OF THE COMPLEX OF RESISTANT STRAIN OF HIV-1 PROTEASE(V82A MUTANT) WITH RITONAVIR
1RPIA:1-99; B:1-99CRYSTAL STRUCTURES OF A MULTIDRUG-RESISTANT HIV-1 PROTEASE REVEAL AN EXPANDED ACTIVE SITE CAVITY
1RQ9A:1-99; B:1-99CRYSTAL STRUCTURES OF A MULTIDRUG-RESISTANT HIV-1 PROTEASE REVEAL AN EXPANDED ACTIVE SITE CAVITY
1RV7A:1-99; B:1-99CRYSTAL STRUCTURES OF A MULTIDRUG-RESISTANT HIV-1 PROTEASE REVEAL AN EXPANDED ACTIVE SITE CAVITY
1SDTA:1-99; B:101-199CRYSTAL STRUCTURES OF HIV PROTEASE V82A AND L90M MUTANTS REVEAL CHANGES IN INDINAVIR BINDING SITE.
1SDUA:1-99; B:101-199CRYSTAL STRUCTURES OF HIV PROTEASE V82A AND L90M MUTANTS REVEAL CHANGES IN INDINAVIR BINDING SITE.
1SDVA:1-99; B:101-199CRYSTAL STRUCTURES OF HIV PROTEASE V82A AND L90M MUTANTS REVEAL CHANGES IN INDINAVIR BINDING SITE.
1SP5A:1-99; B:1-99CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH A PRODUCT OF AUTOPROTEOLYSIS
1T3RA:1-99; B:1-99HIV PROTEASE WILD-TYPE IN COMPLEX WITH TMC114 INHIBITOR
1T7IA:1-99; B:1-99THE STRUCTURAL AND THERMODYNAMIC BASIS FOR THE BINDING OF TMC114, A NEXT-GENERATION HIV-1 PROTEASE INHIBITOR.
1T7JA:1-99; B:1-99CRYSTAL STRUCTURE OF INHIBITOR AMPRENAVIR IN COMPLEX WITH A MULTI-DRUG RESISTANT VARIANT OF HIV-1 PROTEASE (L63P/V82T/I84V)
1T7KA:1-99; B:1-99CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITH ARYLSULFONAMIDE AZACYCLIC UREA
1TCXA:1-99; B:1-99HIV TRIPLE MUTANT PROTEASE COMPLEXED WITH INHIBITOR SB203386
1TW7A:1-99; B:1-99WIDE OPEN 1.3A STRUCTURE OF A MULTI-DRUG RESISTANT HIV-1 PROTEASE REPRESENTS A NOVEL DRUG TARGET
1U8GA:1-99; B:1-99CRYSTAL STRUCTURE OF A HIV-1 PROTEASE IN COMPLEX WITH PEPTIDOMIMETIC INHIBITOR KI2-PHE-GLU-GLU-NH2
1XL2A:1-99; B:1-99HIV-1 PROTEASE IN COMPLEX WITH PYRROLIDINMETHANAMINE
1XL5A:1-99; B:1-99HIV-1 PROTEASE IN COMPLEX WITH AMIDHYROXYSULFONE
1YT9A:1-99; B:1-99HIV PROTEASE WITH OXIMINOARYLSULFONAMIDE BOUND
1ZTZA:1-99; B:1-99CRYSTAL STRUCTURE OF HIV PROTEASE- METALLACARBORANE COMPLEX
2A1EA:1-99; B:1-99HIGH RESOLUTION STRUCTURE OF HIV-1 PR WITH TS-126
2A4FA:1-99; B:1-99SYNTHESIS AND ACTIVITY OF N-AXYL AZACYCLIC UREA HIV-1 PROTEASE INHIBITORS WITH HIGH POTENCY AGAINST MULTIPLE DRUG RESISTANT VIRAL STRAINS.
2AOFA:1-99; B:101-199CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A SUBSTRATE ANALOG P1-P6
2AVOA:1-99; B:1-99KINETICS, STABILITY, AND STRUCTURAL CHANGES IN HIGH RESOLUTION CRYSTAL STRUCTURES OF HIV-1 PROTEASE WITH DRUG RESISTANT MUTATIONS L24I, I50V, AND G73S
2AVSA:1-99; B:1-99KINETICS, STABILITY, AND STRUCTURAL CHANGES IN HIGH RESOLUTION CRYSTAL STRUCTURES OF HIV-1 PROTEASE WITH DRUG RESISTANT MUTATIONS L24I, I50V, AND G73S
2AVVA:1-99; B:1-99; D:1-99; E:1-99KINETICS, STABILITY, AND STRUCTURAL CHANGES IN HIGH RESOLUTION CRYSTAL STRUCTURES OF HIV-1 PROTEASE WITH DRUG RESISTANT MUTATIONS L24I, I50V, AND G73S
2BB9A:1-99; B:201-299STRUCTURE OF HIV1 PROTEASE AND AKC4P_133A COMPLEX.
2BBBA:1-99; B:201-299STRUCTURE OF HIV1 PROTEASE AND HH1_173_3A COMPLEX.
2BPVA:1-99; B:1-99HIV-1 PROTEASE-INHIBITOR COMPLEX
2BPWA:1-99; B:1-99HIV-1 PROTEASE-INHIBITOR COMPLEX
2BPXA:1-99; B:1-99HIV-1 PROTEASE-INHIBITOR COMPLEX
2BPYA:1-99; B:1-99HIV-1 PROTEASE-INHIBITOR COMPLEX
2BPZA:1-99; B:1-99HIV-1 PROTEASE-INHIBITOR COMPLEX
2FXDA:1-99; B:1-99X-RAY CRYSTAL STRUCTURE OF HIV-1 PROTEASE IRM MUTANT COMPLEXED WITH ATAZANAVIR (BMS-232632)
2FXEA:1-99; B:1-99X-RAY CRYSTAL STRUCTURE OF HIV-1 PROTEASE CRM MUTANT COMPLEXED WITH ATAZANAVIR (BMS-232632)
2HB3A:1-99; B:1-99WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH POTENT INHIBITOR GRL06579
2HS1A:1-99; B:101-199ULTRA-HIGH RESOLUTION X-RAY CRYSTAL STRUCTURE OF HIV-1 PROTEASE V32I MUTANT WITH TMC114 (DARUNAVIR) INHIBITOR
2HS2A:1-99; B:101-199CRYSTAL STRUCTURE OF M46L MUTANT OF HIV-1 PROTEASE COMPLEXED WITH TMC114 (DARUNAVIR)
2I4DA:1-99; B:201-299CRYSTAL STRUCTURE OF WT HIV-1 PROTEASE WITH GS-8373
2I4UA:1-99; B:201-299HIV-1 PROTEASE WITH TMC-126
2I4VA:1-99; B:201-299HIV-1 PROTEASE I84V, L90M WITH TMC126
2I4WA:1-99; B:201-299HIV-1 PROTEASE WT WITH GS-8374
2I4XA:1-99; B:201-299HIV-1 PROTEASE I84V, L90M WITH GS-8374
2IDWA:1-99; B:101-199CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A POTENT NON-PEPTIDE INHIBITOR (UIC-94017)
2IENA:1-99; B:101-199CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE WITH A POTENT NON-PEPTIDE INHIBITOR (UIC-94017)
2IEOA:1-99; B:101-199CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT I84V WITH A POTENT NON-PEPTIDE INHIBITOR (UIC-94017)
2NMW  [entry was replaced by entry 3OXC without any CATH domain information]
2NMYA:1-99; B:101-199CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A INHIBITOR SAQUINAVIR
2NMZA:1-99; B:101-199CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A INHIBITOR SAQUINAVIR
2NNKA:1-99; B:101-199CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT I84V WITH A INHIBITOR SAQUINAVIR
2NNPA:1-99; B:101-199CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT I84V WITH A INHIBITOR SAQUINAVIR
2NPHA:1-99; B:1001-1099CRYSTAL STRUCTURE OF HIV1 PROTEASE IN SITU PRODUCT COMPLEX
2P3AA:1-99; B:1-99CRYSTAL STRUCTURE OF THE MULTI-DRUG RESISTANT MUTANT SUBTYPE B HIV PROTEASE COMPLEXED WITH TL-3 INHIBITOR
2P3BA:1-99; B:1-99CRYSTAL STRUCTURE OF THE SUBTYPE B WILD TYPE HIV PROTEASE COMPLEXED WITH TL-3 INHIBITOR
2P3CA:1-99; B:1-99CRYSTAL STRUCTURE OF THE SUBTYPE F WILD TYPE HIV PROTEASE COMPLEXED WITH TL-3 INHIBITOR
2PQZA:1-99; B:1-99HIV-1 PROTEASE IN COMPLEX WITH A PYRROLIDINE-BASED INHIBITOR
2ZYEA:1-99; B:101-199STRUCTURE OF HIV-1 PROTEASE IN COMPLEX WITH POTENT INHIBITOR KNI-272 DETERMINED BY NEUTRON CRYSTALLOGRAPHY
3A2OA:1-99; B:101-199CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH KNI-1689
3BVAA:1-99; B:1-99CYSTAL STRUCTURE OF HIV-1 ACTIVE SITE MUTANT D25N AND P2-NC ANALOG INHIBITOR
3BVBA:1-99; B:1-99CYSTAL STRUCTURE OF HIV-1 ACTIVE SITE MUTANT D25N AND INHIBITOR DARUNAVIR
3CYXA:1-99; B:1-99CRYSTAL STRUCTURE OF HIV-1 MUTANT I50V AND INHIBITOR SAQUINAVIRA
3FX5A:1-99; B:101-199STRUCTURE OF HIV-1 PROTEASE IN COMPLEX WITH POTENT INHIBITOR KNI-272 DETERMINED BY HIGH RESOLUTION X-RAY CRYSTALLOGRAPHY
3GGAA:1-99; B:1-99; C:1-99; D:1-99; G:1-99; H:1-99HIV PROTEASE INHIBITORS WITH PSEUDO-SYMMETRIC CORES
3GGVA:1-99; B:1-99; C:1-99; D:1-99; E:1-99; F:1-99; G:1-99; H:1-99; I:1-99HIV PROTEASE, PSEUDO-SYMMETRIC INHIBITORS
3GGXA:1-99; F:1-99; G:1-99; H:1-99; B:1-99; C:1-99; D:1-99; E:1-99HIV PROTEASE, PSEUDO-SYMMETRIC INHIBITORS
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. (108)
1A8GA:1-99; B:1-99HIV-1 PROTEASE IN COMPLEX WITH SDZ283-910
1A8KA:1-99; B:1-99; D:1-99; E:1-99CRYSTALLOGRAPHIC ANALYSIS OF HUMAN IMMUNODEFICIENCY VIRUS 1 PROTEASE WITH AN ANALOG OF THE CONSERVED CA-P2 SUBSTRATE: INTERACTIONS WITH FREQUENTLY OCCURRING GLUTAMIC ACID RESIDUE AT P2' POSITION OF SUBSTRATES
1A94A:1-99; B:1-99; D:1-99; E:1-99STRUCTURAL BASIS FOR SPECIFICITY OF RETROVIRAL PROTEASES
1A9MA:1-99; B:1-99G48H MUTANT OF HIV-1 PROTEASE IN COMPLEX WITH A PEPTIDIC INHIBITOR U-89360E
1AAQA:1-99; B:1-99HYDROXYETHYLENE ISOSTERE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE: STRUCTURE-ACTIVITY ANALYSIS USING ENZYME KINETICS, X-RAY CRYSTALLOGRAPHY, AND INFECTED T-CELL ASSAYS
1AXAA:1-99; B:1-99ACTIVE-SITE MOBILITY IN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE AS DEMONSTRATED BY CRYSTAL STRUCTURE OF A28S MUTANT
1D4SA:1-99; B:1-99HIV-1 PROTEASE V82F/I84V DOUBLE MUTANT/TIPRANAVIR COMPLEX
1D4YA:1-99; B:1-99HIV-1 PROTEASE TRIPLE MUTANT/TIPRANAVIR COMPLEX
1DAZC:1-99; D:101-199STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE
1DIFA:1-99; B:1-99HIV-1 PROTEASE IN COMPLEX WITH A DIFLUOROKETONE CONTAINING INHIBITOR A79285
1DW6C:1-99; D:101-199STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE
1EBKC:1-99; D:101-199; E:1-99; F:101-199STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE
1EBWA:1-99; B:101-199HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA322
1EBYA:1-99; B:101-199HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA369
1EBZA:1-99; B:101-199HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA388
1EC0A:1-99; B:101-199HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA403
1EC1A:1-99; B:101-199HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA409
1EC2A:1-99; B:101-199HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA428
1EC3A:1-99; B:101-199HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR MSA367
1F7AA:1-99; B:1-99HOW DOES A SYMMETRIC DIMER RECOGNIZE AN ASYMMETRIC SUBSTRATE? A SUBSTRATE COMPLEX OF HIV-1 PROTEASE.
1FB7A:1-99CRYSTAL STRUCTURE OF AN IN VIVO HIV-1 PROTEASE MUTANT IN COMPLEX WITH SAQUINAVIR: INSIGHTS INTO THE MECHANISMS OF DRUG RESISTANCE
1FEJC:1-99; D:101-199STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCTURES OF THE MUTANT PROTEASE/SUBSTRATE ANALOG COMPLEXES
1FF0C:1-99; D:101-199STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCTURES OF THE MUTANT PROTEASE/SUBSTRATE ANALOG COMPLEXES.
1FFFC:1-99; D:101-199STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE : HIGH RESOLUTION CRYSTAL STRUCTURES OF THE MUTANT PROTEASE/SUBSTRATE ANALOG COMPLEXES.
1FFIC:1-99; D:101-199STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCTURES OF THE MUTANT PROTEASE/SUBSTRATE ANALOG COMPLEXES
1FG6C:1-99; D:101-199STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCTURES OF THE MUTANT PROTEASE/SUBSTRATE ANALOG COMPLEXES
1FG8C:1-99; D:101-199STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCTURES OF THE MUTANT PROTEASE/SUBSTRATE ANALOG COMPLEXES
1FGCC:1-99; D:101-199STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCTURES OF THE MUTANT PROTEASE/SUBSTRATE ANALOG COMPLEXES
1FQXA:1-99; B:1-99CRYSTAL STRUCTURE OF THE COMPLEX OF HIV-1 PROTEASE WITH A PEPTIDOMIMETIC INHIBITOR
1G6LA:1-99; A:1001-10991.9A CRYSTAL STRUCTURE OF TETHERED HIV-1 PROTEASE
1GNMA:1-99; B:1-99HIV-1 PROTEASE MUTANT WITH VAL 82 REPLACED BY ASP (V82D) COMPLEXED WITH U89360E (INHIBITOR)
1GNNA:1-99; B:1-99HIV-1 PROTEASE MUTANT WITH VAL 82 REPLACED BY ASN (V82N) COMPLEXED WITH U89360E (INHIBITOR)
1GNOA:1-99; B:1-99HIV-1 PROTEASE (WILD TYPE) COMPLEXED WITH U89360E (INHIBITOR)
1HEFE:1-99THE CRYSTAL STRUCTURES AT 2.2 ANGSTROMS RESOLUTION OF HYDROXYETHYLENE-BASED INHIBITORS BOUND TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE SHOW THAT THE INHIBITORS ARE PRESENT IN TWO DISTINCT ORIENTATIONS
1HEGE:1-99THE CRYSTAL STRUCTURES AT 2.2 ANGSTROMS RESOLUTION OF HYDROXYETHYLENE-BASED INHIBITORS BOUND TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE SHOW THAT THE INHIBITORS ARE PRESENT IN TWO DISTINCT ORIENTATIONS
1HIVA:1-99; B:1-99CRYSTAL STRUCTURE OF A COMPLEX OF HIV-1 PROTEASE WITH A DIHYDROETHYLENE-CONTAINING INHIBITOR: COMPARISONS WITH MOLECULAR MODELING
1HOSA:1-99; B:1-99INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE BY A C2-SYMMETRIC PHOSPHINATE SYNTHESIS AND CRYSTALLOGRAPHIC ANALYSIS
1HPOA:1-99; B:1-99HIV-1 PROTEASE TRIPLE MUTANT/U103265 COMPLEX
1HPSA:1-99; B:1-99RATIONAL DESIGN, SYNTHESIS AND CRYSTALLOGRAPHIC ANALYSIS OF A HYDROXYETHYLENE-BASED HIV-1 PROTEASE INHIBITOR CONTAINING A HETEROCYCLIC P1'-P2' AMIDE BOND ISOSTERE
1HPVA:1-99; B:1-99CRYSTAL STRUCTURE OF HIV-1 PROTEASE IN COMPLEX WITH VX-478, A POTENT AND ORALLY BIOAVAILABLE INHIBITOR OF THE ENZYME
1HTEA:1-99; B:1-99X-RAY CRYSTALLOGRAPHIC STUDIES OF A SERIES OF PENICILLIN-DERIVED ASYMMETRIC INHIBITORS OF HIV-1 PROTEASE
1HTFA:1-99; B:1-99X-RAY CRYSTALLOGRAPHIC STUDIES OF A SERIES OF PENICILLIN-DERIVED ASYMMETRIC INHIBITORS OF HIV-1 PROTEASE
1HTGA:1-99; B:1-99X-RAY CRYSTALLOGRAPHIC STUDIES OF A SERIES OF PENICILLIN-DERIVED ASYMMETRIC INHIBITORS OF HIV-1 PROTEASE
1HVIA:1-99; B:1-99INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C2 SYMMETRY-BASED DIOL INHIBITORS OF HIV-1 PROTEASE
1HVJA:1-99; B:1-99INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C2 SYMMETRY-BASED DIOL INHIBITORS OF HIV-1 PROTEASE
1HVKA:1-99; B:1-99INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C2 SYMMETRY-BASED DIOL INHIBITORS OF HIV-1 PROTEASE
1HVLA:1-99; B:1-99INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C2 SYMMETRY-BASED DIOL INHIBITORS OF HIV-1 PROTEASE
1HVRA:1-99; B:1-99RATIONAL DESIGN OF POTENT, BIOAVAILABLE, NONPEPTIDE CYCLIC UREAS AS HIV PROTEASE INHIBITORS
1HVSA:1-99; B:1-99STRUCTURAL BASIS OF DRUG RESISTANCE FOR THE V82A MUTANT OF HIV-1 PROTEASE: BACKBONE FLEXIBILITY AND SUBSITE REPACKING
1HXWA:1-99; B:1-99HIV-1 PROTEASE DIMER COMPLEXED WITH A-84538
1IIQA:1-99; B:1-99CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR
1IZHA:1-99; B:1-99INHIBITOR OF HIV PROTEASE WITH UNUSUAL BINDING MODE POTENTLY INHIBITING MULTI-RESISTANT PROTEASE MUTANTS
1IZIA:1-99; B:1-99INHIBITOR OF HIV PROTEASE WITH UNUSUAL BINDING MODE POTENTLY INHIBITING MULTI-RESISTANT PROTEASE MUTANTS
1K1TA:1-99; B:101-199COMBINING MUTATIONS IN HIV-1 PROTEASE TO UNDERSTAND MECHANISMS OF RESISTANCE
1K1UA:1-99; B:101-199COMBINING MUTATIONS IN HIV-1 PROTEASE TO UNDERSTAND MECHANISMS OF RESISTANCE
1K2BA:1-99; B:1-99COMBINING MUTATIONS IN HIV-1 PROTEASE TO UNDERSTAND MECHANISMS OF RESISTANCE
1K2CA:1-99; B:1-99COMBINING MUTATIONS IN HIV-1 PROTEASE TO UNDERSTAND MECHANISMS OF RESISTANCE
1LV1A:1-99; A:1001-1099CRYSTAL STRUCTURE ANALYSIS OF THE NON-ACTIVE SITE MUTANT OF TETHERED HIV-1 PROTEASE TO 2.1A RESOLUTION
1LZQA:1-99; B:101-199CRYSTAL STRUCTURE OF THE COMPLEX OF MUTANT HIV-1 PROTEASE (A71V, V82T, I84V) WITH AN ETHYLENAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE-PSI[CH2CH2NH]-PHE-GLU-PHE-NH2
1M0BA:1-99; B:101-199HIV-1 PROTEASE IN COMPLEX WITH AN ETHYLENEAMINE INHIBITOR
1MRWA:1-99; B:1-99STRUCTURE OF HIV PROTEASE (MUTANT Q7K L33I L63I) COMPLEXED WITH KNI-577
1MRXA:1-99; B:1-99STRUCTURE OF HIV PROTEASE (MUTANT Q7K L33I L63I V82F I84V ) COMPLEXED WITH KNI-577
1MSMA:1-99; B:1-99THE HIV PROTEASE (MUTANT Q7K L33I L63I) COMPLEXED WITH KNI-764 (AN INHIBITOR)
1MSNA:1-99; B:1-99THE HIV PROTEASE (MUTANT Q7K L33I L63I V82F I84V) COMPLEXED WITH KNI-764 (AN INHIBITOR)
1MT7A:1-99; B:1-99VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE MUTANT: STRUCTURAL INSIGHTS FOR BETTER ANTIVIRAL THERAPY
1MT8A:1-99; B:1-99VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE MUTANT: STRUCTURAL INSIGHTS FOR BETTER ANTIVIRAL THERAPY
1MT9A:1-99; B:1-99VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE MUTANT: STRUCTURAL INSIGHTS FOR BETTER ANTIVIRAL THERAPY
1MTBA:1-99; B:1-99VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE MUTANT: STRUCTURAL INSIGHTS FOR BETTER ANTIVIRAL THERAPY
1MTRA:1-99; B:1-99HIV-1 PROTEASE COMPLEXED WITH A CYCLIC PHE-ILE-VAL PEPTIDOMIMETIC INHIBITOR
1MUIA:1-99; B:1-99CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH LOPINAVIR.
1NH0A:1-99; B:1-991.03 A STRUCTURE OF HIV-1 PROTEASE: INHIBITOR BINDING INSIDE AND OUTSIDE THE ACTIVE SITE
1OHRA:1-99; B:1-99VIRACEPT (R) (NELFINAVIR MESYLATE, AG1343): A POTENT ORALLY BIOAVAILABLE INHIBITOR OF HIV-1 PROTEASE
1SGUA:1-99; B:1-99COMPARING THE ACCUMULATION OF ACTIVE SITE AND NON-ACTIVE SITE MUTATIONS IN THE HIV-1 PROTEASE
1SH9A:1-99; B:1-99COMPARING THE ACCUMULATION OF ACTIVE SITE AND NON-ACTIVE SITE MUTATIONS IN THE HIV-1 PROTEASE
1VIJA:1-99; B:1-99HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR HOE/BAY 793 HEXAGONAL FORM
1VIKA:1-99; B:1-99HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR HOE/BAY 793 ORTHORHOMBIC FORM
1WBKA:1-99; B:1-99HIV-1 PROTEASE IN COMPLEX WITH ASYMMETRIC INHIBITOR, BEA568
1WBMA:1-99; B:1-99HIV-1 PROTEASE IN COMPLEX WITH SYMMETRIC INHIBITOR, BEA450
1Z8CA:1-99; B:101-199CRYSTAL STRUCTURE OF THE COMPLEX OF MUTANT HIV-1 PROTEASE (L63P, A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE-PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2
1ZBGA:1-99; B:101-199CRYSTAL STRUCTURE OF A COMPLEX OF MUTANT HIV-1 PROTEASE (A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE-PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2
1ZJ7A:1-99CRYSTAL STRUCTURE OF A COMPLEX OF MUTANT HIV-1 PROTEASE (A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE-PSI[S-CH(OH)CH2NH]-PHE-GLU-PHE-NH2
1ZLFA:1-99; B:101-199CRYSTAL STRUCTURE OF A COMPLEX OF MUTANT HIV-1 PROTEASE (A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR
1ZP8A:1-99HIV PROTEASE WITH INHIBITOR AB-2
1ZPAA:1-99HIV PROTEASE WITH SCRIPPS AB-3 INHIBITOR
1ZPKA:1-99; B:101-199CRYSTAL STRUCTURE OF THE COMPLEX OF MUTANT HIV-1 PROTEASE (A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE-PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2
1ZSFA:1-99; B:101-199CRYSTAL STRUCTURE OF COMPLEX OF A HYDROXYETHYLAMINE INHIBITOR WITH HIV-1 PROTEASE AT 2.0A RESOLUTION
1ZSRA:1-99; B:101-199CRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE (BRU ISOLATE) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE-PSI[S-CH(OH) CH2NH]-PHE-GLU-PHE-NH2
2AQUA:1-99; B:1-99STRUCTURE OF HIV-1 PROTEASE BOUND TO ATAZANAVIR
2B60A:1-99; B:1-99STRUCTURE OF HIV-1 PROTEASE MUTANT BOUND TO RITONAVIR
2B7ZA:1-99; B:1-99STRUCTURE OF HIV-1 PROTEASE MUTANT BOUND TO INDINAVIR
2FDDA:1-99; B:1-99CRYSTAL STRUCTURE OF HIV PROTEASE D545701 BOUND WITH GW0385
2FDEA:1-99; B:1-99WILD TYPE HIV PROTEASE BOUND WITH GW0385
2FLEA:1-99; B:1-99STRUCTURAL ANALYSIS OF ASYMMETRIC INHIBITOR BOUND TO THE HIV-1 PROTEASE V82A MUTANT
2G69A:1-99STRUCTURE OF UNLIGANDED HIV-1 PROTEASE F53L MUTANT
2P3DA:1-99; B:1-99CRYSTAL STRUCTURE OF THE MULTI-DRUG RESISTANT MUTANT SUBTYPE F HIV PROTEASE COMPLEXED WITH TL-3 INHIBITOR
2QCIA:1-99; B:101-199HIV-1 PROTEASE MUTANT D30N WITH POTENT ANTIVIRAL INHIBITOR GRL-98065
2QD6A:1-99; B:101-199HIV-1 PROTEASE MUTANT I50V WITH POTENT ANTIVIRAL INHIBITOR GRL-98065
2QD7A:1-99; B:101-199HIV-1 PROTEASE MUTANT V82A WITH POTENT ANTIVIRAL INHIBITOR GRL-98065
2QD8A:1-99; B:101-199HIV-1 PROTEASE MUTANT I84V WITH POTENT ANTIVIRAL INHIBITOR GRL-98065
2WHHA:1-99; A:1001-1099HIV-1 PROTEASE TETHERED DIMER Q-PRODUCT COMPLEX ALONG WITH NUCLEOPHILIC WATER MOLECULE
2Z4OA:1-99; B:101-199WILD TYPE HIV-1 PROTEASE WITH POTENT ANTIVIRAL INHIBITOR GRL-98065
3HVPA:1-99CONSERVED FOLDING IN RETROVIRAL PROTEASES. CRYSTAL STRUCTURE OF A SYNTHETIC HIV-1 PROTEASE
4HVPA:1-99; B:1-99STRUCTURE OF COMPLEX OF SYNTHETIC HIV-1 PROTEASE WITH A SUBSTRATE-BASED INHIBITOR AT 2.3 ANGSTROMS RESOLUTION
4PHVA:1-99; B:1-99X-RAY CRYSTAL STRUCTURE OF THE HIV PROTEASE COMPLEX WITH L-700,417, AN INHIBITOR WITH PSEUDO C2 SYMMETRY
5HVPA:1-99; B:201-299CRYSTALLOGRAPHIC ANALYSIS OF A COMPLEX BETWEEN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE AND ACETYL-PEPSTATIN AT 2.0-ANGSTROMS RESOLUTION
7HVPA:1-99; B:1-99X-RAY CRYSTALLOGRAPHIC STRUCTURE OF A COMPLEX BETWEEN A SYNTHETIC PROTEASE OF HUMAN IMMUNODEFICIENCY VIRUS 1 AND A SUBSTRATE-BASED HYDROXYETHYLAMINE INHIBITOR
8HVPA:1-99; B:1-99STRUCTURE AT 2.5-ANGSTROMS RESOLUTION OF CHEMICALLY SYNTHESIZED HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE COMPLEXED WITH A HYDROXYETHYLENE*-BASED INHIBITOR
9HVPA:1-99; B:1-99DESIGN, ACTIVITY AND 2.8 ANGSTROMS CRYSTAL STRUCTURE OF A C2 SYMMETRIC INHIBITOR COMPLEXED TO HIV-1 PROTEASE
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Cell_line: s2. (1)
1HIHA:1-99; B:1-99COMPARATIVE ANALYSIS OF THE X-RAY STRUCTURES OF HIV-1 AND HIV-2 PROTEASES IN COMPLEX WITH CGP 53820, A NOVEL PSEUDOSYMMETRIC INHIBITOR
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Human immunodeficiency virus 1. Organism_taxid: 11676. (1)
2J9JA:1-99; B:1-99ATOMIC-RESOLUTION CRYSTAL STRUCTURE OF CHEMICALLY-SYNTHESIZED HIV-1 PROTEASE COMPLEXED WITH INHIBITOR JG-365
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: bh10. (1)
2PC0A:1001-1099APO WILD-TYPE HIV PROTEASE IN THE OPEN CONFORMATION
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: bh10. Cell_line: bl21. (2)
1AJVA:1-99; B:1-99HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC SULFAMIDE INHIBITOR AHA006
1AJXA:1-99; B:1-99HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC UREA INHIBITOR AHA001
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: bh102 isolate. (5)
1DMPA:1-99; B:1-99STRUCTURE OF HIV-1 PROTEASE COMPLEX
1MERA:1-99; B:1-99HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP450
1MESA:1-99; B:1-99HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP323
1META:1-99; B:1-99HIV-1 MUTANT (V82F) PROTEASE COMPLEXED WITH DMP323
1MEUA:1-99; B:1-99HIV-1 MUTANT (V82F, I84V) PROTEASE COMPLEXED WITH DMP323
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: bh102. (9)
1BV7A:1-99; B:1-99COUNTERACTING HIV-1 PROTEASE DRUG RESISTANCE: STRUCTURAL ANALYSIS OF MUTANT PROTEASES COMPLEXED WITH XV638 AND SD146, CYCLIC UREA AMIDES WITH BROAD SPECIFICITIES
1BV9A:1-99; B:1-99HIV-1 PROTEASE (I84V) COMPLEXED WITH XV638 OF DUPONT PHARMACEUTICALS
1BWAA:1-99; B:1-99HIV-1 PROTEASE (V82F/I84V) DOUBLE MUTANT COMPLEXED WITH XV638 OF DUPONT PHARMACEUTICALS
1BWBA:1-99; B:1-99HIV-1 PROTEASE (V82F/I84V) DOUBLE MUTANT COMPLEXED WITH SD146 OF DUPONT PHARMACEUTICALS
1HWRA:1-99; B:1-99MOLECULAR RECOGNITION OF CYCLIC UREA HIV PROTEASE INHIBITORS
1QBRA:1-99; B:1-99HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY
1QBSA:1-99; B:1-99HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY
1QBTA:1-99; B:1-99HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY
1QBUA:1-99; B:1-99HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: bh5 isolate. (3)
2F80A:1-99; B:1-99HIV-1 PROTEASE MUTANT D30N COMPLEXED WITH INHIBITOR TMC114
2F81A:1-99; B:101-199HIV-1 PROTEASE MUTANT L90M COMPLEXED WITH INHIBITOR TMC114
2F8GA:1-99; B:101-199HIV-1 PROTEASE MUTANT I50V COMPLEXED WITH INHIBITOR TMC114
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: bh5. (3)
1UPJA:1-99HIV-1 PROTEASE COMPLEX WITH U095438 [3-[1-(4-BROMOPHENYL) ISOBUTYL]-4-HYDROXYCOUMARIN
2UPJA:1-99; B:1-99HIV-1 PROTEASE COMPLEX WITH U100313 ([3-[[3-[CYCLOPROPYL [4-HYDROXY-2OXO-6-[1-(PHENYLMETHYL)PROPYL]-2H-PYRAN-3-YL] METHYL]PHENYL]AMINO]-3-OXO-PROPYL]CARBAMIC ACID TERT-BUTYL ESTER)
7UPJA:1-99; B:1-99HIV-1 PROTEASE/U101935 COMPLEX
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: bh7. (1)
1G35A:1-99; B:1-99CRYSTAL STRUCTURE OF HIV-1 PROTEASE IN COMPLEX WITH INHIBITOR, AHA024
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: gag-pol. (9)
2PWCA:1-99; B:1-99HIV-1 PROTEASE IN COMPLEX WITH A AMINO DECORATED PYRROLIDINE-BASED INHIBITOR
2PWRA:1-99; B:1-99HIV-1 PROTEASE IN COMPLEX WITH A CARBAMOYL DECORATED PYRROLIDINE-BASED INHIBITOR
2QNNA:1-99; B:1-99HIV-1 PROTEASE IN COMPLEX WITH A MULTIPLE DECORATED PYRROLIDINE-BASED INHIBITOR
2QNPA:1-99; B:1-99HIV-1 PROTEASE IN COMPLEX WITH A IODO DECORATED PYRROLIDINE-BASED INHIBITOR
2QNQA:1-99; B:1-99HIV-1 PROTEASE IN COMPLEX WITH A CHLORO DECORATED PYRROLIDINE-BASED INHIBITOR
2R38A:1-99; B:1-99I84V HIV-1 PROTEASE MUTANT IN COMPLEX WITH A CARBAMOYL DECORATED PYRROLIDINE-BASED INHIBITOR
2R3TA:1-99; B:1-99I50V HIV-1 PROTEASE MUTANT IN COMPLEX WITH A CARBAMOYL DECORATED PYRROLIDINE-BASED INHIBITOR
2R3WA:1-99; B:1-99I84V HIV-1 PROTEASE IN COMPLEX WITH A AMINO DECORATED PYRROLIDINE-BASED INHIBITOR
2R43A:1-99; B:1-99I50V HIV-1 PROTEASE IN COMPLEX WITH AN AMINO DECORATED PYRROLIDINE-BASED INHIBITOR
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: hiv-1 d10. Variant: d10. (5)
2CEJA:1-99; B:101-199P1' EXTENDED HIV-1 PROTEASE INHIBITORS ENCOMPASSING A TERTIARY ALCOHOL IN THE TRANSITION-STATE MIMICKING SCAFFOLD
2CEMA:1-99; B:101-199P1' EXTENDED HIV-1 PROTEASE INHIBITORS ENCOMPASSING A TERTIARY ALCOHOL IN THE TRANSITION-STATE MIMICKING SCAFFOLD
2CENA:1-99; B:101-199P1' EXTENDED HIV-1 PROTEASE INHIBITORS ENCOMPASSING A TERTIARY ALCOHOL IN THE TRANSITION-STATE MIMICKING SCAFFOLD
2UXZA:1-99; B:101-199TWO-CARBON-ELONGATED HIV-1 PROTEASE INHIBITORS WITH A TERTIARY-ALCOHOL-CONTAINING TRANSITION-STATE MIMIC
2UY0A:1-99; B:101-199TWO-CARBON-ELONGATED HIV-1 PROTEASE INHIBITORS WITH A TERTIARY-ALCOHOL-CONTAINING TRANSITION-STATE MIMIC
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: hivlai. (1)
1HPXA:1-99; B:1-99HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR KNI-272
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: hxb2. (3)
1BVEA:1-99; B:1-99HIV-1 PROTEASE-DMP323 COMPLEX IN SOLUTION, NMR, 28 STRUCTURES
1BVGA:1-99; B:1-99HIV-1 PROTEASE-DMP323 COMPLEX IN SOLUTION, NMR MINIMIZED AVERAGE STRUCTURE
2FNTA:1-99; B:1-99CRYSTAL STRUCTURE OF A DRUG-RESISTANT (V82A) INACTIVE (D25N) HIV-1 PROTEASE COMPLEXED WITH AP2V VARIANT OF HIV-1 NC-P1 SUBSTRATE.
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: hxb2. (1)
2FNSA:1-99; B:1-99CRYSTAL STRUCTURE OF WILD-TYPE INACTIVE (D25N) HIV-1 PROTEASE COMPLEXED WITH WILD-TYPE HIV-1 NC-P1 SUBSTRATE.
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: iiib. (3)
1BDLA:1-99; B:1-99HIV-1 (2:31-37) PROTEASE COMPLEXED WITH INHIBITOR SB203386
1BDQA:1-99; B:1-99HIV-1 (2:31-37, 47, 82) PROTEASE COMPLEXED WITH INHIBITOR SB203386
1BDRA:1-99; B:1-99HIV-1 (2: 31, 33-37) PROTEASE COMPLEXED WITH INHIBITOR SB203386
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: isolatebh5. (1)
2AVMA:1-99; B:1-99KINETICS, STABILITY, AND STRUCTURAL CHANGES IN HIGH RESOLUTION CRYSTAL STRUCTURES OF HIV-1 PROTEASE WITH DRUG RESISTANT MUTATIONS L24I, I50V, AND G73S
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: isolatehxb2. (1)
1A30A:1-99; B:1-99HIV-1 PROTEASE COMPLEXED WITH A TRIPEPTIDE INHIBITOR
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: nl4-3. (3)
2HB2A:1-99STRUCTURE OF HIV PROTEASE 6X MUTANT IN APO FORM
2HB4A:1-99STRUCTURE OF HIV PROTEASE NL4-3 IN AN UNLIGANDED STATE
2HC0A:1001-1099; B:2101-2199STRUCTURE OF HIV PROTEASE 6X MUTANT IN COMPLEX WITH AB-2.
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: r8. (10)
2AZ8A:1-99HIV-1 PROTEASE NL4-3 IN COMPLEX WITH INHIBITOR, TL-3
2AZ9A:1-99HIV-1 PROTEASE NL4-3 1X MUTANT
2AZBA:1-99HIV-1 PROTEASE NL4-3 3X MUTANT IN COMPLEX WITH INHIBITOR, TL-3
2AZCA:1-99; B:1-99HIV-1 PROTEASE NL4-3 6X MUTANT
3KF0A:1-99; B:1-99HIV PROTEASE WITH FRAGMENT 4D9 BOUND
3KF1  [entry was replaced by entry 4E43 without any CATH domain information]
3KFNA:1-99; B:1-99HIV PROTEASE (PR) WITH INHIBITOR TL-3 AND FRAGMENT HIT 4D9 BY SOAKING
3KFPA:1-99HIV PROTEASE (PR) WITH INHIBITOR TL-3 BOUND, AND DMSOS IN EXO SITE
3KFRA:1-99; B:1-99HIV PROTEASE (PR) DIMER WITH INHIBITOR TL-3 BOUND AND FRAGMENT 1F1 IN THE OUTSIDE/TOP OF FLAP
3KFSA:1-99; B:1-99HIV PROTEASE (PR) DIMER WITH INHIBITOR TL-3 BOUND AND FRAGMENT 2F4 IN THE OUTSIDE/TOP OF FLAP
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: scs-1. (1)
1PROA:1-99; B:1-99HIV-1 PROTEASE DIMER COMPLEXED WITH A-98881
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: sf2 (1)
2F3KA:1-99; B:1-99SUBSTRATE ENVELOPE AND DRUG RESISTANCE: CRYSTAL STRUCTURE OF R01 IN COMPLEX WITH WILD-TYPE HIV-1 PROTEASE
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: sf2. (22)
2FGUA:1-99; B:1-99X-RAY CRYSTAL STRUCTURE OF HIV-1 PROTEASE T80S VARIANT IN COMPLEX WITH THE INHIBITOR SAQUINAVIR USED TO EXPLORE THE ROLE OF INVARIANT THR80 IN HIV-1 PROTEASE STRUCTURE, FUNCTION, AND VIRAL INFECTIVITY.
2FGVA:1-99; B:1-99X-RAY CRYSTAL STRUCTURE OF HIV-1 PROTEASE T80N VARIANT IN COMPLEX WITH THE INHIBITOR SAQUINAVIR USED TO EXPLORE THE ROLE OF INVARIANT THR80 IN HIV-1 PROTEASE STRUCTURE, FUNCTION, AND VIRAL INFECTIVITY.
2I0AA:1-99; B:1-99CRYSTAL STRUCTURE OF KB-19 COMPLEXED WITH WILD TYPE HIV-1 PROTEASE
2I0DA:1-99; B:1-99CRYSTAL STRUCTURE OF AD-81 COMPLEXED WITH WILD TYPE HIV-1 PROTEASE
2PSUA:1-99; B:1-99CRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE IN COMPLEX WITH CARB-AD37
2PSVA:1-99; B:1-99CRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE IN COMPLEX WITH CARB-KB45
2Q3KA:1-99; B:1-99CRYSTAL STRUCTURE OF LYSINE SULFONAMIDE INHIBITOR REVEALS THE DISPLACEMENT OF THE CONSERVED FLAP WATER MOLECULE IN HIV-1 PROTEASE
2Q54A:1-99; B:1-99CRYSTAL STRUCTURE OF KB73 BOUND TO HIV-1 PROTEASE
2Q55A:1-99; B:1-99CRYSTAL STRUCTURE OF KK44 BOUND TO HIV-1 PROTEASE
2Q5KA:1-99; B:1-99CRYSTAL STRUCTURE OF LOPINAVIR BOUND TO WILD TYPE HIV-1 PROTEASE
2QHYA:1-99; B:1-99CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-1-AC86 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE
2QHZA:1-99; B:1-99CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-1-AC87 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE
2QI0A:1-99; B:1-99CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-1-KK80 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE
2QI1A:1-99; B:1-99CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-1-KK81 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE
2QI3A:1-99; B:1-99CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-2-AD94 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE
2QI4A:1-99; B:1-99CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-2-AD93 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE
2QI5A:1-99; B:1-99CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-2-KC08 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE
2QI6A:1-99; B:1-99CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-2-KB98 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE
2QI7A:1-99; B:1-99CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-2-AD86 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE
3GI4A:1-99; B:1-99CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, KB60 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE
3GI5A:1-99; B:1-99CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, KB62 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE
3GI6A:1-99; B:1-99CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, AD78 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: subtypeb. (7)
2O4KA:1-99; B:1-99CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K) IN COMPLEX WITH ATAZANAVIR
2O4LA:1-99; B:1-99CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K, I50V) IN COMPLEX WITH TIPRANAVIR
2O4NA:1-99; B:1-99CRYSTAL STRUCTURE OF HIV-1 PROTEASE (TRM MUTANT) IN COMPLEX WITH TIPRANAVIR
2O4PA:1-99; B:1-99CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K) IN COMPLEX WITH TIPRANAVIR
2O4SA:1-99; B:1-99CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K) IN COMPLEX WITH LOPINAVIR
2PK5A:1-99; B:1-99CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K, L33I, L63I ) IN COMPLEX WITH KNI-10075
2PK6A:1-99; B:1-99CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K, L33I, L63I) IN COMPLEX WITH KNI-10033
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: subtypec. (2)
2R5PA:1-99; B:1-99; C:1-99; D:1-99CRYSTAL STRUCTURE ANALYSIS OF HIV-1 SUBTYPE C PROTEASE COMPLEXED WITH INDINAVIR
2R5QA:1-99; B:1-99; C:1-99; D:1-99CRYSTAL STRUCTURE ANALYSIS OF HIV-1 SUBTYPE C PROTEASE COMPLEXED WITH NELFINAVIR
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: type b. (4)
2PYMA:1-99; B:1-99HIV-1 PR MUTANT IN COMPLEX WITH NELFINAVIR
2PYNA:1-99; B:1-99HIV-1 PR MUTANT IN COMPLEX WITH NELFINAVIR
2Q63A:1-99; B:1-99HIV-1 PR MUTANT IN COMPLEX WITH NELFINAVIR
2Q64A:1-99; B:1-99HIV-1 PR MUTANT IN COMPLEX WITH NELFINAVIR
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: x90. (2)
1YTGA:1-99; B:1-99SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT
1YTHA:1-99; B:1-99SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Variant: bh102isolate. (1)
1HVHA:1-99; B:1-99NONPEPTIDE CYCLIC CYANOGUANIDINES AS HIV PROTEASE INHIBITORS
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Variant: d10. (1)
2BQVA:1-99; B:101-199HIV-1 PROTEASE IN COMPLEX WITH INHIBITOR AHA455
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Variant: isolate lv. (1)
1G2KA:1-99; B:1-99HIV-1 PROTEASE WITH CYCLIC SULFAMIDE INHIBITOR, AHA047
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Variant: sf1 isolate. (3)
1AIDA:1-99; B:1-99STRUCTURE OF A NON-PEPTIDE INHIBITOR COMPLEXED WITH HIV-1 PROTEASE: DEVELOPING A CYCLE OF STRUCTURE-BASED DRUG DESIGN
2AIDA:1-99; B:1-99STRUCTURE OF A NON-PEPTIDE INHIBITOR COMPLEXED WITH HIV-1 PROTEASE: DEVELOPING A CYCLE OF STRUCTURE-BASED DRUG DESIGN
3AIDA:1-99; B:1-99A NEW CLASS OF HIV-1 PROTEASE INHIBITOR: THE CRYSTALLOGRAPHIC STRUCTURE, INHIBITION AND CHEMICAL SYNTHESIS OF AN AMINIMIDE PEPTIDE ISOSTERE
(-)
Human immunodeficiency virus 1. Organism_taxid: 505184. Strain: subtype a. (1)
3IXOA:1-99; B:1-99CRYSTAL STRUCTURE OF UNCOMPLEXED HIV_1 PROTEASE SUBTYPE A
(-)
Human immunodeficiency virus 1. Strain: nh1. (1)
3D3TA:1-99; B:1-99CRYSTAL STRUCTURE OF HIV-1 CRF01_AE IN COMPLEX WITH THE SUBSTRATE P1-P6
(-)
Human immunodeficiency virus 1. Strain: subtype c. (1)
2R8NA:1-99STRUCTURAL ANALYSIS OF THE UNBOUND FORM OF HIV-1 SUBTYPE C PROTEASE
(-)
Human immunodeficiency virus 2. Organism_taxid: 11709. (1)
1HSIA:1-99; B:1-99CRYSTAL STRUCTURE AT 1.9 ANGSTROMS RESOLUTION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) II PROTEASE COMPLEXED WITH L-735,524, AN ORALLY BIOAVAILABLE INHIBITOR OF THE HIV PROTEASES
(-)
Human immunodeficiency virus 2. Organism_taxid: 11709. (11)
1IDAA:1-99; B:1-99CRYSTAL STRUCTURES OF HIV-2 PROTEASE IN COMPLEX WITH INHIBITORS CONTAINING THE HYDROXYETHYLAMINE DIPEPTIDE ISOSTERE
1IDBA:1-99; B:1-99CRYSTAL STRUCTURES OF HIV-2 PROTEASE IN COMPLEX WITH INHIBITORS CONTAINING THE HYDROXYETHYLAMINE DIPEPTIDE ISOSTERE
1IVPA:1-99; B:1-99THE CRYSTALLOGRAPHIC STRUCTURE OF THE PROTEASE FROM HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 WITH TWO SYNTHETIC PEPTIDIC TRANSITION STATE ANALOG INHIBITORS
1IVQA:1-99; B:1-99THE CRYSTALLOGRAPHIC STRUCTURE OF THE PROTEASE FROM HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 WITH TWO SYNTHETIC PEPTIDIC TRANSITION STATE ANALOG INHIBITORS
2HPEA:1-99; B:1-99COMPARISON OF THE STRUCTURES OF HIV-2 PROTEASE COMPLEXES IN THREE CRYSTAL SPACE GROUPS WITH AN HIV-1 PROTEASE COMPLEX STRUCTURE
2HPFA:1-99; B:1-99COMPARISON OF THE STRUCTURES OF HIV-2 PROTEASE COMPLEXES IN THREE CRYSTAL SPACE GROUPS WITH AN HIV-1 PROTEASE COMPLEX STRUCTURE
2MIPA:1-99; B:1-99; C:1-99; D:1-99CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) TYPE 2 PROTEASE IN COMPLEX WITH A REDUCED AMIDE INHIBITOR AND COMPARISON WITH HIV-1 PROTEASE STRUCTURES
3UPJA:1-99; B:3-99HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 PROTEASE MUTANT WITH LYS 57 REPLACED BY LEU (K57L) COMPLEX WITH U096333 [4-HYDROXY-3-[1-(PHENYL) PROPYL]-7-METHOXYCOUMARIN]
4UPJA:1-99; B:1-99HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 PROTEASE MUTANT WITH LYS 57 REPLACED BY LEU (K57L) COMPLEX WITH U097410 [4-HYDROXY-3-[1-[3-[[[[(TERT-BUTYLOXYCARBONYL) AMINOMETHYL]CARBONYL]AMINO]PHENYL]PROPYL]COUMARIN
5UPJA:1-99; B:1-99HIV-2 PROTEASE/U99283 COMPLEX
6UPJA:1-99; B:1-99HIV-2 PROTEASE/U99294 COMPLEX
(-)
Human immunodeficiency virus 2. Organism_taxid: 11709. Cell_line: s2. (1)
1HIIA:1-99; B:1-99COMPARATIVE ANALYSIS OF THE X-RAY STRUCTURES OF HIV-1 AND HIV-2 PROTEASES IN COMPLEX WITH CGP 53820, A NOVEL PSEUDOSYMMETRIC INHIBITOR
(-)
Human immunodeficiency virus 2. Organism_taxid: 11709. Strain: rod isolate. (1)
1JLDA:1-99; B:1-99POTENT HIV PROTEASE INHIBITORS CONTAINING A NOVEL (HYDROXYETHYL)AMIDE ISOSTERE
(-)
Human immunodeficiency virus type 1 (3)
3BC4A:1-99I84V HIV-1 PROTEASE IN COMPLEX WITH A PYRROLIDINE DIESTER
3BGBA:1-99; B:1-99HIV-1 PROTEASE IN COMPLEX WITH A ISOBUTYL DECORATED OLIGOAMINE
3BGCA:1-99; B:1-99HIV-1 PROTEASE IN COMPLEX WITH A BENZYL DECORATED OLIGOAMINE
(-)
Human immunodeficiency virus type 1 (bh5 isolate). Organism_taxid: 11682. Strain: bh5 isolate. (8)
2AOCA:1-99; B:101-199CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT I84V WITH A SUBSTRATE ANALOG P2-NC
2AODA:1-99; B:101-199CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE WITH A SUBSTRATE ANALOG P2-NC
2AOEA:1-99; B:101-199CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A SUBSTRATE ANALOG CA-P2
2AOGA:1-99; B:101-199CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A SUBSTRATE ANALOG P2-NC
2AOHA:1-99; B:101-199CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A SUBSTRATE ANALOG P6-PR
2AOIA:1-99; B:101-199CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE WITH A SUBSTRATE ANALOG P1-P6
2AOJA:1-99; B:101-199CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE WITH A SUBSTRATE ANALOG P6-PR
2AVQA:1-99; B:1-99KINETICS, STABILITY, AND STRUCTURAL CHANGES IN HIGH RESOLUTION CRYSTAL STRUCTURES OF HIV-1 PROTEASE WITH DRUG RESISTANT MUTATIONS L24I, I50V, AND G73S
(-)
Human immunodeficiency virus type 1 (bru isolate). Organism_taxid: 11686. (1)
3BHEA:1-99; B:1-99HIV-1 PROTEASE IN COMPLEX WITH A THREE ARMED PYRROLIDINE DERIVATIVE
(-)
Human immunodeficiency virus type 1 (bru isolate). Organism_taxid: 11686. (1)
1HHPA:1-99THE THREE-DIMENSIONAL STRUCTURE OF THE ASPARTYL PROTEASE FROM THE HIV-1 ISOLATE BRU
(-)
Human immunodeficiency virus type 1 (bru isolate). Organism_taxid: 11686. Strain: type b. (1)
3GGUA:1-99; B:1-99HIV PR DRUG RESISTANT PATIENT'S VARIANT IN COMPLEX WITH DARUNAVIR
(-)
Human immunodeficiency virus type 1 (clone 12). Organism_taxid: 11679. (1)
3TLHA:1-99STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITHAN EFFICIENT INHIBITOR OF FIV PR
(-)
Human immunodeficiency virus type 1 (clone 12). Organism_taxid: 11679.Variant: hxb-3. (1)
1HXBA:1-99; B:1-99HIV-1 PROTEINASE COMPLEXED WITH RO 31-8959
(-)
Human immunodeficiency virus type 1 (isolate hxb2 group m subtype b).Hiv-1, hiv-1 m:b_hxb2r. Organism_taxid: 11706. (1)
3DOXA:1-99; A:1001-1099X-RAY STRUCTURE OF HIV-1 PROTEASE IN SITU PRODUCT COMPLEX
(-)
Human immunodeficiency virus type 1 bh10. Organism_taxid: 11678. (1)
1SBGA:1-99; B:1-99AN ORALLY-BIOAVAILABLE HIV-1 PROTEASE INHIBITOR CONTAINING AN IMIDAZOLE-DERIVED PEPTIDE BOND REPLACEMENT. CRYSTALLOGRAPHIC AND PHARMACOKINETIC ANALYSIS
(-)
Human immunodeficiency virus type 1 bh10. Organism_taxid: 11678. Strain: bh5 isolate. (2)
3B7VA:1-99; B:101-199HIV-1 PROTEASE COMPLEXED WITH GEM-DIOL-AMINE TETRAHEDRAL INTERMEDIATE NLLTQI
3B80A:1-99; B:101-199HIV-1 PROTEASE MUTANT I54V COMPLEXED WITH GEM-DIOL-AMINE INTERMEDIATE NLLTQI
(-)
Human immunodeficiency virus type 1. (2)
3CYWA:1-99; B:1-99EFFECT OF FLAP MUTATIONS ON STRUCTURE OF HIV-1 PROTEASE AND INHIBITION BY SAQUINAVIR AND DARUNAVIR
3D1XA:1-99; B:1-99CRYSTAL STRUCTURE OF HIV-1 MUTANT I54M AND INHIBITOR SAQUINAVIR
(-)
Human immunodeficiency virus type 1. Organism_taxid: 11686. (1)
3I8WA:1-99CRYSTAL STRUCTURE OF A METALLACARBORANE INHIBITOR BOUND TO HIV PROTEASE
(-)
Human immunodeficiency virus type 2 (isolate rod). Organism_taxid: 11720. (3)
3EBZA:1-99; B:101-199HIGH RESOLUTION HIV-2 PROTEASE STRUCTURE IN COMPLEX WITH CLINICAL DRUG DARUNAVIR
3EC0A:1-99; B:101-199HIGH RESOLUTION HIV-2 PROTEASE STRUCTURE IN COMPLEX WITH ANTIVIRAL INHIBITOR GRL-06579A
3ECGA:1-99; B:101-199HIGH RESOLUTION HIV-2 PROTEASE STRUCTURE IN COMPLEX WITH ANTIVIRAL INHIBITOR GRL-98065
(-)
Human immunodeficiency virus. Organism_taxid: 12721. (1)
1KZKA:1-99; B:1-99JE-2147-HIV PROTEASE COMPLEX
(-)
Human immunodeficiency virus. Organism_taxid: 12721. Strain: bh10. (3)
1D4HA:1-99; B:101-199HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA435
1D4IA:1-99; B:101-199HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA425
1D4JA:1-99; B:101-199HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR MSL370
(-)
Hypocrea jecorina (Hypocrea jecorina) (1)
3EMYA:171-326; A:2-170CRYSTAL STRUCTURE OF TRICHODERMA REESEI ASPARTIC PROTEINASE COMPLEXED WITH PEPSTATIN A
(-)
Hypocrea jecorina (Trichoderma reesei) (1)
3C9XA:171-326; A:2-170CRYSTAL STRUCTURE OF TRICHODERMA REESEI ASPARTIC PROTEINASE
(-)
Irpex lacteus. Organism_taxid: 5319. (1)
1WKRA:1-170; A:171-340CRYSTAL STRUCTURE OF ASPARTIC PROTEINASE FROM IRPEX LACTEUS
(-)
Malaria parasite p (Plasmodium falciparum) (14)
1LEEA:176-329; A:1-175CRYSTAL STRUCTURE OF PLASMEPSIN FROM P. FALCIPARUM IN COMPLEX WITH INHIBITOR RS367
1LF2A:176-329; A:1-175CRYSTAL STRUCTURE OF PLASMEPSIN II FROM P FALCIPARUM IN COMPLEX WITH INHIBITOR RS370
1LF3A:176-329; A:1-175CRYSTAL STRUCTURE OF PLASMEPSIN II FROM P FALCIPARUM IN COMPLEX WITH INHIBITOR EH58
1LF4A:176-328; A:1-175STRUCTURE OF PLASMEPSIN II
1LS5A:176-328; B:176-328; A:1-175; B:1-175CRYSTAL STRUCTURE OF PLASMEPSIN IV FROM P. FALCIPARUM IN COMPLEX WITH PEPSTATIN A
1M43A:176-329; B:176-329; A:1-175; B:1-175CRYSTAL STRUCTURE OF PMII IN COMPLEX WITH PEPSTATIN A TO 2.4 A
1ME6A:176-329; B:176-329; A:1-175; B:1-175CRYSTAL STRUCTURE OF PLASMEPSIN II, AN ASPARTYL PROTEASE FROM PLASMODIUM FALCIPARUM, IN COMPLEX WITH A STATINE-BASED INHIBITOR
1PFZB:176-327; B:15-175; C:15-175; D:15-175; A:15-175; A:79P-14,A:176-328; C:176-327; D:176-328PROPLASMEPSIN II FROM PLASMODIUM FALCIPARUM
1SMEA:176-329; B:176-329; A:1-175; B:1-175PLASMEPSIN II, A HEMOGLOBIN-DEGRADING ENZYME FROM PLASMODIUM FALCIPARUM, IN COMPLEX WITH PEPSTATIN A
1XDHA:176-329; B:176-329; A:1-175; B:1-175STRUCTURE OF PLASMEPSIN II IN COMPLEX WITH PEPSTATIN A
1XE5A:176-329; A:1-175; B:1-175; B:176-329STRUCTURE OF PLASMEPSIN II IN COMPLEX OF AN PEPSTATIN ANALOGUE
1XE6A:176-329; B:176-329; A:1-175; B:1-175STRUCTURE OF PLASMEPSIN II IN COMPLEX OF AN PEPSTATIN ANALOGUE
2IGXA:176-329; A:1-175ACHIRAL, CHEAP AND POTENT INHIBITORS OF PLASMEPSINS II
2IGYA:176-329; B:176-329; A:1-175; B:1-175ACHIRAL, CHEAP AND POTENT INHIBITORS OF PLASMEPSINS II
(-)
Malaria parasite p (Plasmodium vivax) (2)
1MIQA:176-327; B:176-327; A:1-175; B:1-175CRYSTAL STRUCTURE OF PROPLASMEPSIN FROM THE HUMAN MALARIAL PATHOGEN PLASMODIUM VIVAX
1QS8A:176-327; B:176-327; A:1-175; B:1-175CRYSTAL STRUCTURE OF THE P. VIVAX ASPARTIC PROTEINASE PLASMEPSIN COMPLEXED WITH THE INHIBITOR PEPSTATIN A
(-)
Mucor miehei (Rhizomucor miehei) (2)
2ASIA:187-360; A:6-186ASPARTIC PROTEINASE
2RMPA:187-359; A:6-186RMP-PEPSTATIN A COMPLEX
(-)
Penicillium janthinellum. Organism_taxid: 5079 (7)
1BXOA:171-322; A:6-170ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL CYCLO[(2S)-2-[[(1R)-1-(N-(L-N-(3-METHYLBUTANOYL)VALYL-L-ASPARTYL)AMINO)-3-METHYLBUT YL] HYDROXYPHOSPHINYLOXY]-3-(3-AMINOMETHYL) PHENYLPROPANOATE
1BXQA:171-322; A:6-170ACID PROTEINASE (PENICILLOPEPSIN) COMPLEX WITH PHOSPHONATE INHIBITOR.
2WEAA:171-322; A:6-170ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL[CYCLO-7[(2R)-((N-VALYL) AMINO)-2-(HYDROXYL-(1S)-1-METHYOXYCARBONYL-2-PHENYLETHOXY) PHOSPHINYLOXY-ETHYL]-1-NAPHTHALENEACETAMIDE], SODIUM SALT
2WEBA:171-322; A:6-170ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL(2S)-[1-(((N-FORMYL)-L-VALYL)AMINO-2-(2-NAPHTHYL)ETHYL)HYDROXYPHOSPHINYLOXY]-3-PHENYLPROPANOATE, SODIUM SALT
2WECA:171-322; A:6-170ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL(2S)-[1-(((N-(1-NAPHTHALENEACETYL))-L-VALYL)AMINOMETHYL)HYDROXY PHOSPHINYLOXY]-3-PHENYLPROPANOATE, SODIUM SALT
2WEDA:171-322; A:6-170ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE MACROCYCLIC INHIBITOR:METHYL[CYCLO-7[(2R)-((N-VALYL)AMINO)-2-(HYDROXYL-(1S)-1-METHYOXYCARBONYL-2-PHENYLETHOXY)PHOSPHINYLOXY-ETHYL]-1-NAPHTHALENEACETAMIDE], SODIUM SALT
3APPA:171-322; A:6-170STRUCTURE AND REFINEMENT OF PENICILLOPEPSIN AT 1.8 ANGSTROMS RESOLUTION
(-)
Penicillium janthinellum. Organism_taxid: 5079. (1)
1APUE:171-322; E:6-170CRYSTALLOGRAPHIC ANALYSIS OF A PEPSTATIN ANALOGUE BINDING TO THE ASPARTYL PROTEINASE PENICILLOPEPSIN AT 1.8 ANGSTROMS RESOLUTION
(-)
Penicillium janthinellum. Organism_taxid: 5079. (3)
1PPKE:171-322; E:6-170CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND TO PENICILLOPEPSIN: PHOSPHOROUS-CONTAINING PEPTIDE ANALOGUES
1PPLE:171-322; E:6-170CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION-STATE MIMICS BOUND TO PENICILLOPEPSIN: PHOSPHORUS-CONTAINING PEPTIDE ANALOGUES
1PPME:171-322; E:6-170CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION-STATE MIMICS BOUND TO PENICILLOPEPSIN: PHOSPHORUS-CONTAINING PEPTIDE ANALOGUES
(-)
Penicillium vitale (Penicillium janthinellum) (3)
1APTE:171-322; E:6-170CRYSTALLOGRAPHIC ANALYSIS OF A PEPSTATIN ANALOGUE BINDING TO THE ASPARTYL PROTEINASE PENICILLOPEPSIN AT 1.8 ANGSTROMS RESOLUTION
1APVE:171-322; E:6-170CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND TO PENICILLOPEPSIN: DIFLUOROSTATINE-AND DIFLUOROSTATONE-CONTAINING PEPTIDES
1APWE:171-322; E:6-170CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND TO PENICILLOPEPSIN: DIFLUOROSTATINE-AND DIFLUOROSTATONE-CONTAINING PEPTIDES
(-)
Pig (Sus scrofa) (8)
1F34A:171-325; A:1-170CRYSTAL STRUCTURE OF ASCARIS PEPSIN INHIBITOR-3 BOUND TO PORCINE PEPSIN
1PSAA:171-326; A:1-170; B:1-170; B:171-326STRUCTURE OF A PEPSIN(SLASH)RENIN INHIBITOR COMPLEX REVEALS A NOVEL CRYSTAL PACKING INDUCED BY MINOR CHEMICAL ALTERATIONS IN THE INHIBITOR
1YX9A:171-327; A:1-170EFFECT OF DIMETHYL SULPHOXIDE ON THE CRYSTAL STRUCTURE OF PORCINE PEPSIN
2PSGA:171-326; A:1-170REFINED STRUCTURE OF PORCINE PEPSINOGEN AT 1.8 ANGSTROMS RESOLUTION
3PEPA:171-326; A:1-170REVISED 2.3 ANGSTROMS STRUCTURE OF PORCINE PEPSIN. EVIDENCE FOR A FLEXIBLE SUBDOMAIN
3PSGA:171-325; A:1-170THE HIGH RESOLUTION CRYSTAL STRUCTURE OF PORCINE PEPSINOGEN
4PEPA:171-326; A:1-170THE MOLECULAR AND CRYSTAL STRUCTURES OF MONOCLINIC PORCINE PEPSIN REFINED AT 1.8 ANGSTROMS RESOLUTION
5PEPA:171-327; A:1-170X-RAY ANALYSES OF ASPARTIC PROTEASES. II. THREE-DIMENSIONAL STRUCTURE OF THE HEXAGONAL CRYSTAL FORM OF PORCINE PEPSIN AT 2.3 ANGSTROMS RESOLUTION
(-)
Plasmodium falciparum 3d7. Organism_taxid: 36329. (1)
3FNSA:173-326; B:173-326; A:0-172; B:0-172CRYSTAL STRUCTURE OF HISTO-ASPARTIC PROTEASE (HAP) FROM PLASMODIUM FALCIPARUM
(-)
Plasmodium falciparum 3d7. Organism_taxid: 36329. Strain: 3d7. (3)
2R9BA:176-329; B:176-329; A:1-175; B:1-175STRUCTURAL ANALYSIS OF PLASMEPSIN 2 FROM PLASMODIUM FALCIPARUM COMPLEXED WITH A PEPTIDE-BASED INHIBITOR
3FNTA:173-326; A:2-172CRYSTAL STRUCTURE OF PEPSTATIN A BOUND HISTO-ASPARTIC PROTEASE (HAP) FROM PLASMODIUM FALCIPARUM
3FNUA:173-327; B:0-172; C:0-172; D:0-172; B:173-327; C:173-327; D:173-327; A:0-172CRYSTAL STRUCTURE OF KNI-10006 BOUND HISTO-ASPARTIC PROTEASE (HAP) FROM PLASMODIUM FALCIPARUM
(-)
Plasmodium falciparum. Organism_taxid: 5833. (4)
1W6HA:176-329; B:176-329; A:1-175; B:1-175NOVEL PLASMEPSIN II-INHIBITOR COMPLEX
1W6IA:176-329; A:1-175; C:1-175; C:176-329PLASMEPSIN II-PEPSTATIN A COMPLEX
2BJUA:176-329; A:1-175PLASMEPSIN II COMPLEXED WITH A HIGHLY ACTIVE ACHIRAL INHIBITOR
3F9QA:176-329; A:1-175RE-REFINEMENT OF UNCOMPLEXED PLASMEPSIN II FROM PLASMODIUM FALCIPARUM.
(-)
Plasmodium malariae. Organism_taxid: 5858. (1)
2ANLA:176-327; B:176-327; A:1-175; B:1-175X-RAY CRYSTAL STRUCTURE OF THE ASPARTIC PROTEASE PLASMEPSIN 4 FROM THE MALARIAL PARASITE PLASMODIUM MALARIAE BOUND TO AN ALLOPHENYLNORSTATINE BASED INHIBITOR
(-)
Pneumophila str (Legionella pneumophila subsp) (1)
2PMAA:23-158; B:23-158STRUCTURAL GENOMICS, THE CRYSTAL STRUCTURE OF A PROTEIN LPG0085 WITH UNKNOWN FUNCTION (DUF785) FROM LEGIONELLA PNEUMOPHILA SUBSP. PNEUMOPHILA STR. PHILADELPHIA 1.
(-)
Rhizomucor pusillus. Organism_taxid: 4840 (1)
1MPPA:170-332; A:1-169X-RAY ANALYSES OF ASPARTIC PROTEINASES. V. STRUCTURE AND REFINEMENT AT 2.0 ANGSTROMS RESOLUTION OF THE ASPARTIC PROTEINASE FROM MUCOR PUSILLUS
(-)
Rous sarcoma virus. (1)
1BAIA:1-124; B:1-124CRYSTAL STRUCTURE OF ROUS SARCOMA VIRUS PROTEASE IN COMPLEX WITH INHIBITOR
(-)
Rous sarcoma virus. Organism_taxid: 11886 (1)
2RSPA:1-124; B:1-124STRUCTURE OF THE ASPARTIC PROTEASE FROM ROUS SARCOMA RETROVIRUS REFINED AT 2 ANGSTROMS RESOLUTION
(-)
Simian immunodeficiency virus. Organism_taxid: 11723 (1)
1SIVA:1-99; B:1-99THREE-DIMENSIONAL STRUCTURE OF A SIV PROTEASE(SLASH)INHIBITOR COMPLEX. IMPLICATIONS FOR THE DESIGN OF HIV-1 AND HIV-2 PROTEASE INHIBITORS
(-)
Simian immunodeficiency virus. Organism_taxid: 11723. (1)
1TCWA:1-99; B:1-99SIV PROTEASE COMPLEXED WITH INHIBITOR SB203386
(-)
Simian immunodeficiency virus. Organism_taxid: 11723. Cell_line: s2. (1)
1SIPA:1-99ALTERNATIVE NATIVE FLAP CONFORMATION REVEALED BY 2.3 ANGSTROMS RESOLUTION STRUCTURE OF SIV PROTEINASE
(-)
Simian immunodeficiency virus. Organism_taxid: 11723. Expression_system_vector_type: plasmid (1)
2SAMA:1-99STRUCTURE OF THE PROTEASE FROM SIMIAN IMMUNODEFICIENCY VIRUS: COMPLEX WITH AN IRREVERSIBLE NON-PEPTIDE INHIBITOR
(-)
Simian immunodeficiency virus. Organism_taxid: 11723. Strain: x90. (2)
1YTIA:1-99SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT
1YTJA:1-99SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT
(-)
Simian immunodeficiency virus. Organism_taxid: 11723. Strain: x90. Variant: siv(mac)239. (1)
1AZ5A:1-99UNLIGANDED SIV PROTEASE STRUCTURE IN AN "OPEN" CONFORMATION
(-)
Simian retrovirus 1. Organism_taxid: 11942. (1)
1NSOA:1-107FOLDED MONOMER OF PROTEASE FROM MASON-PFIZER MONKEY VIRUS
(-)
Wheat (Triticum aestivum) (1)
3HD8C:1-182; A:1-182; C:183-385; A:183-386CRYSTAL STRUCTURE OF THE TRITICUM AESTIVUM XYLANASE INHIBITOR-IIA IN COMPLEX WITH BACILLUS SUBTILIS XYLANASE
(-)
Yeast (Candida albicans) (2)
2QZWA:173-342; B:173-342; A:1-172; B:1-172SECRETED ASPARTIC PROTEINASE (SAP) 1 FROM CANDIDA ALBICANS
2QZXA:173-342; B:173-342; A:1-172; B:1-172SECRETED ASPARTIC PROTEINASE (SAP) 5 FROM CANDIDA ALBICANS
(-)
Topology: conserved putative lor/sdh protein from methanococcus maripaludis s2 fold (1)
(-)
Homologous Superfamily: conserved putative lor/sdh protein from methanococcus maripaludis s2 domain (1)
(-)
Methanococcus maripaludis s2. Organism_taxid: 267377. Strain: s2 / ll. (1)
3C2QA:73-160; B:78-166CRYSTAL STRUCTURE OF CONSERVED PUTATIVE LOR/SDH PROTEIN FROM METHANOCOCCUS MARIPALUDIS S2
(-)
Topology: CV3147-like (1)
(-)
Homologous Superfamily: CV3147-like (1)
(-)
Chromobacterium violaceum. Organism_taxid: 536. Strain: hamap536. (1)
2O3IA:241-381; B:241-381X-RAY CRYSTAL STRUCTURE OF PROTEIN CV_3147 FROM CHROMOBACTERIUM VIOLACEUM. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET CVR68.
(-)
Topology: Cyclophilin (95)
(-)
Homologous Superfamily: Cyclophilin (95)
(-)
Bacillus cereus atcc 14579. Organism_taxid: 226900. Strain: atcc 14579/ dsm 31. (1)
1X7FA:243-361CRYSTAL STRUCTURE OF AN UNCHARACTERIZED B. CEREUS PROTEIN
(-)
Bacillus subtilis. Organism_taxid: 1423. Strain: 168. (1)
2ZP2B:100-231; A:100-231C-TERMINAL DOMAIN OF KIPI FROM BACILLUS SUBTILIS
(-)
Baker's yeast (Saccharomyces cerevisiae) (2)
1ISTA:2-162; B:2-162CRYSTAL STRUCTURE OF YEAST CYCLOPHILIN A, CPR1
1VDNA:2-162CRYSTAL STRUCTURE OF YEAST CYCLOPHILIN A COMPLEXED WITH ACE-ALA-ALA-PRO-ALA-7-AMINO-4-METHYLCOUMARIN
(-)
Brugia malayi. Organism_taxid: 6279. (3)
1A33A:4-177PEPTIDYLPROLYL ISOMERASE, CYCLOPHILIN-LIKE DOMAIN FROM BRUGIA MALAYI
1A58A:1-177CYCLOPHILIN FROM BRUGIA MALAYI
1C5FG:6-177; O:6-177; I:5-177; E:4-177; K:3-177; M:3-177; A:1-177; C:1-177CRYSTAL STRUCTURE OF THE CYCLOPHILIN-LIKE DOMAIN FROM BRUGIA MALAYI COMPLEXED WITH CYCLOSPORIN A
(-)
Caenorhabditis elegans. Organism_taxid: 6239. (2)
1DYWA:1-172BIOCHEMICAL AND STRUCTURAL CHARACTERIZATION OF A DIVERGENT LOOP CYCLOPHILIN FROM CAENORHABDITIS ELEGANS
1E8KA:1-172CYCLOPHILIN 3 COMPLEXED WITH DIPEPTIDE ALA-PRO
(-)
Caenorhabditis elegans. Organism_taxid: 6239. (2)
1E3BA:1-172CYCLOPHILIN 3 FROM C.ELEGANS COMPLEXED WITH AUP(ET)3
1H0PA:22-203CYCLOPHILIN_5 FROM C. ELEGANS
(-)
Cattle (Bos taurus) (2)
1IHGA:2-185BOVINE CYCLOPHILIN 40, MONOCLINIC FORM
1IIPA:2-185BOVINE CYCLOPHILIN 40, TETRAGONAL FORM
(-)
Cryptosporidium parvum iowa ii. Organism_taxid: 353152. Strain: iowa type ii. (2)
2POEA:15-177CRYSTAL STRUCTURE OF CRYPTOSPORIDIUM PARVUM CYCLOPHILIN TYPE PEPTIDYL-PROLYL CIS-TRANS ISOMERASE CGD2_1660
2QERA:17-176CRYSTAL STRUCTURE OF CRYPTOSPORIDIUM PARVUM CYCLOPHILIN TYPE PEPTIDYL-PROLYL CIS-TRANS ISOMERASE CGD2_1660 IN THE PRESENCE OF DIPEPTIDE ALA-PRO
(-)
Enterococcus faecalis v583. Organism_taxid: 226185. Strain: v583. (1)
2P0OA:239-369CRYSTAL STRUCTURE OF A CONSERVED PROTEIN FROM LOCUS EF_2437 IN ENTEROCOCCUS FAECALIS WITH AN UNKNOWN FUNCTION
(-)
Escherichia coli. Organism_taxid: 562 (1)
2NULA:1-163PEPTIDYLPROLYL ISOMERASE FROM E. COLI
(-)
Escherichia coli. Organism_taxid: 562. (2)
1CLHA:1-166THREE-DIMENSIONAL SOLUTION STRUCTURE OF ESCHERICHIA COLI PERIPLASMIC CYCLOPHILIN
1LOPA:1-164CYCLOPHILIN A COMPLEXED WITH SUCCINYL-ALA-PRO-ALA-P-NITROANILIDE
(-)
Escherichia coli. Organism_taxid: 562. (3)
1J2AA:1-166STRUCTURE OF E. COLI CYCLOPHILIN B K163T MUTANT
1V9TA:1-166; B:1-166STRUCTURE OF E. COLI CYCLOPHILIN B K163T MUTANT BOUND TO SUCCINYL-ALA-PRO-ALA-P-NITROANILIDE
1VAIA:1-166; B:1-166STRUCTURE OF E. COLI CYCLOPHILIN B K163T MUTANT BOUND TO N-ACETYL-ALA-ALA-PRO-ALA-7-AMINO-4-METHYLCOUMARIN
(-)
Homo sapiens. (2)
2RMAA:1-165; C:1-165; E:1-165; G:1-165; I:1-165; K:1-165; M:1-165; O:1-165; Q:1-165; S:1-165CRYSTAL STRUCTURES OF CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN A AND N-METHYL-4-[(E)-2-BUTENYL]-4,4-DIMETHYLTHREONINE CYCLOSPORIN A
2RMBA:1-165; C:1-165; E:1-165; G:1-165; I:1-165; K:1-165; M:1-165; O:1-165; Q:1-165; S:1-165CRYSTAL STRUCTURES OF CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN A AND N-METHYL-4-[(E)-2-BUTENYL]-4,4-DIMETHYLTHREONINE CYCLOSPORIN A
(-)
Human (Homo sapiens) (58)
1AK4A:1-165; B:3-165HUMAN CYCLOPHILIN A BOUND TO THE AMINO-TERMINAL DOMAIN OF HIV-1 CAPSID
1AWQA:1002-1165CYPA COMPLEXED WITH HAGPIA (PSEUDO-SYMMETRIC MONOMER)
1AWRA:1002-1165; C:1002-1165; D:1002-1165; E:1002-1165; F:1002-1165; B:1002-1165CYPA COMPLEXED WITH HAGPIA
1AWSA:1002-1165SECYPA COMPLEXED WITH HAGPIA (PSEUDO-SYMMETRIC MONOMER)
1AWTA:1002-1165; B:1002-1165; C:1002-1165; D:1002-1165; E:1002-1165; F:1002-1165SECYPA COMPLEXED WITH HAGPIA
1AWUA:1002-1165CYPA COMPLEXED WITH HVGPIA (PSEUDO-SYMMETRIC MONOMER)
1AWVA:1002-1165; B:1002-1165; C:1002-1165; D:1002-1165; E:1002-1165; F:1002-1165CYPA COMPLEXED WITH HVGPIA
1BCKA:1-165HUMAN CYCLOPHILIN A COMPLEXED WITH 2-THR CYCLOSPORIN
1CWAA:1-165X-RAY STRUCTURE OF A MONOMERIC CYCLOPHILIN A-CYCLOSPORIN A CRYSTAL COMPLEX AT 2.1 ANGSTROMS RESOLUTION
1CWBA:1-165THE X-RAY STRUCTURE OF (MEBM2T)1-CYCLOSPORIN COMPLEXED WITH CYCLOPHILIN A PROVIDES AN EXPLANATION FOR ITS ANOMALOUSLY HIGH IMMUNOSUPPRESSIVE ACTIVITY
1CWCA:1-165IMPROVED BINDING AFFINITY FOR CYCLOPHILIN A BY A CYCLOSPORIN DERIVATIVE SINGLY MODIFIED AT ITS EFFECTOR DOMAIN
1CWFA:1-165HUMAN CYCLOPHILIN A COMPLEXED WITH 2-VAL CYCLOSPORIN
1CWHA:1-165HUMAN CYCLOPHILIN A COMPLEXED WITH 3-D-SER CYCLOSPORIN
1CWIA:1-165HUMAN CYCLOPHILIN A COMPLEXED WITH 2-VAL 3-(N-METHYL)-D-ALANINE CYCLOSPORIN
1CWJA:1-165HUMAN CYCLOPHILIN A COMPLEXED WITH 2-VAL 3-S-METHYL-SARCOSINE CYCLOSPORIN
1CWKA:1-165HUMAN CYCLOPHILIN A COMPLEXED WITH 1-(6,7-DIHYDRO)MEBMT 2-VAL 3-D-(2-S-METHYL)SARCOSINE CYCLOSPORIN
1CWLA:1-165HUMAN CYCLOPHILIN A COMPLEXED WITH 4 4-HYDROXY-MELEU CYCLOSPORIN
1CWMA:1-165HUMAN CYCLOPHILIN A COMPLEXED WITH 4 MEILE CYCLOSPORIN
1CWOA:1-165HUMAN CYCLOPHILIN A COMPLEXED WITH THR2, LEU5, D-HIV8, LEU10 CYCLOSPORIN
1CYNA:7-184CYCLOPHILIN B COMPLEXED WITH [D-(CHOLINYLESTER)SER8]-CYCLOSPORIN
1FGLA:1-165CYCLOPHILIN A COMPLEXED WITH A FRAGMENT OF HIV-1 GAG PROTEIN
1M63C:1-165; G:1-165CRYSTAL STRUCTURE OF CALCINEURIN-CYCLOPHILIN-CYCLOSPORIN SHOWS COMMON BUT DISTINCT RECOGNITION OF IMMUNOPHILIN-DRUG COMPLEXES
1M9CA:1-165; B:3-165X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/HIV-1 CA N-TERMINAL DOMAIN (1-146) M-TYPE COMPLEX.
1M9DA:1-165; B:3-165X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/HIV-1 CA N-TERMINAL DOMAIN (1-146) O-TYPE CHIMERA COMPLEX.
1M9EA:1-164; B:3-164X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/HIV-1 CA N-TERMINAL DOMAIN (1-146) M-TYPE H87A COMPLEX.
1M9FA:1-165; B:2-165X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/HIV-1 CA N-TERMINAL DOMAIN (1-146) M-TYPE H87A,A88M COMPLEX.
1M9XA:1-165; E:1-165; B:2-165; F:2-165X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/HIV-1 CA N-TERMINAL DOMAIN (1-146) M-TYPE H87A,A88M,G89A COMPLEX.
1M9YA:1-165; E:1-165; B:2-165; F:2-165X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/HIV-1 CA N-TERMINAL DOMAIN (1-146) M-TYPE H87A,G89A COMPLEX.
1MF8C:1-164CRYSTAL STRUCTURE OF HUMAN CALCINEURIN COMPLEXED WITH CYCLOSPORIN A AND HUMAN CYCLOPHILIN
1MIKA:1-165THE ROLE OF WATER MOLECULES IN THE STRUCTURE-BASED DESIGN OF (5-HYDROXYNORVALINE)-2-CYCLOSPORIN: SYNTHESIS, BIOLOGICAL ACTIVITY, AND CRYSTALLOGRAPHIC ANALYSIS WITH CYCLOPHILIN A
1MZWA:5-177CRYSTAL STRUCTURE OF A U4/U6 SNRNP COMPLEX BETWEEN HUMAN SPLICEOSOMAL CYCLOPHILIN H AND A U4/U6-60K PEPTIDE
1NMKA:1-165; B:1-165THE SANGLIFEHRIN-CYCLOPHILIN INTERACTION: DEGRADATION WORK, SYNTHETIC MACROCYCLIC ANALOGUES, X-RAY CRYSTAL STRUCTURE AND BINDING DATA
1OCAA:1-165HUMAN CYCLOPHILIN A, UNLIGATED, NMR, 20 STRUCTURES
1QOIA:5-177U4/U6 SNRNP-SPECIFIC CYCLOPHILIN SNUCYP-20
1RMHA:2-165; B:2-165RECOMBINANT CYCLOPHILIN A FROM HUMAN T CELL
1VBSA:2-165STRUCTURE OF CYCLOPHILIN COMPLEXED WITH (D)ALA CONTAINING TETRAPEPTIDE
1VBTA:2-165; B:2-165STRUCTURE OF CYCLOPHILIN COMPLEXED WITH SULFUR-SUBSTITUTED TETRAPEPTIDE AAPF
1W8LA:1-165ENZYMATIC AND STRUCTURAL CHARACTERIZATION OF NON PEPTIDE LIGAND CYCLOPHILIN COMPLEXES
1W8MA:1-165ENZYMATIC AND STRUCTURAL CHARACTERISATION OF NON PEPTIDE LIGAND CYCLOPHILIN COMPLEXES
1W8VA:1-165ENZYMATIC AND STRUCTURAL CHARACTERIZATION OF NON PEPTIDE LIGAND CYCLOPHILIN COMPLEXES
1XWNA:1-166SOLUTION STRUCTURE OF CYCLOPHILIN LIKE 1(PPIL1) AND INSIGHTS INTO ITS INTERACTION WITH SKIP
1XYHA:1-160CRYSTAL STRUCTURE OF RECOMBINANT HUMAN CYCLOPHILIN J
1YNDA:2-165; B:2-165STRUCTURE OF HUMAN CYCLOPHILIN A IN COMPLEX WITH THE NOVEL IMMUNOSUPPRESSANT SANGLIFEHRIN A AT 1.6A RESOLUTION
1ZKCB:279-438; A:271-457CRYSTAL STRUCTURE OF THE CYCLOPHILN_RING DOMAIN OF HUMAN PEPTIDYLPROLYL ISOMERASE (CYCLOPHILIN)-LIKE 2 ISOFORM B
1ZKFA:1-165; B:2-165CYRSTAL STRUCTURE OF HUMAN CYCLOPHILIN-A IN COMPLEX WITH SUC-AGPF-PNA
1ZMFA:139-300C DOMAIN OF HUMAN CYCLOPHILIN-33(HCYP33)
2A2NC:482-646; A:483-646; B:483-646CRYSTAL STRUCTURE OF THE PEPTIDYLPROLYL ISOMERASE DOMAIN OF HUMAN PPWD1
2ALFA:2-165CRYSTAL STRUCTURE OF HUMAN CYPA MUTANT K131A
2BITX:2-165CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN D AT 1.7 A RESOLUTION
2BIUX:2-165CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN D AT 1.7 A RESOLUTION, DMSO COMPLEX
2CPLA:2-165SIMILARITIES AND DIFFERENCES BETWEEN HUMAN CYCLOPHILIN A AND OTHER BETA-BARREL STRUCTURES. STRUCTURAL REFINEMENT AT 1.63 ANGSTROMS RESOLUTION
2CYHA:2-165CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE ALA-PRO
2ESLA:32-212; B:32-212; C:32-212; D:32-212; E:32-212; F:32-212HUMAN CYCLOPHILIN C IN COMPLEX WITH CYCLOSPORIN A
2R99A:138-301CRYSTAL STRUCTURE OF CYCLOPHILIN ABH-LIKE DOMAIN OF HUMAN PEPTIDYLPROLYL ISOMERASE E ISOFORM 1
3CYHA:2-165CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE SER-PRO
3CYSA:1-165DETERMINATION OF THE NMR SOLUTION STRUCTURE OF THE CYCLOPHILIN A-CYCLOSPORIN A COMPLEX
4CYHA:2-165CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE HIS-PRO
5CYHA:2-165CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE GLY-PRO
(-)
Leishmania donovani. Organism_taxid: 5661. (1)
2HAQA:22-187CRYSTAL STRUCTURE OF CYCLOPHILIN A FROM LEISHMANIA DONOVANI
(-)
Leishmania major. Organism_taxid: 5664. (1)
2HQJA:1-179CYCLOPHILIN FROM LEISHMANIA MAJOR
(-)
Mus musculus. (1)
2RMCA:31-212; C:31-212; E:31-212; G:31-212CRYSTAL STRUCTURE OF MURINE CYCLOPHILIN C COMPLEXED WITH IMMUNOSUPPRESSIVE DRUG CYCLOSPORIN A
(-)
Mycobacterium tuberculosis. Organism_taxid: 83332. Strain: h37rv. (1)
1W74A:12-182; B:12-182X-RAY STRUCTURE OF PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A, PPIA, RV0009, FROM MYCOBACTERIUM TUBERCULOSIS.
(-)
Plasmodium falciparum. Organism_taxid: 5833. (2)
1QNGA:2-171PLASMODIUM FALCIPARUM CYCLOPHILIN COMPLEXED WITH CYCLOSPORIN A
1QNHA:3-171; B:2-171PLASMODIUM FALCIPARUM CYCLOPHILIN (DOUBLE MUTANT) COMPLEXED WITH CYCLOSPORIN A
(-)
Plasmodium yoelii yoelii. Organism_taxid: 73239. Strain: yoelii. (1)
1Z81A:25-210CRYSTAL STRUCTURE OF CYCLOPHILIN FROM PLASMODIUM YOELII.
(-)
Plasmodium yoelii. Organism_taxid: 5861. (1)
2B71A:23-191PLASMODIUM YOELII CYCLOPHILIN-LIKE PROTEIN
(-)
Pyrococcus horikoshii ot3. Organism_taxid: 70601. Strain: ot3. (1)
2PHCB:85-217CRYSTAL STRUCTURE OF CONSERVED UNCHARACTERIZED PROTEIN PH0987 FROM PYROCOCCUS HORIKOSHII
(-)
Toxoplasma gondii. Organism_taxid: 5811. (2)
3BKPA:12-206CRYSTAL STRUCTURE OF THE TOXOPLASMA GONDII CYCLOPHILIN, 49.M03261
3BO7B:5-177; A:5-176; D:4-177; C:5-177CRYSTAL STRUCTURE OF TOXOPLASMA GONDII PEPTIDYL-PROLYL CIS-TRANS ISOMERASE, 541.M00136
(-)
Trypanosoma cruzi. Organism_taxid: 5693. (2)
1XO7A:1-166; B:1-166; C:1-166; D:1-166CRYSTAL STRUCTURE OF CYCLOPHILIN FROM TRYPANOSOMA CRUZI
1XQ7A:1-166; B:1-166; C:1-166CYCLOPHILIN FROM TRYPANOSOMA CRUZI BOUND TO CYCLOSPORIN A
(-)
Topology: Dna-directed Rna Polymerase Ii 140kd Polypeptide; Chain: B; Domain 6 (18)
(-)
Homologous Superfamily: [code=2.40.270.10, no name defined] (18)
(-)
[unclassified] (3)
2O5IC:1-6,C:668-700,C:833-997; M:1-6,M:668-700,M:833-997CRYSTAL STRUCTURE OF THE T. THERMOPHILUS RNA POLYMERASE ELONGATION COMPLEX
2O5JC:1-6,C:668-700,C:833-997; M:1-6,M:668-700,M:833-997CRYSTAL STRUCTURE OF THE T. THERMOPHILUS RNAP POLYMERASE ELONGATION COMPLEX WITH THE NTP SUBSTRATE ANALOG
2PPBC:1-6,C:668-700,C:833-997; M:1-6,M:668-700,M:833-997CRYSTAL STRUCTURE OF THE T. THERMOPHILUS RNAP POLYMERASE ELONGATION COMPLEX WITH THE NTP SUBSTRATE ANALOG AND ANTIBIOTIC STREPTOLYDIGIN
(-)
Thermus aquaticus. Organism_taxid: 271. Thermus aquaticus. Organism_taxid: 271. Thermus aquaticus. Organism_taxid: 271. (4)
1HQMC:2-8,C:668-702,C:831-1004CRYSTAL STRUCTURE OF THERMUS AQUATICUS CORE RNA POLYMERASE-INCLUDES COMPLETE STRUCTURE WITH SIDE-CHAINS (EXCEPT FOR DISORDERED REGIONS)-FURTHER REFINED FROM ORIGINAL DEPOSITION-CONTAINS ADDITIONAL SEQUENCE INFORMATION
1I6VC:2-8,C:668-702,C:831-1004THERMUS AQUATICUS CORE RNA POLYMERASE-RIFAMPICIN COMPLEX
1YNJC:1-8,C:668-702,C:831-1004TAQ RNA POLYMERASE-SORANGICIN COMPLEX
1YNNC:1-8,C:668-702,C:831-1004TAQ RNA POLYMERASE-RIFAMPICIN COMPLEX
(-)
Thermus thermophilus hb8. Organism_taxid: 300852. Thermus thermophilushb8. Organism_taxid: 300852. Thermus thermophilus hb8. Organism_taxid: 300852. Thermus thermophilus hb8. Organism_taxid: 300852. (1)
3DXJC:1-6,C:668-700,C:833-997; M:1-6,M:668-700,M:833-997CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS RNA POLYMERASE HOLOENZYME IN COMPLEX WITH THE ANTIBIOTIC MYXOPYRONIN
(-)
Thermus thermophilus. Organism_taxid: 274. Thermus thermophilus hb8. Organism_taxid: 300852. Strain: hb8. Thermus thermophilus hb8. Organism_taxid: 300852. Strain: hb8. Thermus thermophilus. Organism_taxid: 274. (1)
2CW0C:2-8,C:668-698,C:832-1004; M:2-8,M:668-698,M:832-1004CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS RNA POLYMERASE HOLOENZYME AT 3.3 ANGSTROMS RESOLUTION
(-)
Thermus thermophilus. Organism_taxid: 274. Thermus thermophilus. Organism_taxid: 274. Thermus thermophilus. Organism_taxid: 274. Thermus thermophilus. Organism_taxid: 274. (9)
1IW7M:2-8,M:668-698,M:832-1004; C:1-6,C:668-700,C:833-997CRYSTAL STRUCTURE OF THE RNA POLYMERASE HOLOENZYME FROM THERMUS THERMOPHILUS AT 2.6A RESOLUTION
1SMYC:2-8,C:668-698,C:832-1004; M:2-8,M:668-698,M:832-1004STRUCTURAL BASIS FOR TRANSCRIPTION REGULATION BY ALARMONE PPGPP
1ZYRC:2-8,C:668-698,C:832-1004; M:2-8,M:668-698,M:832-1004STRUCTURE OF THERMUS THERMOPHILUS RNA POLYMERASE HOLOENZYME IN COMPLEX WITH THE ANTIBIOTIC STREPTOLYDIGIN
2A68C:2-8,C:668-698,C:832-1004; M:2-8,M:668-698,M:832-1004CRYSTAL STRUCTURE OF THE T. THERMOPHILUS RNA POLYMERASE HOLOENZYME IN COMPLEX WITH ANTIBIOTIC RIFABUTIN
2A69C:2-8,C:668-698,C:832-1004; M:2-8,M:668-698,M:832-1004CRYSTAL STRUCTURE OF THE T. THERMOPHILUS RNA POLYMERASE HOLOENZYME IN COMPLEX WITH ANTIBIOTIC RIFAPENTIN
2A6EC:2-8,C:668-698,C:832-1004; M:2-8,M:668-698,M:832-1004CRYSTAL STRUCTURE OF THE T. THERMOPHILUS RNA POLYMERASE HOLOENZYME
2A6HC:2-8,C:668-698,C:832-1004; M:2-8,M:668-698,M:832-1004CRYSTAL STRUCTURE OF THE T. THERMOPHILUS RNA POLYMERASE HOLOENZYME IN COMPLEX WITH ANTIBIOTIC STERPTOLYDIGIN
2BE5C:2-8,C:668-698,C:832-1004; M:2-8,M:668-698,M:832-1004CRYSTAL STRUCTURE OF THE T. THERMOPHILUS RNA POLYMERASE HOLOENZYME IN COMPLEX WITH INHIBITOR TAGETITOXIN
3EQLC:1-6,C:668-700,C:833-997; M:1-6,M:668-700,M:833-997CRYSTAL STRUCTURE OF THE T. THERMOPHILUS RNA POLYMERASE HOLOENZYME IN COMPLEX WITH ANTIBIOTIC MYXOPYRONIN
(-)
Topology: Elongation Factor Tu (Ef-tu); domain 3 (323)
(-)
Homologous Superfamily: [code=2.40.30.20, no name defined] (40)
(-)
Baker's yeast (Saccharomyces cerevisiae) (3)
2HLDK:21-95; B:25-95; A:26-95; C:26-95; J:26-95; L:26-95; T:26-95; U:26-95; S:27-95CRYSTAL STRUCTURE OF YEAST MITOCHONDRIAL F1-ATPASE
2WPDB:25-95; A:26-95; C:26-95THE MG.ADP INHIBITED STATE OF THE YEAST F1C10 ATP SYNTHASE
2XOKB:25-95; A:26-95; C:26-95REFINED STRUCTURE OF YEAST F1C10 ATPASE COMPLEX TO 3 A RESOLUTION
(-)
Bovine (Bos taurus) (17)
1E1QA:24-93; B:24-93; C:24-93BOVINE MITOCHONDRIAL F1-ATPASE AT 100K
1E1RA:24-93; B:24-93; C:24-93BOVINE MITOCHONDRIAL F1-ATPASE INHIBITED BY MG2+ADP AND ALUMINIUM FLUORIDE
1E79A:24-93; B:24-93; C:24-93BOVINE F1-ATPASE INHIBITED BY DCCD (DICYCLOHEXYLCARBODIIMIDE)
1H8EA:24-93; B:24-93; C:24-93(ADP.ALF4)2(ADP.SO4) BOVINE F1-ATPASE (ALL THREE CATALYTIC SITES OCCUPIED)
1H8HA:24-93; B:24-93; C:24-93BOVINE MITOCHONDRIAL F1-ATPASE CRYSTALLISED IN THE PRESENCE OF 5MM AMPPNP
1OHHA:24-93; B:24-93; C:24-93BOVINE MITOCHONDRIAL F1-ATPASE COMPLEXED WITH THE INHIBITOR PROTEIN IF1
1W0JA:24-93; B:24-93; C:24-93BERYLLIUM FLUORIDE INHIBITED BOVINE F1-ATPASE
1W0KA:24-93; B:24-93; C:24-93ADP INHIBITED BOVINE F1-ATPASE
2CK3A:24-93; B:24-93; C:24-93AZIDE INHIBITED BOVINE F1-ATPASE
2JDIA:24-93; B:24-93; C:24-93GROUND STATE STRUCTURE OF F1-ATPASE FROM BOVINE HEART MITOCHONDRIA (BOVINE F1-ATPASE CRYSTALLISED IN THE ABSENCE OF AZIDE)
2JIZA:24-93; B:24-93; C:24-93; H:24-93; I:24-93; J:24-93THE STRUCTURE OF F1-ATPASE INHIBITED BY RESVERATROL.
2JJ1A:24-93; B:24-93; C:24-93; H:24-93; I:24-93; J:24-93THE STRUCTURE OF F1-ATPASE INHIBITED BY PICEATANNOL.
2JJ2A:24-93; B:24-93; C:24-93; H:24-93; I:24-93; J:24-93THE STRUCTURE OF F1-ATPASE INHIBITED BY QUERCETIN.
2W6IA:24-93; B:24-93; C:24-93LOW RESOLUTION STRUCTURES OF BOVINE MITOCHONDRIAL F1-ATPASE DURING CONTROLLED DEHYDRATION: HYDRATION STATE 4B.
2W6JA:24-93; B:24-93; C:24-93LOW RESOLUTION STRUCTURES OF BOVINE MITOCHONDRIAL F1-ATPASE DURING CONTROLLED DEHYDRATION: HYDRATION STATE 5.
2WSSB:24-93; J:24-93; K:24-93; C:27-93; L:30-93; A:1-93THE STRUCTURE OF THE MEMBRANE EXTRINSIC REGION OF BOVINE ATP SYNTHASE
2XNDA:24-93; B:24-93; C:24-93CRYSTAL STRUCTURE OF BOVINE F1-C8 SUB-COMPLEX OF ATP SYNTHASE
(-)
Cattle (Bos taurus) (4)
1BMFA:24-93; B:24-93; C:24-93BOVINE MITOCHONDRIAL F1-ATPASE
1COWA:24-93; B:24-93; C:24-93BOVINE MITOCHONDRIAL F1-ATPASE COMPLEXED WITH AUROVERTIN B
1EFRA:24-93; B:24-93; C:24-93BOVINE MITOCHONDRIAL F1-ATPASE COMPLEXED WITH THE PEPTIDE ANTIBIOTIC EFRAPEPTIN
1NBMA:24-93; B:24-93; C:24-93THE STRUCTURE OF BOVINE F1-ATPASE COVALENTLY INHIBITED WITH 4-CHLORO-7-NITROBENZOFURAZAN
(-)
Coliphage k1f. Organism_taxid: 344021. (2)
1V0ED:425-509; A:424-510; B:424-510; C:424-510; E:424-510; F:424-510ENDOSIALIDASE OF BACTERIOPHAGE K1F
1V0FF:425-505; B:424-508; D:424-508; A:425-506; C:424-510; E:424-510ENDOSIALIDASE OF BACTERIOPHAGE K1F IN COMPLEX WITH OLIGOMERIC ALPHA-2,8-SIALIC ACID
(-)
Cow (Bos taurus) (1)
2V7QA:24-93; B:24-93; C:24-93THE STRUCTURE OF F1-ATPASE INHIBITED BY I1-60HIS, A MONOMERIC FORM OF THE INHIBITOR PROTEIN, IF1.
(-)
Escherichia coli. Organism_taxid: 562. (2)
1I8DC:102-199; B:102-205; A:102-206; A:1-89; B:1-89; C:1-89CRYSTAL STRUCTURE OF RIBOFLAVIN SYNTHASE
1PKVA:1-87; B:1-87THE N-TERMINAL DOMAIN OF RIBOFLAVIN SYNTHASE IN COMPLEX WITH RIBOFLAVIN
(-)
Escherichia coli. Organism_taxid: 562. (2)
1HZEA:1-97; B:1-97SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF RIBOFLAVIN SYNTHASE FROM E. COLI
1I18A:1-97; B:1-97SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF RIBOFLAVIN SYNTHASE FROM E. COLI
(-)
Fission yeast (Schizosaccharomyces pombe) (1)
1KZLA:1-89; A:102-202RIBOFLAVIN SYNTHASE FROM S.POMBE BOUND TO CARBOXYETHYLLUMAZINE
(-)
Norway rat (Rattus norvegicus) (2)
1MABA:24-93RAT LIVER F1-ATPASE
2F43A:24-93RAT LIVER F1-ATPASE
(-)
Ps3 (Bacillus sp) (1)
1SKYB:24-93CRYSTAL STRUCTURE OF THE NUCLEOTIDE FREE ALPHA3BETA3 SUB-COMPLEX OF F1-ATPASE FROM THE THERMOPHILIC BACILLUS PS3
(-)
Spinach (Spinacia oleracea) (2)
1FX0A:25-94CRYSTAL STRUCTURE OF THE CHLOROPLAST F1-ATPASE FROM SPINACH
1KMHA:25-94CRYSTAL STRUCTURE OF SPINACH CHLOROPLAST F1-ATPASE COMPLEXED WITH TENTOXIN
(-)
Ta2 (Bacillus sp) (1)
2QE7A:27-93; B:27-93; C:27-93CRYSTAL STRUCTURE OF THE F1-ATPASE FROM THE THERMOALKALIPHILIC BACTERIUM BACILLUS SP. TA2.A1
(-)
Thermotoga maritima msb8. Organism_taxid: 243274. Strain: msb8, dsm 3109, jcm 10099. (1)
2R9VA:24-94CRYSTAL STRUCTURE OF ATP SYNTHASE SUBUNIT ALPHA (TM1612) FROM THERMOTOGA MARITIMA AT 2.10 A RESOLUTION
(-)
Yeast (Saccharomyces cerevisiae) (1)
3FKSA:24-95; B:25-95; T:25-95; C:26-95; J:26-95; L:26-95; U:26-95; K:18-95; S:27-95YEAST F1 ATPASE IN THE ABSENCE OF BOUND NUCLEOTIDES
(-)
Homologous Superfamily: AF2212/PG0164-like domains (1)
(-)
Porphyromonas gingivalis w83. Organism_taxid: 242619. Strain: w83. (1)
2D9RA:20-104STRUCTURE OF CONSERVED PROTEIN OF UNKNOWN FUNCTION PG0164 FROM PORPHYROMONAS GINGIVALIS [W83]
(-)
Homologous Superfamily: Aminomethyltransferase beta-barrel domains (17)
(-)
Arthrobacter globiformis. Organism_taxid: 1665. (1)
3GSIA:740-817CRYSTAL STRUCTURE OF D552A DIMETHYLGLYCINE OXIDASE MUTANT OF ARTHROBACTER GLOBIFORMIS IN COMPLEX WITH TETRAHYDROFOLATE
(-)
Arthrobacter globiformis. Organism_taxid: 1665. (3)
1PJ5A:740-817CRYSTAL STRUCTURE OF DIMETHYLGLYCINE OXIDASE OF ARTHROBACTER GLOBIFORMIS IN COMPLEX WITH ACETATE
1PJ6A:740-817CRYSTAL STRUCTURE OF DIMETHYLGLYCINE OXIDASE OF ARTHROBACTER GLOBIFORMIS IN COMPLEX WITH FOLIC ACID
1PJ7A:740-817STRUCTURE OF DIMETHYLGLYCINE OXIDASE OF ARTHROBACTER GLOBIFORMIS IN COMPLEX WITH FOLINIC ACID
(-)
Bacillus subtilis. Organism_taxid: 1423. (1)
1YX2B:280-362; A:280-359CRYSTAL STRUCTURE OF THE PROBABLE AMINOMETHYLTRANSFERASE FROM BACILLUS SUBTILIS
(-)
Escherichia coli k12. Organism_taxid: 83333. Strain: k12. (1)
1VLOA:277-367CRYSTAL STRUCTURE OF AMINOMETHYLTRANSFERASE (T PROTEIN; TETRAHYDROFOLATE-DEPENDENT) OF GLYCINE CLEAVAGE SYSTEM (NP417381) FROM ESCHERICHIA COLI K12 AT 1.70 A RESOLUTION
(-)
Escherichia coli. Organism_taxid: 83333. Strain: k12 substr. W3110. (3)
3A8IA:276-363; C:276-363; D:276-363; B:276-363CRYSTAL STRUCTURE OF ET-EHRED-5-CH3-THF COMPLEX
3A8JA:276-363; B:276-363; C:276-363; D:276-363CRYSTAL STRUCTURE OF ET-EHRED COMPLEX
3A8KC:276-362; D:276-362; A:276-363; B:276-363CRYSTAL STRUCTURE OF ETD97N-EHRED COMPLEX
(-)
Human (Homo sapiens) (2)
1WSRA:287-363; B:287-363CRYSTAL STRUCTURE OF HUMAN T-PROTEIN OF GLYCINE CLEAVAGE SYSTEM
1WSVA:287-363; B:287-363CRYSTAL STRUCTURE OF HUMAN T-PROTEIN OF GLYCINE CLEAVAGE SYSTEM
(-)
Pyrococcus horikoshii. Organism_taxid: 53953. (1)
1V5VA:312-386; B:312-386CRYSTAL STRUCTURE OF A COMPONENT OF GLYCINE CLEAVAGE SYSTEM: T-PROTEIN FROM PYROCOCCUS HORIKOSHII OT3 AT 1.5 A RESOLUTION
(-)
Rochalimaea henselae (Bartonella henselae) (1)
3GIRA:284-361CRYSTAL STRUCTURE OF GLYCINE CLEAVAGE SYSTEM AMINOMETHYLTRANSFERASE T FROM BARTONELLA HENSELAE
(-)
Thermotoga maritima. Organism_taxid: 2336. (4)
1WOOA:276-362CRYSTAL STRUCTURE OF T-PROTEIN OF THE GLYCINE CLEAVAGE SYSTEM
1WOPA:276-362CRYSTAL STRUCTURE OF T-PROTEIN OF THE GLYCINE CLEAVAGE SYSTEM
1WORA:276-362CRYSTAL STRUCTURE OF T-PROTEIN OF THE GLYCINE CLEAVAGE SYSTEM
1WOSA:276-361CRYSTAL STRUCTURE OF T-PROTEIN OF THE GLYCINE CLEAVAGE SYSTEM
(-)
Homologous Superfamily: Aminopeptidase/glucanase lid domain; domain 2 (14)
(-)
2457t (Shigella flexneri 2a str) (1)
1YLOA:67-148; B:67-148; C:67-148; D:67-148; F:67-148; E:67-150CRYSTAL STRUCTURE OF PROTEIN OF UNKNOWN FUNCTION (POSSIBLE AMINOPEPTIDASE) S2589 FROM SHIGELLA FLEXNERI 2A STR. 2457T
(-)
Bacillus cereus. Organism_taxid: 1396. (1)
2GREF:74-169; G:74-169; C:74-169; E:74-169; I:74-169; M:74-169; N:74-169; P:74-169; J:74-169; L:74-169; A:74-169; D:74-169; H:74-169; K:74-169; O:74-169; B:74-169CRYSTAL STRUCTURE OF DEBLOCKING AMINOPEPTIDASE FROM BACILLUS CEREUS
(-)
Bacillus subtilis. Organism_taxid: 1423. (1)
1VHEA:77-164CRYSTAL STRUCTURE OF A AMINOPEPTIDASE/GLUCANASE HOMOLOG
(-)
Cytophaga hutchinsonii atcc 33406. Organism_taxid: 269798. Strain: ncimb 9469. (1)
3CPXA:69-130; B:69-130; C:69-130CRYSTAL STRUCTURE OF PUTATIVE M42 GLUTAMYL AMINOPEPTIDASE (YP_676701.1) FROM CYTOPHAGA HUTCHINSONII ATCC 33406 AT 2.39 A RESOLUTION
(-)
Pyrococcus horikoshii ot3. Organism_taxid: 70601. Strain: ot3. (1)
2PE3B:75-168; C:75-168; A:75-168; D:75-168CRYSTAL STRUCTURE OF FRV OPERON PROTEIN FRVX (PH1821)FROM PYROCOCCUS HORIKOSHII OT3
(-)
Pyrococcus horikoshii. Organism_taxid: 53953. (4)
1XFOA:72-165; B:72-165; C:72-165; D:72-165CRYSTAL STRUCTURE OF AN ARCHAEAL AMINOPEPTIDASE
1Y0RA:72-165CRYSTAL STRUCTURE OF THE TETRAHEDRAL AMINOPEPTIDASE FROM P. HORIKOSHII
1Y0YA:72-165CRYSTAL STRUCTURE OF TETRAHEDRAL AMINOPEPTIDASE FROM P. HORIKOSHII IN COMPLEX WITH AMASTATIN
2VPU  [entry was replaced by entry 2WZN without any CATH domain information]
(-)
Pyrococcus horikoshii. Organism_taxid: 70601. Strain: ot3. (1)
2CF4A:65-155PYROCOCCUS HORIKOSHII TET1 PEPTIDASE CAN ASSEMBLE INTO A TETRAHEDRON OR A LARGE OCTAHEDRAL SHELL
(-)
Streptococcus pneumoniae r6. Organism_taxid: 171101. Strain: r6. (1)
3KL9A:75-163; B:75-163; K:75-163; L:75-163; C:75-163; D:75-163; E:75-163; F:75-163; G:75-163; H:75-163; I:75-163; J:75-163CRYSTAL STRUCTURE OF PEPA FROM STREPTOCOCCUS PNEUMONIAE
(-)
Thermotoga maritima msb8. Organism_taxid: 243274. Strain: msb8. (1)
2FVGA:64-150CRYSTAL STRUCTURE OF ENDOGLUCANASE (TM1049) FROM THERMOTOGA MARITIMA AT 2.01 A RESOLUTION
(-)
Thermotoga maritima. Organism_taxid: 2336. (2)
1VHOA:70-154CRYSTAL STRUCTURE OF A PUTATIVE PEPTIDASE/ENDOGLUCANASE
3ISXA:64-152CRYSTAL STRUCTURE OF ENDOGLUCANASE (TM1050) FROM THERMOTOGA MARITIMA AT 1.40 A RESOLUTION
(-)
Homologous Superfamily: Bacterial fluorinating enzyme like (2)
(-)
Thermotoga maritima msb8. Organism_taxid: 243274. Strain: msb8. (2)
2ZBUA:159-263; B:159-263; C:159-263; D:159-263CRYSTAL STRUCTURE OF UNCHARACTERIZED CONSERVED PROTEIN FROM THERMOTOGA MARITIMA
2ZBVA:159-263; C:159-262; B:159-263CRYSTAL STRUCTURE OF UNCHARACTERIZED CONSERVED PROTEIN FROM THERMOTOGA MARITIMA
(-)
Homologous Superfamily: Riboflavin kinase-like (22)
(-)
Fission yeast (Schizosaccharomyces pombe) (4)
1N05A:10-162CRYSTAL STRUCTURE OF SCHIZOSACCHAROMYCES POMBE RIBOFLAVIN KINASE REVEALS A NOVEL ATP AND RIBOFLAVIN BINDING FOLD
1N06A:9-162; B:8-162CRYSTAL STRUCTURE OF SCHIZOSACCHAROMYCES POMBE RIBOFLAVIN KINASE REVEALS A NOVEL ATP AND RIBOFLAVIN BINDING FOLD
1N07A:9-162; B:8-162CRYSTAL STRUCTURE OF SCHIZOSACCHAROMYCES POMBE RIBOFLAVIN KINASE REVEALS A NOVEL ATP AND RIBOFLAVIN BINDING FOLD
1N08A:9-162; B:8-162CRYSTAL STRUCTURE OF SCHIZOSACCHAROMYCES POMBE RIBOFLAVIN KINASE REVEALS A NOVEL ATP AND RIBOFLAVIN BINDING FOLD
(-)
Human (Homo sapiens) (4)
1NB0A:9-155CRYSTAL STRUCTURE OF HUMAN RIBOFLAVIN KINASE
1NB9A:9-155CRYSTAL STRUCTURE OF RIBOFLAVIN KINASE
1P4MA:9-155CRYSTAL STRUCTURE OF RIBOFLAVIN KINASE
1Q9SA:7-155CRYSTAL STRUCTURE OF RIBOFLAVIN KINASE WITH TERNARY PRODUCT COMPLEX
(-)
Methanocaldococcus jannaschii dsm 2661. Organism_taxid: 243232. Strain: dsm 2661, jal-1, jcm 10045, nbrc 100440. (1)
2OYNA:3-132CRYSTAL STRUCTURE OF CDP-BOUND PROTEIN MJ0056 FROM METHANOCOCCUS JANNASCHII, PFAM DUF120
(-)
Methanocaldococcus jannaschii. Organism_taxid: 2190. (1)
2P3MA:3-132SOLUTION STRUCTURE OF MJ0056
(-)
Methanococcus jannaschii. Organism_taxid: 2190. (4)
2VBSA:3-132RIBOFLAVIN KINASE MJ0056 FROM METHANOCALDOCOCCUS JANNASCHII IN COMPLEX WITH PO4
2VBTA:3-132RIBOFLAVIN KINASE MJ0056 FROM METHANOCALDOCOCCUS JANNASCHII IN COMPLEX WITH CDP AND PO4
2VBUA:3-132RIBOFLAVIN KINASE MJ0056 FROM METHANOCALDOCOCCUS JANNASCHII IN COMPLEX WITH CDP
2VBVA:3-132; B:3-132RIBOFLAVIN KINASE MJ0056 FROM METHANOCALDOCOCCUS JANNASCHII IN COMPLEX WITH CDP AND FMN
(-)
Thermoplasma acidophilum dsm 1728. Organism_taxid: 273075. Strain: dsm1728 / amrc-c165 / ifo 15155 / jcm 9062. (1)
3CTAA:89-220CRYSTAL STRUCTURE OF RIBOFLAVIN KINASE FROM THERMOPLASMA ACIDOPHILUM
(-)
Thermotoga maritima. Organism_taxid: 2336. (2)
1MRZB:460-589; A:160-288CRYSTAL STRUCTURE OF A FLAVIN BINDING PROTEIN FROM THERMOTOGA MARITIMA, TM379
2I1LB:460-589; A:160-290CRYSTAL STRUCTURE OF THE C2 FORM OF FAD SYNTHETASE FROM THERMOTOGA MARITIMA
(-)
Thermotoga maritima. Organism_taxid: 2336. (4)
1S4MA:160-288; B:460-589CRYSTAL STRUCTURE OF FLAVIN BINDING TO FAD SYNTHETASE FROM THERMOTOGA MARITINA
1T6XB:460-589; A:160-288CRYSTAL STRUCTURE OF ADP BOUND TM379
1T6YB:460-589; A:160-288CRYSTAL STRUCTURE OF ADP, AMP, AND FMN BOUND TM379
1T6ZB:460-589; A:160-288CRYSTAL STRUCTURE OF RIBOFLAVIN BOUND TM379
(-)
Trypanosoma brucei. Organism_taxid: 5691. Strain: 927/4 gutat10.1. (1)
3BNWB:5-171; A:0-171CRYSTAL STRUCTURE OF RIBOFLAVIN KINASE FROM TRYPANOSOMA BRUCEI
(-)
Homologous Superfamily: RimM N-terminal domain-like (2)
(-)
Acinetobacter calcoaceticus. Organism_taxid: 471. Strain: adp1, amms 248. (1)
2QGGA:6-98X-RAY STRUCTURE OF THE PROTEIN Q6F7I0 FROM ACINETOBACTER CALCOACETICUS AMMS 248. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ASR73.
(-)
Pseudomonas aeruginosa. Organism_taxid: 287. (1)
2F1LA:7-95CRYSTAL STRUCTURE OF A PUTATIVE 16S RIBOSOMAL RNA PROCESSING PROTEIN RIMM (PA3744) FROM PSEUDOMONAS AERUGINOSA AT 2.46 A RESOLUTION
(-)
Homologous Superfamily: Translation factors (223)
(-)
[unclassified] (4)
1TTTA:311-404; B:311-404; C:311-404; A:216-307; B:216-307; C:216-307PHE-TRNA, ELONGATION FACTOR EF-TU:GDPNP TERNARY COMPLEX
2DERA:282-368; B:282-368COCRYSTAL STRUCTURE OF AN RNA SULFURATION ENZYME MNMA AND TRNA-GLU IN THE INITIAL TRNA BINDING STATE
2DETA:282-368COCRYSTAL STRUCTURE OF AN RNA SULFURATION ENZYME MNMA AND TRNA-GLU IN THE PRE-REACTION STATE
2DEUA:282-368; B:282-368COCRYSTAL STRUCTURE OF AN RNA SULFURATION ENZYME MNMA AND TRNA-GLU IN THE ADENYLATED INTERMEDIATE STATE
(-)
Acinetobacter sp.. Organism_taxid: 472. (1)
1KRHA:105-201; B:105-201X-RAY STRUCTURE OF BENZOATE DIOXYGENASE REDUCTASE
(-)
Anabaena pcc7119. Organism_taxid: 1168. (1)
1W35A:9-136FERREDOXIN-NADP+ REDUCTASE (MUTATION: Y 303 W)
(-)
Anabaena sp.. Cyanobacteria anabaena. Organism_taxid: 1168. Strain: pcc 7119. (1)
1E63A:9-136FERREDOXIN:NADP+ REDUCTASE MUTANT WITH LYS 75 REPLACED BY SER (K75S)
(-)
Anabaena sp.. Cyanobacteria. Organism_taxid: 1168. Strain: pcc 7119. (1)
2BMWA:9-136FERREDOXIN: NADP+ REDUCTASE MUTANT WITH THR 155 REPLACED BY GLY, ALA 160 REPLACED BY THR, LEU 263 REPLACED BY PRO, ARG 264 REPLACED BY PRO AND GLY 265 REPLACED BY PRO (T155G-A160T-L263P-R264P-G265P)
(-)
Anabaena sp.. Cyanobacterium anabaena. Organism_taxid: 1168. Strain: pcc 7119. (2)
1W34A:9-136FERREDOXIN-NADP REDUCTASE (MUTATION: Y 303 S)
1W87A:9-136; B:9-136FERREDOXIN-NADP REDUCTASE (MUTATION: Y 303 W) COMPLEXED WITH NADP BY COCRYSTALLIZATION
(-)
Anabaena sp.. Organism_taxid: 1167. Strain: pcc7119. (1)
2BSAA:9-136FERREDOXIN-NADP REDUCTASE (MUTATION: Y 303 S) COMPLEXED WITH NADP
(-)
Anabaena sp.. Organism_taxid: 1168. Strain: pcc 7119. (2)
1GJRA:9-136FERREDOXIN-NADP+ REDUCTASE COMPLEXED WITH NADP+ BY COCRYSTALLIZATION
1H42A:9-136FERREDOXIN:NADP+ REDUCTASE MUTANT WITH THR 155 REPLACED BY GLY, ALA 160 REPLACED BY THR AND LEU 263 REPLACED BY PRO (T155G-A160T-L263P)
(-)
Anabaena sp.. Organism_taxid: 1168. Strain: pcc7119. (1)
2X3UA:9-136FERREDOXIN-NADP REDUCTASE MUTANT WITH TYR 303 REPLACED BY PHE (Y303F)
(-)
Azotobacter vinelandii. Organism_taxid: 354. Strain: lm100 (1)
1A8PA:2-96FERREDOXIN REDUCTASE FROM AZOTOBACTER VINELANDII
(-)
Baker's yeast (Saccharomyces cerevisiae) (13)
1F60A:333-440; A:239-327CRYSTAL STRUCTURE OF THE YEAST ELONGATION FACTOR COMPLEX EEF1A:EEF1BA
1G7CA:333-440; A:239-327YEAST EEF1A:EEF1BA IN COMPLEX WITH GDPNP
1IJEA:333-440; A:239-327NUCLEOTIDE EXCHANGE INTERMEDIATES IN THE EEF1A-EEF1BA COMPLEX
1IJFA:333-440; A:239-327NUCLEOTIDE EXCHANGE MECHANISMS IN THE EEF1A-EEF1BA COMPLEX
1N0UA:67-73,A:345-485CRYSTAL STRUCTURE OF YEAST ELONGATION FACTOR 2 IN COMPLEX WITH SORDARIN
1N0VC:345-481; D:345-481CRYSTAL STRUCTURE OF ELONGATION FACTOR 2
1U2RA:67-73,A:345-485CRYSTAL STRUCTURE OF ADP-RIBOSYLATED RIBOSOMAL TRANSLOCASE FROM SACCHAROMYCES CEREVISIAE
1ZM2A:345-481; C:345-481; E:345-481STRUCTURE OF ADP-RIBOSYLATED EEF2 IN COMPLEX WITH CATALYTIC FRAGMENT OF ETA
1ZM3A:345-481; C:345-481; E:345-481STRUCTURE OF THE APO EEF2-ETA COMPLEX
1ZM4A:345-481; C:345-481; E:345-481STRUCTURE OF THE EEF2-ETA-BTAD COMPLEX
1ZM9A:345-481; C:345-481; E:345-481STRUCTURE OF EEF2-ETA IN COMPLEX WITH PJ34
2B7BA:333-440; A:239-327YEAST GUANINE NUCLEOTIDE EXCHANGE FACTOR EEF1BALPHA K205A MUTANT IN COMPLEX WITH EEF1A AND GDP
2B7CA:333-440; A:239-327YEAST GUANINE NUCLEOTIDE EXCHANGE FACTOR EEF1BALPHA K205A MUTANT IN COMPLEX WITH EEF1A
(-)
Burkholderia cepacia. Organism_taxid: 292 (1)
2PIAA:1-104PHTHALATE DIOXYGENASE REDUCTASE: A MODULAR STRUCTURE FOR ELECTRON TRANSFER FROM PYRIDINE NUCLEOTIDES TO [2FE-2S]
(-)
Capsicum annuum. Organism_taxid: 4072. (1)
1SM4A:67-199; B:1067-1199CRYSTAL STRUCTURE ANALYSIS OF THE FERREDOXIN-NADP+ REDUCTASE FROM PAPRIKA
(-)
Cattle (Bos taurus) (2)
1D2EA:347-440; B:347-440; C:347-440; D:347-440; A:253-343; B:253-343; C:253-343; D:253-343CRYSTAL STRUCTURE OF MITOCHONDRIAL EF-TU IN COMPLEX WITH GDP
1XB2A:350-441,A:443-452; A:257-341CRYSTAL STRUCTURE OF BOS TAURUS MITOCHONDRIAL ELONGATION FACTOR TU/TS COMPLEX
(-)
Cupriavidus necator. Organism_taxid: 106590 (1)
1CQXA:151-261; B:151-261CRYSTAL STRUCTURE OF THE FLAVOHEMOGLOBIN FROM ALCALIGENES EUTROPHUS AT 1.75 A RESOLUTION
(-)
Escherichia coli. Organism_taxid: 511693. Strain: bl21 (1)
2BVNA:300-392; B:300-392; A:205-299; B:205-299E. COLI EF-TU:GDPNP IN COMPLEX WITH THE ANTIBIOTIC ENACYLOXIN IIA
(-)
Escherichia coli. Organism_taxid: 511693. Strain: bl21. (1)
1OB2A:300-392; A:205-299E. COLI ELONGATION FACTOR EF-TU COMPLEXED WITH THE ANTIBIOTIC KIRROMYCIN, A GTP ANALOG, AND PHE-TRNA
(-)
Escherichia coli. Organism_taxid: 562 (2)
1D8TB:299-392; A:300-392; A:205-299; B:205-298CRYSTAL STRUCTURE OF ELONGATION FACTOR, TU (EF-TU-MGGDP) COMPLEXED WITH GE2270A, A THIAZOLYL PEPTIDE ANTIBIOTIC
1GVHA:149-254THE X-RAY STRUCTURE OF FERRIC ESCHERICHIA COLI FLAVOHEMOGLOBIN REVEALS AN UNESPECTED GEOMETRY OF THE DISTAL HEME POCKET
(-)
Escherichia coli. Organism_taxid: 562. (1)
1B23P:311-404; P:216-307E. COLI CYSTEINYL-TRNA AND T. AQUATICUS ELONGATION FACTOR EF-TU:GTP TERNARY COMPLEX
(-)
Escherichia coli. Organism_taxid: 562. (2)
1DG1H:299-392; G:300-392; G:205-299; H:205-298WHOLE, UNMODIFIED, EF-TU(ELONGATION FACTOR TU).
2FX3A:300-392; A:205-299CRYSTAL STRUCTURE DETERMINATION OF E. COLI ELONGATION FACTOR, TU USING A TWINNED DATA SET
(-)
Escherichia coli. Organism_taxid: 562. (3)
1DDGA:226-279,A:385-444; B:226-279,B:385-444CRYSTAL STRUCTURE OF SIR-FP60
1DDIA:226-279,A:385-444CRYSTAL STRUCTURE OF SIR-FP60
1EFCA:300-392; B:300-392; A:205-299; B:205-299INTACT ELONGATION FACTOR FROM E.COLI
(-)
Escherichia coli. Organism_taxid: 562. Strain: jm109. (1)
1QFJA:1-97; B:1-97; C:1-97; D:1-97CRYSTAL STRUCTURE OF NAD(P)H:FLAVIN OXIDOREDUCTASE FROM ESCHERICHIA COLI
(-)
Escherichia coli. Organism_taxid: 562. Strain: k12 c600. (1)
1FDRA:2-96FLAVODOXIN REDUCTASE FROM E. COLI
(-)
Escherichia coli. Organism_taxid: 562. Strain: n4830-1. (1)
1EFUA:300-392; C:301-392; C:205-300; A:205-299ELONGATION FACTOR COMPLEX EF-TU/EF-TS FROM ESCHERICHIA COLI
(-)
Fission yeast (Schizosaccharomyces pombe) (4)
1R5BA:553-662; A:464-552CRYSTAL STRUCTURE ANALYSIS OF SUP35
1R5NA:553-662; A:464-552CRYSTAL STRUCTURE ANALYSIS OF SUP35 COMPLEXED WITH GDP
1R5OA:553-662; A:464-552CRYSTAL STRUCTURE ANALYSIS OF SUP35 COMPLEXED WITH GMPPNP
3E20A:555-662; A:467-554; D:467-554; E:467-554; J:467-554; D:555-662; E:555-662; J:555-662CRYSTAL STRUCTURE OF S.POMBE ERF1/ERF3 COMPLEX
(-)
Geobacillus stearothermophilus. Organism_taxid: 1422. (1)
1D1NA:143-241SOLUTION STRUCTURE OF THE FMET-TRNAFMET BINDING DOMAIN OF BECILLUS STEAROTHERMOPHILLUS TRANSLATION INITIATION FACTOR IF2
(-)
Haemophilus influenzae. Organism_taxid: 727. (1)
2GQFA:193-265,A:327-343CRYSTAL STRUCTURE OF FLAVOPROTEIN HI0933 FROM HAEMOPHILUS INFLUENZAE RD
(-)
Haloarcula marismortui atcc 43049. Organism_taxid: 272569. Haloarculamarismortui. Halobacterium marismortui. Organism_taxid: 2238. Haloarcula marismortui. Halobacterium marismortui. Organism_taxid: 2238. Haloarcula marismortui. Halobacterium marismortui. Organism_taxid: 2238. Haloarcula marismortui. Halobacterium marismortui. Organism_taxid: 2238.Haloarcula marismortui. Halobacterium marismortui. Organism_taxid: 2238. Haloarcula marismortui. Halobacterium marismortui. Organism_taxid:2238. Haloarcula marismortui. Halobacterium marismortui. Organism_taxid: 2238. Haloarcula marismortui. Halobacterium marismortui. Organism_taxid: 2238. Haloarcula marismortui. Halobacterium marismortui. Organism_taxid: 2238. Haloarcula marismortui. Halobacterium marismortui. Organism_taxid: 2238. Haloarcula marismortui. Halobacterium marismortui.Organism_taxid: 2238. Haloarcula marismortui. Halobacterium marismortui. Organism_taxid: 2238. Haloarcula marismortui. Halobacterium marismortui. Organism_taxid: 2238. Haloarcula marismortui. Halobacterium marismortui. Organism_taxid: 2238. Haloarcula marismortui. Halobacterium marismortui. Organism_taxid: 2238. Haloarcula marismortui. Halobacterium marismortui. Organism_taxid: 2238. Haloarcula marismortui. Halobacterium marismortui. Organism_taxid: 2238. Haloarcula marismortui. Halobacterium marismortui. Organism_taxid: 2238. Haloarcula marismortui. Halobacterium marismortui. Organism_taxid: 2238. Haloarcula marismortui.Halobacterium marismortui. Organism_taxid: 2238. Haloarcula marismortui. Halobacterium marismortui. Organism_taxid: 2238. Haloarcula marismortui. Halobacterium marismortui. Organism_taxid: 2238. Haloarcula marismortui. Halobacterium marismortui. Organism_taxid: 2238. Haloarcula marismortui. Halobacterium marismortui. Organism_taxid: 2238. Haloarcula marismortui. Halobacterium marismortui. Organism_taxid: 2238. Haloarcula marismortui. Halobacterium marismortui. Organism_taxid: 2238. Haloarcula marismortui. Halobacterium marismortui. Organism_taxid: 2238.Haloarcula marismortui. Halobacterium marismortui. Organism_taxid: 2238. Haloarcula marismortui. Halobacterium marismortui. Organism_taxid:2238. Haloarcula marismortui. Organism_taxid: 2238. (1)
3I55B:39-77,B:189-206,B:258-337CO-CRYSTAL STRUCTURE OF MYCALAMIDE A BOUND TO THE LARGE RIBOSOMAL SUBUNIT
(-)
Haloarcula marismortui. Organism_taxid: 2238. (4)
1N8RD:39-77,D:189-206,D:258-337STRUCTURE OF LARGE RIBOSOMAL SUBUNIT IN COMPLEX WITH VIRGINIAMYCIN M
1NJID:39-77,D:189-206,D:258-337STRUCTURE OF CHLORAMPHENICOL BOUND TO THE 50S RIBOSOMAL SUBUNIT
2OTJB:39-77,B:189-206,B:258-33713-DEOXYTEDANOLIDE BOUND TO THE LARGE SUBUNIT OF HALOARCULA MARISMORTUI
2OTLB:39-77,B:189-206,B:258-337GIRODAZOLE BOUND TO THE LARGE SUBUNIT OF HALOARCULA MARISMORTUI
(-)
Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui.Archaea. Organism_taxid: 2238. Haloarcula marismortui. Archaea. Organism_taxid: 2238. Haloarcula marismortui. Archaea. Organism_taxid: 2238.Haloarcula marismortui. Archaea. Organism_taxid: 2238. Haloarcula marismortui. Archaea. Organism_taxid: 2238. Haloarcula marismortui. Archaea. Organism_taxid: 2238. Haloarcula marismortui. Archaea. Organism_taxid: 2238. Haloarcula marismortui. Archaea. Organism_taxid: 2238. Haloarcula marismortui. Archaea. Organism_taxid: 2238. Haloarcula marismortui. Archaea. Organism_taxid: 2238. Haloarcula marismortui. Archaea. Organism_taxid: 2238. Haloarcula marismortui. Archaea. Organism_taxid:2238. Haloarcula marismortui. Archaea. Organism_taxid: 2238. Haloarcula marismortui. Archaea. Organism_taxid: 2238. Haloarcula marismortui.Archaea. Organism_taxid: 2238. Haloarcula marismortui. Archaea. Organism_taxid: 2238. Haloarcula marismortui. Archaea. Organism_taxid: 2238.Haloarcula marismortui. Archaea. Organism_taxid: 2238. Haloarcula marismortui. Archaea. Organism_taxid: 2238. Haloarcula marismortui. Archaea. Organism_taxid: 2238. Haloarcula marismortui. Archaea. Organism_taxid: 2238. Haloarcula marismortui. Archaea. Organism_taxid: 2238. Haloarcula marismortui. Archaea. Organism_taxid: 2238. Haloarcula marismortui. Archaea. Organism_taxid: 2238. Haloarcula marismortui. Archaea. Organism_taxid: 2238. Haloarcula marismortui. Archaea. Organism_taxid:2238. Haloarcula marismortui. Archaea. Organism_taxid: 2238. Haloarcula marismortui. Archaea. Organism_taxid: 2238. Haloarcula marismortui.Archaea. Organism_taxid: 2238. (1)
1W2BB:39-77,B:189-206,B:258-337TRIGGER FACTOR RIBOSOME BINDING DOMAIN IN COMPLEX WITH 50S
(-)
Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui.Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarculamarismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid:2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. (7)
1JJ2B:39-77,B:189-206,B:258-337FULLY REFINED CRYSTAL STRUCTURE OF THE HALOARCULA MARISMORTUI LARGE RIBOSOMAL SUBUNIT AT 2.4 ANGSTROM RESOLUTION
1K73D:39-77,D:189-206,D:258-337CO-CRYSTAL STRUCTURE OF ANISOMYCIN BOUND TO THE 50S RIBOSOMAL SUBUNIT
1K8AD:39-77,D:189-206,D:258-337CO-CRYSTAL STRUCTURE OF CARBOMYCIN A BOUND TO THE 50S RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
1K9MD:39-77,D:189-206,D:258-337CO-CRYSTAL STRUCTURE OF TYLOSIN BOUND TO THE 50S RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
1KC8D:39-77,D:189-206,D:258-337CO-CRYSTAL STRUCTURE OF BLASTICIDIN S BOUND TO THE 50S RIBOSOMAL SUBUNIT
1KD1D:39-77,D:189-206,D:258-337CO-CRYSTAL STRUCTURE OF SPIRAMYCIN BOUND TO THE 50S RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
1M1KD:39-77,D:189-206,D:258-337CO-CRYSTAL STRUCTURE OF AZITHROMYCIN BOUND TO THE 50S RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
(-)
Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui.Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarculamarismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid:2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. (9)
1S72B:39-77,B:189-206,B:258-337REFINED CRYSTAL STRUCTURE OF THE HALOARCULA MARISMORTUI LARGE RIBOSOMAL SUBUNIT AT 2.4 ANGSTROM RESOLUTION
1YIJB:39-77,B:189-206,B:258-337CRYSTAL STRUCTURE OF TELITHROMYCIN BOUND TO THE G2099A MUTANT 50S RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
1YITB:39-77,B:189-206,B:258-337CRYSTAL STRUCTURE OF VIRGINIAMYCIN M AND S BOUND TO THE 50S RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
1YJNB:39-77,B:189-206,B:258-337CRYSTAL STRUCTURE OF CLINDAMYCIN BOUND TO THE G2099A MUTANT 50S RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
2QA4B:39-77,B:189-206,B:258-337A MORE COMPLETE STRUCTURE OF THE THE L7/L12 STALK OF THE HALOARCULA MARISMORTUI 50S LARGE RIBOSOMAL SUBUNIT
2QEXB:39-77,B:189-206,B:258-337NEGAMYCIN BINDS TO THE WALL OF THE NASCENT CHAIN EXIT TUNNEL OF THE 50S RIBOSOMAL SUBUNIT
3G4SB:39-77,B:189-206,B:258-337CO-CRYSTAL STRUCTURE OF TIAMULIN BOUND TO THE LARGE RIBOSOMAL SUBUNIT
3G6EB:39-77,B:189-206,B:258-337CO-CRYSTAL STRUCTURE OF HOMOHARRINGTONINE BOUND TO THE LARGE RIBOSOMAL SUBUNIT
3G71B:39-77,B:189-206,B:258-337CO-CRYSTAL STRUCTURE OF BRUCEANTIN BOUND TO THE LARGE RIBOSOMAL SUBUNIT
(-)
Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui.Organism_taxid: 2238. Yes. (18)
1KQSB:39-77,B:189-206,B:258-337THE HALOARCULA MARISMORTUI 50S COMPLEXED WITH A PRETRANSLOCATIONAL INTERMEDIATE IN PROTEIN SYNTHESIS
1M90D:39-77,D:189-206,D:258-337CO-CRYSTAL STRUCTURE OF CCA-PHE-CAPROIC ACID-BIOTIN AND SPARSOMYCIN BOUND TO THE 50S RIBOSOMAL SUBUNIT
1Q7YD:39-77,D:189-206,D:258-337CRYSTAL STRUCTURE OF CCDAP-PUROMYCIN BOUND AT THE PEPTIDYL TRANSFERASE CENTER OF THE 50S RIBOSOMAL SUBUNIT
1Q81D:39-77,D:189-206,D:258-337CRYSTAL STRUCTURE OF MINIHELIX WITH 3' PUROMYCIN BOUND TO A-SITE OF THE 50S RIBOSOMAL SUBUNIT.
1Q82D:39-77,D:189-206,D:258-337CRYSTAL STRUCTURE OF CC-PUROMYCIN BOUND TO THE A-SITE OF THE 50S RIBOSOMAL SUBUNIT
1Q86D:39-77,D:189-206,D:258-337CRYSTAL STRUCTURE OF CCA-PHE-CAP-BIOTIN BOUND SIMULTANEOUSLY AT HALF OCCUPANCY TO BOTH THE A-SITE AND P-SITE OF THE THE 50S RIBOSOMAL SUBUNIT.
1VQ4B:39-77,B:189-206,B:258-337THE STRUCTURE OF THE TRANSITION STATE ANALOGUE "DAA" BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
1VQ5B:39-77,B:189-206,B:258-337THE STRUCTURE OF THE TRANSITION STATE ANALOGUE "RAA" BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
1VQ6B:39-77,B:189-206,B:258-337THE STRUCTURE OF C-HPMN AND CCA-PHE-CAP-BIO BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
1VQ7B:39-77,B:189-206,B:258-337THE STRUCTURE OF THE TRANSITION STATE ANALOGUE "DCA" BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
1VQ8B:39-77,B:189-206,B:258-337THE STRUCTURE OF CCDA-PHE-CAP-BIO AND THE ANTIBIOTIC SPARSOMYCIN BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
1VQ9B:39-77,B:189-206,B:258-337THE STRUCTURE OF CCA-PHE-CAP-BIO AND THE ANTIBIOTIC SPARSOMYCIN BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
1VQKB:39-77,B:189-206,B:258-337THE STRUCTURE OF CCDA-PHE-CAP-BIO BOUND TO THE A SITE OF THE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
1VQLB:39-77,B:189-206,B:258-337THE STRUCTURE OF THE TRANSITION STATE ANALOGUE "DCSN" BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
1VQMB:39-77,B:189-206,B:258-337THE STRUCTURE OF THE TRANSITION STATE ANALOGUE "DAN" BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
1VQNB:39-77,B:189-206,B:258-337THE STRUCTURE OF CC-HPMN AND CCA-PHE-CAP-BIO BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
1VQOB:39-77,B:189-206,B:258-337THE STRUCTURE OF CCPMN BOUND TO THE LARGE RIBOSOMAL SUBUNIT HALOARCULA MARISMORTUI
1VQPB:39-77,B:189-206,B:258-337THE STRUCTURE OF THE TRANSITION STATE ANALOGUE "RAP" BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
(-)
Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui.Organism_taxid: 2238. Yes. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238.Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui.Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarculamarismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. Haloarcula marismortui. Organism_taxid: 2238. (3)
1QVFB:39-77,B:189-206,B:258-337STRUCTURE OF A DEACYLATED TRNA MINIHELIX BOUND TO THE E SITE OF THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
1QVGB:39-77,B:189-206,B:258-337STRUCTURE OF CCA OLIGONUCLEOTIDE BOUND TO THE TRNA BINDING SITES OF THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
3CXCB:39-77,B:189-206,B:258-337THE STRUCTURE OF AN ENHANCED OXAZOLIDINONE INHIBITOR BOUND TO THE 50S RIBOSOMAL SUBUNIT OF H. MARISMORTUI
(-)
Haloarcula marismortui. Organism_taxid: 2238. Strain: dt38. Haloarculamarismortui. Organism_taxid: 2238. Strain: dt38. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt38. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt38. Haloarcula marismortui. Organism_taxid:2238. Strain: dt38. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt38. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt38.Haloarcula marismortui. Organism_taxid: 2238. Strain: dt38. Haloarculamarismortui. Organism_taxid: 2238. Strain: dt38. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt38. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt38. Haloarcula marismortui. Organism_taxid:2238. Strain: dt38. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt38. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt38.Haloarcula marismortui. Organism_taxid: 2238. Strain: dt38. Haloarculamarismortui. Organism_taxid: 2238. Strain: dt38. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt38. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt38. Haloarcula marismortui. Organism_taxid:2238. Strain: dt38. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt38. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt38.Haloarcula marismortui. Organism_taxid: 2238. Strain: dt38. Haloarculamarismortui. Organism_taxid: 2238. Strain: dt38. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt38. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt38. Haloarcula marismortui. Organism_taxid:2238. Strain: dt38. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt38. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt38.Haloarcula marismortui. Organism_taxid: 2238. Strain: dt38. Haloarculamarismortui. Organism_taxid: 2238. Strain: dt38. (1)
1YI2B:39-77,B:189-206,B:258-337CRYSTAL STRUCTURE OF ERYTHROMYCIN BOUND TO THE G2099A MUTANT 50S RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
(-)
Haloarcula marismortui. Organism_taxid: 2238. Strain: dt41. Haloarculamarismortui. Organism_taxid: 2238. Strain: dt41. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt41. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt41. Haloarcula marismortui. Organism_taxid:2238. Strain: dt41. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt41. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt41.Haloarcula marismortui. Organism_taxid: 2238. Strain: dt41. Haloarculamarismortui. Organism_taxid: 2238. Strain: dt41. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt41. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt41. Haloarcula marismortui. Organism_taxid:2238. Strain: dt41. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt41. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt41.Haloarcula marismortui. Organism_taxid: 2238. Strain: dt41. Haloarculamarismortui. Organism_taxid: 2238. Strain: dt41. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt41. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt41. Haloarcula marismortui. Organism_taxid:2238. Strain: dt41. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt41. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt41.Haloarcula marismortui. Organism_taxid: 2238. Strain: dt41. Haloarculamarismortui. Organism_taxid: 2238. Strain: dt41. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt41. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt41. Haloarcula marismortui. Organism_taxid:2238. Strain: dt41. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt41. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt41.Haloarcula marismortui. Organism_taxid: 2238. Strain: dt41. Haloarculamarismortui. Organism_taxid: 2238. Strain: dt41. (2)
1YHQB:39-77,B:189-206,B:258-337CRYSTAL STRUCTURE OF AZITHROMYCIN BOUND TO THE G2099A MUTANT 50S RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
1YJWB:39-77,B:189-206,B:258-337CRYSTAL STRUCTURE OF QUINUPRISTIN BOUND TO THE G2099A MUTANT 50S RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
(-)
Haloarcula marismortui. Organism_taxid: 2238. Strain: dt50. Haloarculamarismortui. Organism_taxid: 2238. Strain: dt50. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt50. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt50. Haloarcula marismortui. Organism_taxid:2238. Strain: dt50. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt50. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt50.Haloarcula marismortui. Organism_taxid: 2238. Strain: dt50. Haloarculamarismortui. Organism_taxid: 2238. Strain: dt50. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt50. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt50. Haloarcula marismortui. Organism_taxid:2238. Strain: dt50. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt50. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt50.Haloarcula marismortui. Organism_taxid: 2238. Strain: dt50. Haloarculamarismortui. Organism_taxid: 2238. Strain: dt50. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt50. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt50. Haloarcula marismortui. Organism_taxid:2238. Strain: dt50. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt50. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt50.Haloarcula marismortui. Organism_taxid: 2238. Strain: dt50. Haloarculamarismortui. Organism_taxid: 2238. Strain: dt50. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt50. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt50. Haloarcula marismortui. Organism_taxid:2238. Strain: dt50. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt50. Haloarcula marismortui. Organism_taxid: 2238. Strain: dt50.Haloarcula marismortui. Organism_taxid: 2238. Strain: dt50. Haloarculamarismortui. Organism_taxid: 2238. Strain: dt50. (1)
1YJ9B:39-77,B:189-206,B:258-337CRYSTAL STRUCTURE OF THE MUTANT 50S RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI CONTAINING A THREE RESIDUE DELETION IN L22
(-)
Halobacterium marismortui (Haloarcula marismortui) (16)
3CC2B:39-77,B:189-206,B:258-337THE REFINED CRYSTAL STRUCTURE OF THE HALOARCULA MARISMORTUI LARGE RIBOSOMAL SUBUNIT AT 2.4 ANGSTROM RESOLUTION WITH RRNA SEQUENCE FOR THE 23S RRNA AND GENOME-DERIVED SEQUENCES FOR R-PROTEINS
3CC4B:39-77,B:189-206,B:258-337CO-CRYSTAL STRUCTURE OF ANISOMYCIN BOUND TO THE 50S RIBOSOMAL SUBUNIT
3CC7B:39-77,B:189-206,B:258-337STRUCTURE OF ANISOMYCIN RESISTANT 50S RIBOSOMAL SUBUNIT: 23S RRNA MUTATION C2487U
3CCEB:39-77,B:189-206,B:258-337STRUCTURE OF ANISOMYCIN RESISTANT 50S RIBOSOMAL SUBUNIT: 23S RRNA MUTATION U2535A
3CCJB:39-77,B:189-206,B:258-337STRUCTURE OF ANISOMYCIN RESISTANT 50S RIBOSOMAL SUBUNIT: 23S RRNA MUTATION C2534U
3CCLB:39-77,B:189-206,B:258-337STRUCTURE OF ANISOMYCIN RESISTANT 50S RIBOSOMAL SUBUNIT: 23S RRNA MUTATION U2535C. DENSITY FOR ANISOMYCIN IS VISIBLE BUT NOT INCLUDED IN MODEL.
3CCMB:39-77,B:189-206,B:258-337STRUCTURE OF ANISOMYCIN RESISTANT 50S RIBOSOMAL SUBUNIT: 23S RRNA MUTATION G2611U
3CCQB:39-77,B:189-206,B:258-337STRUCTURE OF ANISOMYCIN RESISTANT 50S RIBOSOMAL SUBUNIT: 23S RRNA MUTATION A2488U
3CCRB:39-77,B:189-206,B:258-337STRUCTURE OF ANISOMYCIN RESISTANT 50S RIBOSOMAL SUBUNIT: 23S RRNA MUTATION A2488C. DENSITY FOR ANISOMYCIN IS VISIBLE BUT NOT INCLUDED IN THE MODEL.
3CCSB:39-77,B:189-206,B:258-337STRUCTURE OF ANISOMYCIN RESISTANT 50S RIBOSOMAL SUBUNIT: 23S RRNA MUTATION G2482A
3CCUB:39-77,B:189-206,B:258-337STRUCTURE OF ANISOMYCIN RESISTANT 50S RIBOSOMAL SUBUNIT: 23S RRNA MUTATION G2482C
3CCVB:39-77,B:189-206,B:258-337STRUCTURE OF ANISOMYCIN RESISTANT 50S RIBOSOMAL SUBUNIT: 23S RRNA MUTATION G2616A
3CD6B:39-77,B:189-206,B:258-337CO-CYSTAL OF LARGE RIBOSOMAL SUBUNIT MUTANT G2616A WITH CC-PUROMYCIN
3CMAB:39-77,B:189-206,B:258-337THE STRUCTURE OF CCA AND CCA-PHE-CAP-BIO BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
3CMEB:39-77,B:189-206,B:258-337THE STRUCTURE OF CA AND CCA-PHE-CAP-BIO BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
3I56B:39-77,B:189-206,B:258-337CO-CRYSTAL STRUCTURE OF TRIACETYLOLEANDOMCYIN BOUND TO THE LARGE RIBOSOMAL SUBUNIT
(-)
Halobacterium marismortui (haloarcula marismortui) (1)
3CPWB:39-77,B:189-206,B:258-337THE STRUCTURE OF THE ANTIBIOTIC LINEZOLID BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI
(-)
Human (Homo sapiens) (2)
1UMKA:31-145THE STRUCTURE OF HUMAN ERYTHROCYTE NADH-CYTOCHROME B5 REDUCTASE
3E1YE:526-634; F:526-634; G:526-634; H:526-634CRYSTAL STRUCTURE OF HUMAN ERF1/ERF3 COMPLEX
(-)
Lactococcus lactis. Organism_taxid: 1358. (3)
1EP1B:2-100CRYSTAL STRUCTURE OF LACTOCOCCUS LACTIS DIHYDROOROTATE DEHYDROGENASE B
1EP2B:2-100CRYSTAL STRUCTURE OF LACTOCOCCUS LACTIS DIHYDROOROTATE DEHYDROGENASE B COMPLEXED WITH OROTATE
1EP3B:2-100CRYSTAL STRUCTURE OF LACTOCOCCUS LACTIS DIHYDROOROTATE DEHYDROGENASE B. DATA COLLECTED UNDER CRYOGENIC CONDITIONS.
(-)
Leptospira interrogans. Organism_taxid: 173. (2)
2RC5B:8-153; C:8-153; A:7-153; D:8-153REFINED STRUCTURE OF FNR FROM LEPTOSPIRA INTERROGANS
2RC6A:7-153; B:7-153; C:7-153; D:7-153REFINED STRUCTURE OF FNR FROM LEPTOSPIRA INTERROGANS BOUND TO NADP+
(-)
Methanocaldococcus jannaschii. Organism_taxid: 2190. (1)
1S0UA:231-345; A:346-437EIF2GAMMA APO
(-)
Methanococcus maripaludis. Organism_taxid: 39152. Strain: jj. (3)
1WB1  [entry was replaced by entry 4AC9 without any CATH domain information]
1WB2  [entry was replaced by entry 4ACA without any CATH domain information]
1WB3  [entry was replaced by entry 4ACB without any CATH domain information]
(-)
Methanothermobacter thermautotrophicus. Organism_taxid: 145262. (3)
1G7RA:226-337; A:462-550X-RAY STRUCTURE OF TRANSLATION INITIATION FACTOR IF2/EIF5B
1G7SA:226-337; A:462-550X-RAY STRUCTURE OF TRANSLATION INITIATION FACTOR IF2/EIF5B COMPLEXED WITH GDP
1G7TA:226-337; A:462-550X-RAY STRUCTURE OF TRANSLATION INITIATION FACTOR IF2/EIF5B COMPLEXED WITH GDPNP
(-)
Norway rat (Rattus norvegicus) (9)
1AMOA:271-324,A:451-518; B:271-324,B:451-518THREE-DIMENSIONAL STRUCTURE OF NADPH-CYTOCHROME P450 REDUCTASE: PROTOTYPE FOR FMN-AND FAD-CONTAINING ENZYMES
1F20A:988-1037,A:1172-1234CRYSTAL STRUCTURE OF RAT NEURONAL NITRIC-OXIDE SYNTHASE FAD/NADP+ DOMAIN AT 1.9A RESOLUTION.
1I7PA:40-145CRYSTAL STRUCTURE OF RAT B5R IN COMPLEX WITH FAD
1IB0A:40-145CRYSTAL STRUCTURE OF RAT B5R IN COMPLEX WITH FAD AND NAD
1J9ZB:271-324,B:451-518; A:271-324,A:451-518CYPOR-W677G
1JA0A:271-324,A:451-518; B:271-323,B:453-517CYPOR-W677X
1JA1A:271-324,A:451-518; B:271-324,B:451-518CYPOR-TRIPLE MUTANT
1QX4A:40-145; B:40-145STRUCTRUE OF S127P MUTANT OF CYTOCHROME B5 REDUCTASE
1TLLA:988-1037,A:1172-1234; B:2988-3037,B:3172-3234CRYSTAL STRUCTURE OF RAT NEURONAL NITRIC-OXIDE SYNTHASE REDUCTASE MODULE AT 2.3 A RESOLUTION.
(-)
Nostoc sp.. Organism_taxid: 1168. Strain: pcc 7119. (2)
2VYQA:9-136FERREDOXIN:NADP REDUCTASE MUTANT WITH THR 155 REPLACED BY GLY, ALA 160 REPLACED BY THR, LEU 263 REPLACED BY PRO AND TYR 303 REPLACED BY SER (T155G-A160T-L263P-Y303S)
2VZLA:9-136FERREDOXIN-NADP REDUCTASE (MUTATIONS: T155G, A160T, L263P AND Y303S) COMPLEXED WITH NAD BY COCRYSTALLIZATION
(-)
Pc7119 (Nostoc sp) (1)
1E62A:9-136FERREDOXIN:NADP+ REDUCTASE MUTANT WITH LYS 75 REPLACED BY ARG (K75R)
(-)
Pcc 7002 (Synechococcus sp) (1)
2B5OA:111-239; B:111-239FERREDOXIN-NADP REDUCTASE
(-)
Pcc 7119 (Anabaena sp) (1)
1H85A:9-136FERREDOXIN:NADP+ REDUCTASE MUTANT WITH VAL 136 REPLACED BY LEU (V136L)
(-)
Pcc 7119 (Nostoc sp) (11)
1B2RA:9-136FERREDOXIN-NADP+ REDUCTASE (MUTATION: E 301 A)
1BJKA:9-136FERREDOXIN:NADP+ REDUCTASE MUTANT WITH ARG 264 REPLACED BY GLU (R264E)
1BQEA:9-136FERREDOXIN:NADP+ REDUCTASE MUTANT WITH THR 155 REPLACED BY GLY (T155G)
1E64A:9-136FERREDOXIN:NADP+ REDUCTASE MUTANT WITH LYS 75 REPLACED BY GLN (K75Q)
1EWYA:2-136; B:2-136ANABAENA PCC7119 FERREDOXIN:FERREDOXIN-NADP+-REDUCTASE COMPLEX
1GO2A:9-136STRUCTURE OF FERREDOXIN-NADP+ REDUCTASE WITH LYS 72 REPLACED BY GLU (K72E)
1QGYA:9-136FERREDOXIN:NADP+ REDUCTASE MUTANT WITH LYS 75 REPLACED BY GLU (K75E)
1QGZA:9-136FERREDOXIN:NADP+ REDUCTASE MUTANT WITH LEU 78 REPLACED BY ASP (L78D)
1QH0A:9-136FERREDOXIN:NADP+ REDUCTASE MUTANT WITH LEU 76 MUTATED BY ASP AND LEU 78 MUTATED BY ASP
1QUEA:2-136X-RAY STRUCTURE OF THE FERREDOXIN:NADP+ REDUCTASE FROM THE CYANOBACTERIUM ANABAENA PCC 7119 AT 1.8 ANGSTROMS
1QUFA:8-136X-RAY STRUCTURE OF A COMPLEX NADP+-FERREDOXIN:NADP+ REDUCTASE FROM THE CYANOBACTERIUM ANABAENA PCC 7119 AT 2.25 ANGSTROMS
(-)
Pcc7119 (Nostoc sp) (1)
1GR1A:9-136STRUCTURE OF FERREDOXIN-NADP+ REDUCTASE WITH GLU 139 REPLACED BY LYS (E139K)
(-)
Pea (Pisum sativum) (4)
1QFYB:514-645; A:13-145PEA FNR Y308S MUTANT IN COMPLEX WITH NADP+
1QFZB:514-645; A:13-145PEA FNR Y308S MUTANT IN COMPLEX WITH NADPH
1QG0A:13-145; B:1013-1145WILD-TYPE PEA FNR
1QGAB:514-645; A:13-145PEA FNR Y308W MUTANT IN COMPLEX WITH NADP+
(-)
Pig (Sus scrofa) (1)
1NDHA:3-117CRYSTAL STRUCTURE OF NADH-CYTOCHROME B5 REDUCTASE FROM PIG LIVER AT 2.4 ANGSTROMS RESOLUTION
(-)
Porphyromonas gingivalis w83. Organism_taxid: 242619. Strain: w83. (1)
2R6HA:128-270; D:128-270; B:126-270; C:124-270CRYSTAL STRUCTURE OF THE DOMAIN COMPRISING THE NAD BINDING AND THE FAD BINDING REGIONS OF THE NADH:UBIQUINONE OXIDOREDUCTASE, NA TRANSLOCATING, F SUBUNIT FROM PORPHYROMONAS GINGIVALIS
(-)
Pseudomonas aeruginosa. Organism_taxid: 287. (2)
2QDXA:2-96P.AERUGINOSA FPR WITH FAD
3CRZA:2-96FERREDOXIN-NADP REDUCTASE
(-)
Pyrococcus abyssi. Organism_taxid: 29292. (5)
1KJZA:204-318; A:319-410STRUCTURE OF THE LARGE GAMMA SUBUNIT OF INITIATION FACTOR EIF2 FROM PYROCOCCUS ABYSSI-G235D MUTANT
1KK0A:204-318; A:319-410STRUCTURE OF THE LARGE GAMMA SUBUNIT OF INITIATION FACTOR EIF2 FROM PYROCOCCUS ABYSSI
1KK1A:204-318; A:319-410STRUCTURE OF THE LARGE GAMMA SUBUNIT OF INITIATION FACTOR EIF2 FROM PYROCOCCUS ABYSSI-G235D MUTANT COMPLEXED WITH GDPNP-MG2+
1KK2A:204-318; A:319-410STRUCTURE OF THE LARGE GAMMA SUBUNIT OF INITIATION FACTOR EIF2 FROM PYROCOCCUS ABYSSI-G235D MUTANT COMPLEXED WITH GDP-MG2+
1KK3A:204-318; A:319-410STRUCTURE OF THE WILD-TYPE LARGE GAMMA SUBUNIT OF INITIATION FACTOR EIF2 FROM PYROCOCCUS ABYSSI COMPLEXED WITH GDP-MG2+
(-)
Pyrococcus furiosus dsm 3638. Organism_taxid: 186497. Strain: dsm 3638. (2)
2D74A:205-319; A:320-412CRYSTAL STRUCTURE OF TRANSLATION INITIATION FACTOR AIF2BETAGAMMA HETERODIMER
2DCUA:205-319; A:320-412CRYSTAL STRUCTURE OF TRANSLATION INITIATION FACTOR AIF2BETAGAMMA HETERODIMER WITH GDP
(-)
Pyrococcus furiosus. Organism_taxid: 2261. (1)
1XE1A:18-108HYPOTHETICAL PROTEIN FROM PYROCOCCUS FURIOSUS PFU-880080-001
(-)
Rhodobacter capsulatus. Organism_taxid: 1061. Strain: 37b4. Variant: dsm938. (6)
2BGIA:20-106X-RAY STRUCTURE OF THE FERREDOXIN-NADP(H) REDUCTASE FROM RHODOBACTER CAPSULATUS COMPLEXED WITH THREE MOLECULES OF THE DETERGENT N-HEPTYL-BETA-D-THIOGLUCOSIDE AT 1.7 ANGSTROMS
2BGJA:20-106; B:20-106; C:20-106; D:20-106X-RAY STRUCTURE OF THE FERREDOXIN-NADP(H) REDUCTASE FROM RHODOBACTER CAPSULATUS AT 2.1 ANGSTROMS
2VNHA:20-106X-RAY STRUCTURE OF THE FERREDOXIN-NADP(H) REDUCTASE FROM RHODOBACTER CAPSULATUS IN COMPLEX WITH NADP. FORM II AT 2. 27 ANGSTROMS RESOLUTION
2VNIA:20-106X-RAY STRUCTURE OF THE FERREDOXIN-NADP(H) REDUCTASE FROM RHODOBACTER CAPSULATUS IN COMPLEX WITH 2P-AMP AT 2.37 ANGSTROMS RESOLUTION
2VNJA:20-106X-RAY STRUCTURE OF THE FERREDOXIN-NADP(H) REDUCTASE FROM RHODOBACTER CAPSULATUS IN COMPLEX WITH NADP. FORM I AT 2. 13 ANGSTROMS RESOLUTION
2VNKA:20-106; B:20-106; C:20-106; D:20-106X-RAY STRUCTURE OF THE FERREDOXIN-NADP(H) REDUCTASE FROM RHODOBACTER CAPSULATUS IN COMPLEX WITH NADP. FORM III AT 1. 93 ANGSTROMS RESOLUTION
(-)
Salmonella typhimurium. Organism_taxid: 99287. Strain: lt2. (1)
3FPKA:2-96; B:2-96CRYSTAL STRUCTURE OF FERREDOXIN-NADP REDUCTASE FROM SALMONELLA TYPHIMURIUM
(-)
Shewanella putrefaciens cn-32. Organism_taxid: 319224. Strain: cn-32. (1)
2GPJA:5-104CRYSTAL STRUCTURE OF A SIDEROPHORE-INTERACTING PROTEIN (SPUTCN32_0076) FROM SHEWANELLA PUTREFACIENS CN-32 AT 2.20 A RESOLUTION
(-)
Spinach (Spinacia oleracea) (7)
1BX0A:19-151FERREDOXIN:NADP+ OXIDOREDUCTASE (FERREDOXIN REDUCTASE) MUTANT E312L
1BX1A:19-151FERREDOXIN:NADP+ OXIDOREDUCTASE (FERREDOXIN REDUCTASE) MUTANT E312Q
1FNBA:19-151REFINED CRYSTAL STRUCTURE OF SPINACH FERREDOXIN REDUCTASE AT 1.7 ANGSTROMS RESOLUTION: OXIDIZED, REDUCED, AND 2'-PHOSPHO-5'-AMP BOUND STATES
1FNCA:19-151REFINED CRYSTAL STRUCTURE OF SPINACH FERREDOXIN REDUCTASE AT 1.7 ANGSTROMS RESOLUTION: OXIDIZED, REDUCED, AND 2'-PHOSPHO-5'-AMP BOUND STATES
1FNDA:19-151REFINED CRYSTAL STRUCTURE OF SPINACH FERREDOXIN REDUCTASE AT 1.7 ANGSTROMS RESOLUTION: OXIDIZED, REDUCED, AND 2'-PHOSPHO-5'-AMP BOUND STATES
1FRNA:19-151THE INVOLVEMENT OF SER96 IN THE CATALYTIC MECHANISM OF FERREDOXIN-NADP+ REDUCTASE: STRUCTURE-FUNCTION RELATIONSHIP AS STUDIED BY SITE-DIRECTED MUTAGENESIS AND X-RAY CRYSTALLOGRAPHY
1FRQA:19-151FERREDOXIN:NADP+ OXIDOREDUCTASE (FERREDOXIN REDUCTASE) MUTANT E312A
(-)
strain pcc 7119) (Anabaena sp (2)
1OGIA:9-136FERREDOXIN:NADP+ REDUCTASE MUTANT WITH THR 155 REPLACED BY GLY AND ALA 160 REPLACED BY THR (T155G-A160T)
1OGJA:9-136FERREDOXIN:NADP+ REDUCTASE MUTANT WITH LEU 263 REPLACED BY PRO (L263P)
(-)
Streptococcus pneumoniae. Organism_taxid: 1313. (1)
2HMAA:283-373THE CRYSTAL STRUCTURE OF TRNA (5-METHYLAMINOMETHYL-2-THIOURIDYLATE)-METHYLTRANSFERASE TRMU FROM STREPTOCOCCUS PNEUMONIAE
(-)
Sulfolobus solfataricus p2. Organism_taxid: 273057. Strain: p2. (2)
2QMUA:208-322; A:323-415STRUCTURE OF AN ARCHAEAL HETEROTRIMERIC INITIATION FACTOR 2 REVEALS A NUCLEOTIDE STATE BETWEEN THE GTP AND THE GDP STATES
2QN6A:208-322; A:323-415STRUCTURE OF AN ARCHAEAL HETEROTRIMERIC INITIATION FACTOR 2 REVEALS A NUCLEOTIDE STATE BETWEEN THE GTP AND THE GDP STATES
(-)
Sulfolobus solfataricus. Organism_taxid: 2287 (1)
1JNYA:321-428; B:321-428; A:228-316; B:228-316CRYSTAL STRUCTURE OF SULFOLOBUS SOLFATARICUS ELONGATION FACTOR 1 ALPHA IN COMPLEX WITH GDP
(-)
Sulfolobus solfataricus. Organism_taxid: 2287. (3)
2PLFA:208-322; A:323-415THE STRUCTURE OF AIF2GAMMA SUBUNIT FROM THE ARCHAEON SULFOLOBUS SOLFATARICUS IN THE NUCLEOTIDE-FREE FORM.
2PMDA:208-322; B:208-322; A:323-415; B:323-415THE STRUCTURES OF AIF2GAMMA SUBUNIT FROM THE ARCHAEON SULFOLOBUS SOLFATARICUS IN THE GDP-BOUND FORM.
3CW2A:208-322; E:323-415; F:323-415; B:323-415; B:208-322; E:208-322; F:208-322; A:323-415CRYSTAL STRUCTURE OF THE INTACT ARCHAEAL TRANSLATION INITIATION FACTOR 2 FROM SULFOLOBUS SOLFATARICUS .
(-)
Sulfolobus solfataricus. Organism_taxid: 2287. (1)
2AHOA:208-322; A:323-415STRUCTURE OF THE ARCHAEAL INITIATION FACTOR EIF2 ALPHA-GAMMA HETERODIMER FROM SULFOLOBUS SOLFATARICUS COMPLEXED WITH GDPNP
(-)
Sulfolobus solfataricus. Organism_taxid: 2287. Strain: mt4. (1)
1SKQB:320-428; A:321-428; A:228-316; B:228-315THE CRYSTAL STRUCTURE OF SULFOLOBUS SOLFATARICUS ELONGATION FACTOR 1-ALPHA IN COMPLEX WITH MAGNESIUM AND GDP
(-)
Thermus aquaticus. Organism_taxid: 271 (1)
1EFTA:311-404; A:216-307THE CRYSTAL STRUCTURE OF ELONGATION FACTOR EF-TU FROM THERMUS AQUATICUS IN THE GTP CONFORMATION
(-)
Thermus aquaticus. Organism_taxid: 271. (1)
1OB5A:311-404; C:311-404; E:311-404; A:216-307; C:216-307; E:216-307T. AQUATICUS ELONGATION FACTOR EF-TU COMPLEXED WITH THE ANTIBIOTIC ENACYLOXIN IIA, A GTP ANALOG, AND PHE-TRNA
(-)
Thermus aquaticus. Organism_taxid: 271. Strain: yt-1 (1)
1TUIA:311-404; B:311-404; C:311-404; A:216-307; B:216-307; C:216-307INTACT ELONGATION FACTOR TU IN COMPLEX WITH GDP
(-)
Thermus thermophilus hb8. Organism_taxid: 300852. Strain: hb8 (2)
1DARA:303-400ELONGATION FACTOR G IN COMPLEX WITH GDP
1ELOA:303-409ELONGATION FACTOR G WITHOUT NUCLEOTIDE
(-)
Thermus thermophilus hb8. Organism_taxid: 300852. Strain: hb8. (1)
2EFGA:303-400TRANSLATIONAL ELONGATION FACTOR G COMPLEXED WITH GDP
(-)
Thermus thermophilus. Organism_taxid: 274 (1)
1EXMA:311-404; A:216-307CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS ELONGATION FACTOR TU (EF-TU) IN COMPLEX WITH THE GTP ANALOGUE GPPNHP.
(-)
Thermus thermophilus. Organism_taxid: 274. (1)
1KTVA:303-409; B:303-409CRYSTAL STRUCTURE OF ELONGATION FACTOR G DIMER WITHOUT NUCLEOTIDE
(-)
Thermus thermophilus. Organism_taxid: 274. (5)
1AIPA:311-404; A:216-307; B:350-404; F:350-404; E:216-345; B:216-346; F:216-346; E:349-404EF-TU EF-TS COMPLEX FROM THERMUS THERMOPHILUS
1FNMA:303-400STRUCTURE OF THERMUS THERMOPHILUS EF-G H573A
2BM0A:303-405RIBOSOMAL ELONGATION FACTOR G (EF-G) FUSIDIC ACID RESISTANT MUTANT T84A
2BM1A:303-405RIBOSOMAL ELONGATION FACTOR G (EF-G) FUSIDIC ACID RESISTANT MUTANT G16V
2BV3A:303-405CRYSTAL STRUCTURE OF A MUTANT ELONGATION FACTOR G TRAPPED WITH A GTP ANALOGUE
(-)
Thermus thermophilus. Organism_taxid: 300852. Strain: hb8. (1)
1HA3A:311-404; B:311-404; A:216-307; B:216-307ELONGATION FACTOR TU IN COMPLEX WITH AURODOX
(-)
Thermus thermophilus. Organism_taxid: 300852. Strain: hb8. (3)
2C77A:311-404; A:216-307EF-TU COMPLEXED WITH A GTP ANALOG AND THE ANTIBIOTIC GE2270 A
2C78A:311-404; A:216-307EF-TU COMPLEXED WITH A GTP ANALOG AND THE ANTIBIOTIC PULVOMYCIN
2J7KA:303-405CRYSTAL STRUCTURE OF THE T84A MUTANT EF-G:GDPCP COMPLEX
(-)
Zea mays. Organism_taxid: 4577. (3)
1CNEA:11-116STRUCTURAL STUDIES ON CORN NITRATE REDUCTASE: REFINED STRUCTURE OF THE CYTOCHROME B REDUCTASE FRAGMENT AT 2.5 ANGSTROMS, ITS ADP COMPLEX AND AN ACTIVE SITE MUTANT AND MODELING OF THE CYTOCHROME B DOMAIN
1CNFA:11-116STRUCTURAL STUDIES ON CORN NITRATE REDUCTASE: REFINED STRUCTURE OF THE CYTOCHROME B REDUCTASE FRAGMENT AT 2.5 ANGSTROMS, ITS ADP COMPLEX AND AN ACTIVE SITE MUTANT AND MODELING OF THE CYTOCHROME B DOMAIN
2CNDA:11-116STRUCTURAL STUDIES ON CORN NITRATE REDUCTASE: REFINED STRUCTURE OF THE CYTOCHROME B REDUCTASE FRAGMENT AT 2.5 ANGSTROMS, ITS ADP COMPLEX AND AN ACTIVE SITE MUTANT AND MODELING OF THE CYTOCHROME B DOMAIN
(-)
Zea mays. Organism_taxid: 4577. (3)
1GAQA:19-151; C:19-151CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN FERREDOXIN AND FERREDOXIN-NADP+ REDUCTASE
1GAWA:19-151; B:19-151CRYSTAL STRUCTURE ANALYSIS OF THE FERREDOXIN-NADP+ REDUCTASE FROM MAIZE LEAF
1JB9A:15-153CRYSTAL STRUCTURE OF THE FERREDOXIN:NADP+ REDUCTASE FROM MAIZE ROOT AT 1.7 ANGSTROMS
(-)
Homologous Superfamily: YaeB-like domains (1)
(-)
Archaeoglobus fulgidus. Organism_taxid: 2234. (1)
2NV4A:2-133; B:2-133CRYSTAL STRUCTURE OF UPF0066 PROTEIN AF0241 IN COMPLEX WITH S-ADENOSYLMETHIONINE. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET GR27
(-)
Homologous Superfamily: YkvR-like (1)
(-)
Bacillus subtilis. Organism_taxid: 1423. (1)
2JN9A:1-91NMR SOLUTION STRUCTURE OF YKVR PROTEIN FROM BACILLUS SUBTILIS: NESG TARGET SR358
(-)
Topology: FomD barrel-like fold (3)
(-)
Homologous Superfamily: FomD barrel-like domain (3)
(-)
Rha1 (Rhodococcus sp) (1)
2P12A:8-168; B:9-168CRYSTAL STRUCTURE OF PROTEIN OF UNKNOWN FUNCTION DUF402 FROM RHODOCOCCUS SP. RHA1
(-)
Streptomyces coelicolor a3(2). Organism_taxid: 100226. Strain: a3(2) /m145. (2)
3CBTA:23-217CRYSTAL STRUCTURE OF SC4828, A UNIQUE PHOSPHATASE FROM STREPTOMYCES COELICOLOR
3EXMA:23-217CRYSTAL STRUCTURE OF THE PHOSPHATASE SC4828 WITH THE NON-HYDROLYZABLE NUCLEOTIDE GPCP
(-)
Topology: Green Fluorescent Protein (102)
(-)
Homologous Superfamily: Green Fluorescent Protein (102)
(-)
Aequorea victoria. Organism_taxid: 6100. (30)
1C4FA:3-229GREEN FLUORESCENT PROTEIN S65T AT PH 4.6
1CV7A:1-228CRYSTAL STRUCTURE OF ENHANCED CYAN-EMISSION VARIANT OF GFP
1EMAA:2-229GREEN FLUORESCENT PROTEIN FROM AEQUOREA VICTORIA
1EMCA:4-230; B:4-230; D:4-230; C:4-231GREEN FLUORESCENT PROTEIN FROM AEQUOREA VICTORIA, MUTANT
1EMEA:6-230GREEN FLUORESCENT PROTEIN FROM AEQUOREA VICTORIA, MUTANT
1EMFA:6-230GREEN FLUORESCENT PROTEIN FROM AEQUOREA VICTORIA, MUTANT
1EMKA:6-229GREEN FLUORESCENT PROTEIN FROM AEQUOREA VICTORIA, MUTANT
1EMLA:7-229GREEN FLUORESCENT PROTEIN FROM AEQUOREA VICTORIA, MUTANT
1EMMA:7-229GREEN FLUORESCENT PROTEIN FROM AEQUOREA VICTORIA, MUTANT
1HUYA:-1-230CRYSTAL STRUCTURE OF CITRINE, AN IMPROVED YELLOW VARIANT OF GREEN FLUORESCENT PROTEIN
1QXTA:4-229CRYSTAL STRUCTURE OF PRECYCLIZED INTERMEDIATE FOR THE GREEN FLUORESCENT PROTEIN R96A VARIANT (A)
1QY3A:3-229CRYSTAL STRUCTURE OF PRECYCLIZED INTERMEDIATE FOR THE GREEN FLUORESCENT PROTEIN R96A VARIANT (B)
1QYFA:3-229CRYSTAL STRUCTURE OF MATURED GREEN FLUORESCENT PROTEIN R96A VARIANT
1QYOA:2-237ANAEROBIC PRECYLIZATION INTERMEDIATE CRYSTAL STRUCTURE FOR S65G Y66G GFP VARIANT
1QYQA:2-228CRYSTAL STRUCTURE OF THE CYCLIZED S65G Y66G GFP VARIANT
1YFPA:3-229; B:3-229STRUCTURE OF YELLOW-EMISSION VARIANT OF GFP
2AH8A:3-238; B:3-238ROGFP1-R7. CYSTAL STRUCTURE ANALYSIS OF A RATE-ENHANCED VARIANT OF REDOX-SENSITIVE GREEN FLUORESCENT PROTEIN IN THE OXIDIZED FORM.
2AHAA:2-229; B:2-229CRYSTAL STRUCTURE ANALYSIS OF A RATE-ENHANCED VARIANT OF REDOX-SENSITIVE GREEN FLUORESCENT PROTEIN IN THE REDUCED FORM, ROGFP1-R8.
2AWJA:3-229GFP R96M PRE-CYCLIZED INTERMEDIATE IN CHROMOPHORE FORMATION
2AWKA:3-229GFP R96M MATURE CHROMOPHORE
2AWLA:3-229MATURE R96K GFP MUTANT
2AWMA:3-229GFP R96A CHROMOPHORE MATURATION RECOVERY MUTANT R96A Q183R
2B3PA:2-232CRYSTAL STRUCTURE OF A SUPERFOLDER GREEN FLUORESCENT PROTEIN
2B3QA:3-231; B:3-231; C:3-231; D:3-231CRYSTAL STRUCTURE OF A WELL-FOLDED VARIANT OF GREEN FLUORESCENT PROTEIN
2EMDA:6-230GREEN FLUORESCENT PROTEIN FROM AEQUOREA VICTORIA, MUTANT
2EMNA:6-229GREEN FLUORESCENT PROTEIN FROM AEQUOREA VICTORIA, MUTANT
2EMOA:6-229GREEN FLUORESCENT PROTEIN FROM AEQUOREA VICTORIA, MUTANT
2FWQA:3-237REDUCED ENOLATE CHROMOPHORE INTERMEDIATE FOR Y66H GFP VARIANT
2FZUA:3-238REDUCED ENOLATE CHROMOPHORE INTERMEDIATE FOR GFP VARIANT
2YFPA:2-229STRUCTURE OF YELLOW-EMISSION VARIANT OF GFP
(-)
Aequorea victoria. Organism_taxid: 6100. (34)
1B9CA:4-230; D:4-230; B:4-230; C:4-230GREEN FLUORESCENT PROTEIN MUTANT F99S, M153T AND V163A
1BFPA:1-229BLUE VARIANT OF GREEN FLUORESCENT PROTEIN
1EMBA:2-229GREEN FLUORESCENT PROTEIN (GFP) FROM AEQUOREA VICTORIA, GLN 80 REPLACED WITH ARG
1F09A:2-229CRYSTAL STRUCTURE OF THE GREEN FLUORESCENT PROTEIN (GFP) VARIANT YFP-H148Q WITH TWO BOUND IODIDES
1F0BA:3-230CRYSTAL STRUCTURE OF THE GREEN FLUORESCENT PROTEIN (GFP) VARIANT YFP-H148Q
1GFLA:1-230; B:1-230STRUCTURE OF GREEN FLUORESCENT PROTEIN
1JBYA:4-229CRYSTAL STRUCTURE ANALYSIS OF A DUAL-WAVELENGTH EMISSION GREEN FLUORESCENT PROTEIN VARIANT AT LOW PH
1JBZA:4-229CRYSTAL STRUCTURE ANALYSIS OF A DUAL-WAVELENGTH EMISSION GREEN FLUORESCENT PROTEIN VARIANT AT HIGH PH
1JC0A:1-228; B:1-228; C:2-229CRYSTAL STRUCTURE ANALYSIS OF A REDOX-SENSITIVE GREEN FLUORESCENT PROTEIN VARIANT IN A REDUCED FORM
1JC1B:1-228; C:2-229; A:1-229CRYSTAL STRUCTURE ANALYSIS OF A REDOX-SENSITIVE GREEN FLUORESCENT PROTEIN VARIANT IN A OXIDIZED FORM
1KP5A:1-245; B:301-545CYCLIC GREEN FLUORESCENT PROTEIN
1KYPA:2-229CRYSTAL STRUCTURE OF AN APO GREEN FLUORESCENT PROTEIN ZN BIOSENSOR
1KYRA:4-230CRYSTAL STRUCTURE OF A CU-BOUND GREEN FLUORESCENT PROTEIN ZN BIOSENSOR
1KYSA:4-230CRYSTAL STRUCTURE OF A ZN-BOUND GREEN FLUORESCENT PROTEIN BIOSENSOR
1MYWA:0-230CRYSTAL STRUCTURE OF A YELLOW FLUORESCENT PROTEIN WITH IMPROVED MATURATION AND REDUCED ENVIRONMENTAL SENSITIVITY
1Q4AA:2-230S65T Q80R GREEN FLUORESCENT PROTEIN (GFP) PH 8.5
1Q4BA:2-230S65T Q80R GREEN FLUORESCENT PROTEIN (GFP) PH 5.5
1Q4CA:2-230S65T Q80R T203C GREEN FLUORESCENT PROTEIN (GFP) PH 8.5
1Q4DA:2-229S65T Q80R T203C GREEN FLUORESCENT PROTEIN (GFP) PH 5.5
1Q4EA:2-230S65T Q80R Y145C GREEN FLUORESCENT PROTEIN (GFP) PH 8.5
1Q73A:2-230S65T Q80R Y145C T203C GREEN FLUORESCENT PROTEIN (GFP) PH 8.5
1RM9A:3-229PROBING THE ROLE OF TRYPTOPHANS IN AEQUOREA VICTORIA GREEN FLUORESCENT PROTEINS WITH AN EXPANDED GENETIC CODE
1RMMA:2-229PROBING THE ROLE OF TRYPTOPHANS IN AEQUOREA VICTORIA GREEN FLUORESCENT PROTEINS WITH AN EXPANDED GENETIC CODE
1RMOA:4-229PROBING THE ROLE OF TRYPTOPHANS IN AEQUOREA VICTORIA GREEN FLUORESCENT PROTEINS WITH AN EXPANDED GENETIC CODE
1RMPA:4-229PROBING THE ROLE OF TRYPTOPHANS IN AEQUOREA VICTORIA GREEN FLUORESCENT PROTEINS WITH AN EXPANDED GENETIC CODE
1RRXA:2-229CRYSTALLOGRAPHIC EVIDENCE FOR ISOMERIC CHROMOPHORES IN 3-FLUOROTYROSYL-GREEN FLUORESCENT PROTEIN
1YHGB:306-529; A:4-229UNCYCLIZED PRECURSOR STRUCTURE OF S65G Y66S V68G GFP VARIANT
1YHHA:2-230UNCYCLIZED PRECURSOR STRUCTURE OF S65A Y66S G67A GFP VARIANT
1YHIA:2-228UNCYCLIZED PRECURSOR STRUCTURE OF S65A Y66S R96A GFP VARIANT
1YJ2A:4-229CYCLIZED, NON-DEHYDRATED POST-TRANSLATIONAL PRODUCT FOR S65A Y66S H148G GFP VARIANT
1YJFA:4-231CYCLIZED POST-TRANSLATIONAL PRODUCT FOR S65A Y66S (GFPHAL) GREEN FLUORESCENT PROTEIN VARIANT
1Z1PA:2-230Y66L VARIANT OF ENHANCED GREEN FLUORESCENT PROTEIN WITH 412-NM ABSORBING CHROMOPHORE
1Z1QA:2-230Y66L VARIANT OF ENHANCED GREEN FLUORESCENT PROTEIN WITH 374-NM ABSORBING CHROMOPHORE
3ED8E:3-255; B:2-255; A:2-254; D:2-255; C:2-255APPLICATION OF THE SUPERFOLDER YFP BIMOLECULAR FLUORESCENCE COMPLEMENTATION FOR STUDYING PROTEIN-PROTEIN INTERACTIONS IN VITRO
(-)
Aequorea victoria. Organism_taxid: 6100. Strain: jm109(de3). (1)
1EMGA:2-229GREEN FLUORESCENT PROTEIN (65-67 REPLACED BY CRO, S65T SUBSTITUTION, Q80R)
(-)
Anemonia majano. Organism_taxid: 105399. (2)
2A46A:5-224CRYSTAL STRUCTURES OF AMFP486, A CYAN FLUORESCENT PROTEIN FROM ANEMONIA MAJANO, AND VARIANTS
2A47A:5-224CRYSTAL STRUCTURE OF AMFP486 H199T
(-)
Cfp marker plasmid pwm1009. Organism_taxid: 141850. (3)
1OXDA:1-229EXPANSION OF THE GENETIC CODE ENABLES DESIGN OF A NOVEL "GOLD" CLASS OF GREEN FLUORESCENT PROTEINS
1OXEA:1-229EXPANSION OF THE GENETIC CODE ENABLES DESIGN OF A NOVEL "GOLD" CLASS OF GREEN FLUORESCENT PROTEINS
1OXFA:2-228EXPANSION OF THE GENETIC CODE ENABLES DESIGN OF A NOVEL "GOLD" CLASS OF GREEN FLUORESCENT PROTEINS
(-)
Clytia gregaria. Organism_taxid: 27801. (1)
2HPWA:5-235GREEN FLUORESCENT PROTEIN FROM CLYTIA GREGARIA
(-)
Discosoma sp.. Organism_taxid: 86600. (1)
1G7KA:6-225; B:6-225; C:6-225; D:6-225CRYSTAL STRUCTURE OF DSRED, A RED FLUORESCENT PROTEIN FROM DISCOSOMA SP. RED
(-)
Discosoma sp.. Organism_taxid: 86600. (4)
1GGXA:7-225; B:7-225; C:7-225; D:7-225RED FLUORESCENT PROTEIN (FP583 OR DSRED(CLONTECH)) FROM DISCOSOMA SP.
1ZGOA:6-225; B:6-225; C:6-225; D:6-225HIGH RESOLUTION CRYSTAL STRUCTURE OF THE DISCOSOMA RED FLUORESCENT PROTEIN (DSRED)
1ZGPA:6-225; B:6-225; C:6-225; D:6-225CRYSTAL STRUCTURE OF THE DISCOSOMA RED FLUORESCENT PROTEIN (DSRED) VARIANT K70M
1ZGQA:6-225; C:6-225; D:6-225; E:6-225; F:6-225; G:6-225; H:6-225; B:6-225CRYSTAL STRUCTURE OF THE DISCOSOMA RED FLUORESCENT PROTEIN (DSRED) VARIANT Q66M
(-)
Entacmaea quadricolor. Organism_taxid: 6118. (4)
1UISA:-1-225; B:-1-225THE 2.0 CRYSTAL STRUCTURE OF EQFP611, A FAR-RED FLUORESCENT PROTEIN FROM THE SEA ANEMONE ENTACMAEA QUADRICOLOR
3BX9A:2-228; B:2-228MONOMERIC FAR-RED FLUORESCENT PROTEIN MKATE CRYSTALLIZED AT PH 2.0
3BXAA:3-228; B:3-228MONOMERIC FAR-RED FLUORESCENT PROTEIN MKATE CRYSTALLIZED AT PH 4.2
3BXBA:4-228; G:4-228; H:4-228; B:4-228; C:4-228; D:4-228; E:4-228; F:4-228MONOMERIC FAR-RED FLUORESCENT PROTEIN MKATE CRYSTALLIZED AT PH 7.0
(-)
Jellyfish (Aequorea victoria) (8)
1HCJA:3-231; B:3-231; D:3-231; C:2-231PHOTOPRODUCT OF THE WILD-TYPE AEQUOREA VICTORIA GREEN FLUORESCENT PROTEIN
1W7SB:3-231; A:2-231; C:2-231; D:2-231WILD-TYPE AEQUOREA VICTORIA GREEN FLUORESCENT PROTEIN
1W7TB:3-231; A:2-231; C:2-231; D:2-231PHOTOPRODUCT OF THE WILD-TYPE AEQUOREA VICTORIA GREEN FLUORESCENT PROTEIN AT 100 K
1W7UB:3-231; A:2-231; C:2-231; D:2-231PHOTOPRODUCT OF THE WILD-TYPE AEQUOREA VICTORIA GREEN FLUORESCENT PROTEIN AFTER STRUCTURAL ANNEALING AT 170K
3CB9A:2-231DEVELOPMENT OF A FAMILY OF REDOX-SENSITIVE GREEN FLUORESCENT PROTEIN INDICATORS FOR USE IN RELATIVELY OXIDIZING SUBCELLULAR ENVIRONMENTS
3CBEA:2-230DEVELOPMENT OF A FAMILY OF REDOX-SENSITIVE GREEN FLUORESCENT PROTEIN INDICATORS FOR USE IN RELATIVELY OXIDIZING SUBCELLULAR ENVIRONMENTS
3CD1A:3-230DEVELOPMENT OF A FAMILY OF REDOX-SENSITIVE GREEN FLUORESCENT PROTEIN INDICATORS FOR USE IN RELATIVELY OXIDIZING SUBCELLULAR ENVIRONMENTS
3CD9A:3-230DEVELOPMENT OF A FAMILY OF REDOX-SENSITIVE GREEN FLUORESCENT PROTEIN INDICATORS FOR USE IN RELATIVELY OXIDIZING SUBCELLULAR ENVIRONMENTS
(-)
Montipora efflorescens. Organism_taxid: 105610. (2)
1MOUA:5-225CRYSTAL STRUCTURE OF CORAL PIGMENT
1MOVA:5-225CRYSTAL STRUCTURE OF CORAL PROTEIN MUTANT
(-)
Renilla reniformis. Organism_taxid: 6136. (1)
2RH7B:7-226; A:7-226; C:7-226; D:7-226CRYSTAL STRUCTURES OF THE LUCIFERASE AND GREEN FLUORESCENT PROTEIN FROM RENILLA RENIFORMIS
(-)
Snake-locks sea anemone (Anemonia sulcata) (1)
1XMZA:4-232; B:-3-232CRYSTAL STRUCTURE OF THE DARK STATE OF KINDLING FLUORESCENT PROTEIN KFP FROM ANEMONIA SULCATA
(-)
Striped mushroom (Discosoma striata) (1)
3CGLA:1-226CRYSTAL STRUCTURE AND RAMAN STUDIES OF DSFP483, A CYAN FLUORESCENT PROTEIN FROM DISCOSOMA STRIATA
(-)
Synthetic construct. Organism_taxid: 32630. (1)
1S6ZA:2-230ENHANCED GREEN FLUORESCENT PROTEIN CONTAINING THE Y66L SUBSTITUTION
(-)
Zoanthus sp.. Organism_taxid: 105402. (8)
1XA9A:4-230CRYSTAL STRUCTURE OF YELLOW FLUORESCENT PROTEIN ZFP538 K66M GREEN MUTANT
1XAEA:6-230; B:6-229CRYSTAL STRUCTURE OF WILD TYPE YELLOW FLUORESCENT PROTEIN ZFP538 FROM ZOANTHUS
2FL1A:4-231; B:4-231; C:4-231; D:4-231CRYSTAL STRUCTURE OF RED FLUORESCENT PROTEIN FROM ZOANTHUS, ZRFP574, AT 2.4A RESOLUTION
2ICRA:4-231; B:4-231; D:4-231; C:3-231RED FLUORESCENT PROTEIN ZRFP574 FROM ZOANTHUS SP.
2OGRA:6-231; C:6-231; D:6-231; B:6-231CRYSTAL STRUCTURE OF YELLOW FLUORESCENT PROTEIN FROM ZOANTHUS SP. AT 1.8 A RESOLUTION
2OJKA:4-231; B:4-231CRYSTAL STRUCTURE OF GREEN FLUORESCENT PROTEIN FROM ZOANTHUS SP AT 2.2 A RESOLUTION
2PXSA:4-231; B:4-231CRYSTAL STRUCTURE OF N66D MUTANT OF GREEN FLUORESCENT PROTEIN FROM ZOANTHUS SP. AT 2.2 A RESOLUTION (MATURE STATE)
2PXWA:4-231; B:4-231CRYSTAL STRUCTURE OF N66D MUTANT OF GREEN FLUORESCENT PROTEIN FROM ZOANTHUS SP. AT 2.4 A RESOLUTION (TRANSITION STATE)
(-)
Topology: Hypothetical Protein Pfu-838710-001 (5)
(-)
Homologous Superfamily: Hypothetical Protein Pfu-838710-001 (5)
(-)
House mouse (Mus musculus) (1)
2JMUA:1-213NMR STRUCTURE OF THE MOUSE THIAMINE TRIPHOSPHATASE
(-)
Human (Homo sapiens) (1)
3BHDB:3-208; A:2-214CRYSTAL STRUCTURE OF HUMAN THIAMINE TRIPHOSPHATASE (THTPA)
(-)
Nitrosomonas europaea. Organism_taxid: 915. (1)
2FBLB:2-151; A:2-151THE CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN NE1496
(-)
Pyrococcus furiosus. Organism_taxid: 2261. (1)
1YEMB:1-166; A:1-163CONSERVED HYPOTHETICAL PROTEIN PFU-838710-001 FROM PYROCOCCUS FURIOSUS
(-)
Pyrococcus horikoshii. Organism_taxid: 53953. (1)
2DC4A:1-164; B:1-164STRUCTURE OF PH1012 PROTEIN FROM PYROCOCCUS HORIKOSHII OT3
(-)
Topology: Intramolecular trans-sialidase; domain 3 (9)
(-)
Homologous Superfamily: Intramolecular Trans-sialidase; Domain 3 (9)
(-)
North american leech (Macrobdella decora) (5)
1SLIA:405-504LEECH INTRAMOLECULAR TRANS-SIALIDASE COMPLEXED WITH DANA
1SLLA:405-504SIALIDASE L FROM LEECH MACROBDELLA DECORA
2SLIA:405-504LEECH INTRAMOLECULAR TRANS-SIALIDASE COMPLEXED WITH 2,7-ANHYDRO-NEU5AC, THE REACTION PRODUCT
3SLIA:405-504LEECH INTRAMOLECULAR TRANS-SIALIDASE COMPLEXED WITH 2,7-ANHYDRO-NEU5AC PREPARED BY SOAKING WITH 3'-SIALYLLACTOSE
4SLIA:405-504LEECH INTRAMOLECULAR TRANS-SIALIDASE COMPLEXED WITH 2-PROPENYL-NEU5AC, AN INACTIVE SUBSTRATE ANALOGUE
(-)
Streptococcus pneumoniae. Organism_taxid: 1313. Strain: tigr. (3)
2VW0A:358-455CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE
2VW1A:358-455CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE
2VW2A:358-455CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE
(-)
Streptococcus pneumoniae. Organism_taxid: 170187. Strain: tigr4. (1)
2JKBA:358-455CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANB IN COMPLEX WITH 2,7-ANHYDRO-NEU5AC
(-)
Topology: Ku70; Chain: A; Domain 2 (3)
(-)
Homologous Superfamily: [code=2.40.290.10, no name defined] (3)
(-)
[unclassified] (1)
1JEYB:243-443; A:251-278,A:342-439CRYSTAL STRUCTURE OF THE KU HETERODIMER BOUND TO DNA
(-)
Human (Homo sapiens) (2)
1JEQB:243-443; A:251-278,A:342-439CRYSTAL STRUCTURE OF THE KU HETERODIMER
1OW1A:3495-3664CRYSTAL STRUCTURE OF THE SPOC DOMAIN OF THE HUMAN TRANSCRIPTIONAL COREPRESSOR, SHARP.
(-)
Topology: L,D-transpeptidase catalytic domain-like (1)
(-)
Homologous Superfamily: L,D-transpeptidase catalytic domain-like (1)
(-)
Subtilis str (Bacillus subtilis subsp) (1)
1Y7MA:48-164; B:48-164CRYSTAL STRUCTURE OF THE B. SUBTILIS YKUD PROTEIN AT 2 A RESOLUTION
(-)
Topology: Lipocalin (526)
(-)
Homologous Superfamily: [code=2.40.128.10, no name defined] (3)
(-)
Pseudomonas aeruginosa. Organism_taxid: 287. (1)
2RN4A:1-106SOLUTION STRUCTURE OF THE ALKALINE PROTEINASE INHIBITOR APRIN FROM PSEUDOMONAS AERUGINOSA
(-)
Pseudomonas aeruginosa. Organism_taxid: 287. (1)
1JIWI:1-105CRYSTAL STRUCTURE OF THE APR-APRIN COMPLEX
(-)
Serratia marcescens. Organism_taxid: 615. (1)
1SMPI:1-100CRYSTAL STRUCTURE OF A COMPLEX BETWEEN SERRATIA MARCESCENS METALLO-PROTEASE AND AN INHIBITOR FROM ERWINIA CHRYSANTHEMI
(-)
Homologous Superfamily: [code=2.40.128.20, no name defined] (352)
(-)
[unclassified] (1)
1I4UB:2-181; A:1-181THE C1 SUBUNIT OF ALPHA-CRUSTACYANIN
(-)
American house dust mite (Dermatophagoides farinae) (1)
2A0AA:1-131SOLUTION STRUCTURE OF DER F 13, GROUP 13 ALLERGEN FROM HOUSE DUST MITES
(-)
Axolotl (Ambystoma mexicanum) (2)
2FT9A:1-125CRYSTAL STRUCTURE OF AXOLOTL (AMBYSTOMA MEXICANUM) LIVER BILE ACID-BINDING PROTEIN BOUND TO CHOLIC ACID
2FTBA:1-125CRYSTAL STRUCTURE OF AXOLOTL (AMBYSTOMA MEXICANUM) LIVER BILE ACID-BINDING PROTEIN BOUND TO OLEIC ACID
(-)
Bacillus subtilis. Organism_taxid: 1423. (2)
1R0UA:-6-140CRYSTAL STRUCTURE OF YWIB PROTEIN FROM BACILLUS SUBTILIS
2JOZA:18-113SOLUTION NMR STRUCTURE OF PROTEIN YXEF, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET SR500A
(-)
Bacillus subtilis. Organism_taxid: 1423. Strain: 168. (1)
2P8GA:0-161CRYSTAL STRUCTURE OF PHENOLIC ACID DECARBOXYLASE (2635953) FROM BACILLUS SUBTILIS AT 1.36 A RESOLUTION
(-)
Black rat (Rattus rattus) (4)
1CRBA:1-134CRYSTALLOGRAPHIC STUDIES ON A FAMILY OF CELLULAR LIPOPHILIC TRANSPORT PROTEINS. REFINEMENT OF P2 MYELIN PROTEIN AND THE STRUCTURE DETERMINATION AND REFINEMENT OF CELLULAR RETINOL-BINDING PROTEIN IN COMPLEX WITH ALL-TRANS-RETINOL
1IFBA:1-131REFINED APOPROTEIN STRUCTURE OF RAT INTESTINAL FATTY ACID BINDING PROTEIN PRODUCED IN ESCHERICHIA COLI
1OPAA:1-133; B:1-133THE CRYSTAL STRUCTURES OF HOLO-AND APO-CELLULAR RETINOL BINDING PROTEIN II
1OPBA:1-133; B:1-133; C:1-133; D:1-133THE CRYSTAL STRUCTURES OF HOLO-AND APO-CELLULAR RETINOL BINDING PROTEIN II
(-)
Blood fluke (Schistosoma mansoni) (3)
1VYFA:-1-133SCHISTOSOMA MANSONI FATTY ACID BINDING PROTEIN IN COMPLEX WITH OLEIC ACID
1VYGA:-1-133SCHISTOSOMA MANSONI FATTY ACID BINDING PROTEIN IN COMPLEX WITH ARACHIDONIC ACID
2POAA:1-133SCHISTOSOMA MANSONI SM14 FATTY ACID-BINDING PROTEIN: IMPROVEMENT OF PROTEIN STABILITY BY SUBSTITUTION OF THE SINGLE CYS62 RESIDUE
(-)
Bovine (Bos taurus) (8)
1GT1B:3-158; A:2-159COMPLEX OF BOVINE ODORANT BINDING PROTEIN WITH AMINOANTHRACENE AND PYRAZINE
1GT3B:3-158; A:1-159COMPLEX OF BOVINE ODORANT BINDING PROTEIN WITH DIHYDROMYRCENOL
1GT4B:3-158; A:1-159COMPLEX OF BOVINE ODORANT BINDING PROTEIN WITH UNDECANAL
1GT5B:3-158; A:1-159COMPLEXE OF BOVINE ODORANT BINDING PROTEIN WITH BENZOPHENONE
1GX8A:2-162BOVINE BETA-LACTOGLOBULIN COMPLEXED WITH RETINOL, TRIGONAL LATTICE Z
1GX9A:2-162BOVINE BETA-LACTOGLOBULIN COMPLEXED WITH RETINOIC ACID, TRIGONAL LATTICE Z
1GXAA:2-162BOVINE BETA-LACTOGLOBULIN COMPLEXED WITH RETINOL AND PALMITIC ACID, TRIGONAL LATTICE Z
1UZ2X:1-158THE CYS121SER MUTANT OF BETA-LACTOGLOBULIN
(-)
Brown ear tick (Rhipicephalus appendiculatus) (2)
3G7XB:2-171; A:1-171FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2, D24R MUTANT
3GAQA:0-171; B:0-171FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN, D24R MUTANT
(-)
Bufo arenarum. Organism_taxid: 38577. (1)
1P6PA:1-125CRYSTAL STRUCTURE OF TOAD LIVER BASIC FATTY ACID-BINDING PROTEIN
(-)
Cattle (Bos taurus) (38)
1AVGI:1-142THROMBIN INHIBITOR FROM TRIATOMA PALLIDIPENNIS
1B0OA:2-162BOVINE BETA-LACTOGLOBULIN COMPLEXED WITH PALMITATE, LATTICE Z
1B8EA:1-152HIGH RESOLUTION CRYSTAL STRUCTURE OF THE BOVINE BETA-LACTOGLOBULIN (ISOFORMS A AND B) IN ORTHOROMBIC SPACE GROUP
1BEBA:5-160; B:5-160BOVINE BETA-LACTOGLOBULIN, LATTICE X
1BJ7A:7-156BOVINE LIPOCALIN ALLERGEN BOS D 2
1BSOA:1-16212-BROMODODECANOIC ACID BINDS INSIDE THE CALYX OF BOVINE BETA-LACTOGLOBULIN
1BSQA:1-162STRUCTURAL AND FUNCTIONAL CONSEQUENCES OF POINT MUTATIONS OF VARIANTS A AND B OF BOVINE BETA-LACTOGLOBULIN
1BSYA:1-162STRUCTURAL BASIS OF THE TANFORD TRANSITION OF BOVINE BETA-LACTOGLOBULIN FROM CRYSTAL STRUCTURES AT THREE PH VALUES; PH 7.1
1BWYA:1-132NMR STUDY OF BOVINE HEART FATTY ACID BINDING PROTEIN
1CJ5A:1-162BOVINE BETA-LACTOGLOBULIN A
1DV9A:1-162STRUCTURAL CHANGES ACCOMPANYING PH-INDUCED DISSOCIATION OF THE B-LACTOGLOBULIN DIMER
1ERBA:2-175THE INTERACTION OF N-ETHYL RETINAMIDE WITH PLASMA RETINOL-BINDING PROTEIN (RBP) AND THE CRYSTAL STRUCTURE OF THE RETINOID-RBP COMPLEX AT 1.9 ANGSTROMS RESOLUTION
1FELA:1-175CRYSTALLOGRAPHIC STUDIES ON COMPLEXES BETWEEN RETINOIDS AND PLASMA RETINOL-BINDING PROTEIN
1FEMA:1-177CRYSTALLOGRAPHIC STUDIES ON COMPLEXES BETWEEN RETINOIDS AND PLASMA RETINOL-BINDING PROTEIN
1FENA:1-177CRYSTALLOGRAPHIC STUDIES ON COMPLEXES BETWEEN RETINOIDS AND PLASMA RETINOL-BINDING PROTEIN
1G85B:3-157; A:1-159CRYSTAL STRUCTURE OF BOVINE ODORANT BINDING PROTEIN COMPLEXED WITH IS NATURAL LIGAND
1HBPA:1-175CRYSTAL STRUCTURE OF LIGANDED AND UNLIGANDED FORMS OF BOVINE PLASMA RETINOL-BINDING PROTEIN
1HBQA:1-177CRYSTAL STRUCTURE OF LIGANDED AND UNLIGANDED FORMS OF BOVINE PLASMA RETINOL-BINDING PROTEIN
1HN2B:2003-2157; A:1001-1159CRYSTAL STRUCTURE OF BOVINE OBP COMPLEXED WITH AMINOANTHRACENE
1KT3A:1-175CRYSTAL STRUCTURE OF BOVINE HOLO-RBP AT PH 2.0
1KT4A:1-175CRYSTAL STRUCTURE OF BOVINE HOLO-RBP AT PH 3.0
1KT5A:1-175CRYSTAL STRUCTURE OF BOVINE HOLO-RBP AT PH 4.0
1KT6A:1-175CRYSTAL STRUCTURE OF BOVINE HOLO-RBP AT PH 9.0
1KT7A:1-175CRYSTAL STRUCTURE OF BOVINE HOLO-RBP AT PH 7.0
1OBPB:3-157; A:2-159ODORANT-BINDING PROTEIN FROM BOVINE NASAL MUCOSA
1PBOA:1-157; B:9-159COMPLEX OF BOVINE ODORANT BINDING PROTEIN (OBP) WITH A SELENIUM CONTAINING ODORANT
1PMPA:1-131; B:1-131; C:1-131CRYSTALLOGRAPHIC STUDIES ON A FAMILY OF CELLULAR LIPOPHILIC TRANSPORT PROTEINS. REFINEMENT OF P2 MYELIN PROTEIN AND THE STRUCTURE DETERMINATION AND REFINEMENT OF CELLULAR RETINOL-BINDING PROTEIN IN COMPLEX WITH ALL-TRANS-RETINOL
1QG5A:1-154HIGH RESOLUTION CRYSTAL STRUCTURE OF THE BOVINE BETA-LACTOGLOBULIN (ISOFORM A)
2AKQA:5-160; B:5-160; C:5-160; D:5-160THE STRUCTURE OF BOVINE B-LACTOGLOBULIN A IN CRYSTALS GROWN AT VERY LOW IONIC STRENGTH
2BLGA:1-162STRUCTURAL BASIS OF THE TANFORD TRANSITION OF BOVINE BETA-LACTOGLOBULIN FROM CRYSTAL STRUCTURES AT THREE PH VALUES; PH 8.2
2CBRA:1-136CELLULAR RETINOIC ACID BINDING PROTEIN I IN COMPLEX WITH A RETINOBENZOIC ACID (AM80)
2GJ5A:2-162CRYSTAL STRUCTURE OF A SECONDARY VITAMIN D3 BINDING SITE OF MILK BETA-LACTOGLOBULIN
2HLVA:11-158BOVINE ODORANT BINDING PROTEIN DESWAPPED TRIPLE MUTANT
2Q2MA:1-152BETA-LACTOGLOBULIN (NATIVE)
2Q2PA:1-152BETA-LACTOGLOBULIN (REVERSE NATIVE)
2Q39B:205-355; A:1-160BETA-LACTOGLOBULIN (LOW HUMIDITY)
2R56A:4-162; B:4-162CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN
3BLGA:1-162STRUCTURAL BASIS OF THE TANFORD TRANSITION OF BOVINE BETA-LACTOGLOBULIN FROM CRYSTAL STRUCTURES AT THREE PH VALUES; PH 6.2
(-)
Chicken (Gallus gallus) (6)
1IIUA:2-175CHICKEN PLASMA RETINOL-BINDING PROTEIN (RBP)
1MVGA:1-125NMR SOLUTION STRUCTURE OF CHICKEN LIVER BASIC FATTY ACID BINDING PROTEIN (LB-FABP)
1TVQA:1-125CRYSTAL STRUCTURE OF APO CHICKEN LIVER BASIC FATTY ACID BINDING PROTEIN (OR BILE ACID BINDING PROTEIN)
1TW4A:1-125; B:1-125CRYSTAL STRUCTURE OF CHICKEN LIVER BASIC FATTY ACID BINDING PROTEIN (BILE ACID BINDING PROTEIN) COMPLEXED WITH CHOLIC ACID
1ZRYA:1-125NMR STRUCTURAL ANALYSIS OF APO CHICKEN LIVER BILE ACID BINDING PROTEIN
2JN3A:1-125NMR STRUCTURE OF CL-BABP COMPLEXED TO CHENODEOXYCHOLIC ACID
(-)
Common quail (Coturnix coturnix) (1)
1JZUA:1-157CELL TRANSFORMATION BY THE MYC ONCOGENE ACTIVATES EXPRESSION OF A LIPOCALIN: ANALYSIS OF THE GENE (Q83) AND SOLUTION STRUCTURE OF ITS PROTEIN PRODUCT
(-)
Dogs (Canis familiaris) (1)
3L4RA:7-157CRYSTAL STRUCTURE OF THE DOG LIPOCALIN ALLERGEN CAN F 2 AND IMPLICATIONS FOR CROSS-REACTIVITY TO THE CAT ALLERGEN FEL D 4
(-)
Domestic pig (Sus scrofa domestica) (1)
1AQBA:1-175RETINOL-BINDING PROTEIN (RBP) FROM PIG PLASMA
(-)
Echinococcus granulosus. Organism_taxid: 6210. (1)
1O8VA:1-133THE CRYSTAL STRUCTURE OF ECHINOCOCCUS GRANULOSUS FATTY-ACID-BINDING PROTEIN 1
(-)
Escherichia coli. Organism_taxid: 562 (3)
1OEEA:9-193YODA FROM ESCHERICHIA COLI CRYSTALLISED WITH CADMIUM IONS
1OEJA:7-193YODA FROM ESCHERICHIA COLI CRYSTALLISED WITH NO ADDED IONS
1OEKA:9-193YODA FROM ESCHERICHIA COLI CRYSTALLISED WITH ZINC IONS
(-)
Escherichia coli. Organism_taxid: 562. (4)
1QWDB:10-175; A:10-176CRYSTAL STRUCTURE OF A BACTERIAL LIPOCALIN, THE BLC GENE PRODUCT FROM E. COLI
1S7DA:7-193CRYSTAL STRUCTURE OF REFINED TETRAGONAL CRYSTAL OF YODA FROM ESCHERICHIA COLI
1TXLA:28-215CRYSTAL STRUCTURE OF METAL-BINDING PROTEIN YODA FROM E. COLI, PFAM DUF149
2ACOB:10-175; A:10-177XRAY STRUCTURE OF BLC DIMER IN COMPLEX WITH VACCENIC ACID
(-)
European lobster (Homarus gammarus) (6)
1GKAA:2-181; B:1-174THE MOLECULAR BASIS OF THE COLORATION MECHANISM IN LOBSTER SHELL. BETA-CRUSTACYANIN AT 3.2 A RESOLUTION
1H91A:2-181; B:2-181THE CRYSTAL STRUCTURE OF LOBSTER APOCRUSTACYANIN A1 USING SOFTER X-RAYS.
1OBQB:2-181; A:1-181APOCRUSTACYANIN C1 CRYSTALS GROWN IN SPACE AND EARTH USING VAPOUR DIFFUSION GEOMETRY
1OBUB:2-181; A:1-181APOCRUSTACYANIN C1 CRYSTALS GROWN IN SPACE AND EARTH USING VAPOUR DIFFUSION GEOMETRY
1S2PA:2-181; B:2-181THE STRUCTURE AND REFINEMENT OF APOCRUSTACYANIN C2 TO 1.3A RESOLUTION AND THE SEARCH FOR DIFFERENCES BETWEEN THIS PROTEIN AND THE HOMOLOGOUS APOPROTEINS A1 AND C1
1S44A:2-181; B:2-181THE STRUCTURE AND REFINEMENT OF APOCRUSTACYANIN C2 TO 1.6A RESOLUTION AND THE SEARCH FOR DIFFERENCES BETWEEN THIS PROTEIN AND THE HOMOLOGOUS APOPROTEINS A1 AND C1.
(-)
Gallus gallus. Organism_taxid: 9031. (1)
2K62A:1-125NMR SOLUTION STRUCTURE OF THE SUPRAMOLECULAR ADDUCT BETWEEN A LIVER CYTOSOLIC BILE ACID BINDING PROTEIN AND A BILE ACID-BASED GD(III)-CHELATE
(-)
Golden hamster (Mesocricetus auratus) (1)
1E5PA:3-151; D:3-151; B:4-151; C:5-151CRYSTAL STRUCTURE OF APHRODISIN, A SEX PHEROMONE FROM FEMALE HAMSTER
(-)
Horse (Equus caballus) (2)
1EW3A:23-181CRYSTAL STRUCTURE OF THE MAJOR HORSE ALLERGEN EQU C 1
1YIVA:1-131STRUCTURE OF MYELIN P2 PROTEIN FROM EQUINE SPINAL CORD
(-)
House mouse (Mus musculus) (39)
1A18A:1-131PHENANTHROLINE MODIFIED MURINE ADIPOCYTE LIPID BINDING PROTEIN
1A2DA:1-131; B:1-131PYRIDOXAMINE MODIFIED MURINE ADIPOCYTE LIPID BINDING PROTEIN
1AB0A:1-131C1G/V32D/F57H MUTANT OF MURINE ADIPOCYTE LIPID BINDING PROTEIN AT PH 4.5
1ACDA:1-131V32D/F57H MUTANT OF MURINE ADIPOCYTE LIPID BINDING PROTEIN
1ADLA:1-131ADIPOCYTE LIPID BINDING PROTEIN COMPLEXED WITH ARACHIDONIC ACID: X-RAY CRYSTALLOGRAPHIC AND TITRATION CALORIMETRY STUDIES
1ALBA:1-131CRYSTAL STRUCTURE OF RECOMBINANT MURINE ADIPOCYTE LIPID-BINDING PROTEIN
1CBIA:1-136; B:1-136APO-CELLULAR RETINOIC ACID BINDING PROTEIN I
1CBRA:1-136; B:1-136CRYSTAL STRUCTURE OF CELLULAR RETINOIC-ACID-BINDING PROTEINS I AND II IN COMPLEX WITH ALL-TRANS-RETINOIC ACID AND A SYNTHETIC RETINOID
1DF3A:1-162SOLUTION STRUCTURE OF A RECOMBINANT MOUSE MAJOR URINARY PROTEIN
1G74A:1-131TOWARD CHANGING SPECIFICITY: ADIPOCYTE LIPID BINDING PROTEIN MUTANT, OLEIC ACID BOUND FORM
1G7NA:1-131TOWARD CHANGING SPECIFICITY: ADIPOCYTE LIPID BINDING PROTEIN MUTANT, APO FORM
1I04A:19-177CRYSTAL STRUCTURE OF MOUSE MAJOR URINARY PROTEIN-I FROM MOUSE LIVER
1I05A:20-175CRYSTAL STRUCTURE OF MOUSE MAJOR URINARY PROTEIN (MUP-I) COMPLEXED WITH HYDROXY-METHYL-HEPTANONE
1I06A:19-174CRYSTAL STRUCTURE OF MOUSE MAJOR URINARY PROTEIN (MUP-I) COMPLEXED WITH SEC-BUTYL-THIAZOLINE
1JV4A:1-157CRYSTAL STRUCTURE OF RECOMBINANT MAJOR MOUSE URINARY PROTEIN (RMUP) AT 1.75 A RESOLUTION
1LIBA:1-131THE ADIPOCYTE LIPID-BINDING PROTEIN AT 1.6 ANGSTROMS RESOLUTION: CRYSTAL STRUCTURES OF THE APOPROTEIN AND WITH BOUND SATURATED AND UNSATURATED FATTY ACIDS
1LICA:1-131X-RAY CRYSTALLOGRAPHIC STRUCTURES OF ADIPOCYTE LIPID BINDING PROTEIN COMPLEXED WITH PALMITATE AND HEXADECANESULFONIC ACID. PROPERTIES OF CAVITY BINDING SITES.
1LIDA:1-131THE ADIPOCYTE LIPID-BINDING PROTEIN AT 1.6 ANGSTROMS RESOLUTION: CRYSTAL STRUCTURES OF THE APOPROTEIN AND WITH BOUND SATURATED AND UNSATURATED FATTY ACIDS
1LIEA:1-131X-RAY CRYSTALLOGRAPHIC STRUCTURES OF ADIPOCYTE LIPID BINDING PROTEIN COMPLEXED WITH PALMITATE AND HEXADECANESULFONIC ACID. PROPERTIES OF CAVITY BINDING SITES
1LIFA:1-131THE ADIPOCYTE LIPID-BINDING PROTEIN AT 1.6 ANGSTROMS RESOLUTION: CRYSTAL STRUCTURES OF THE APOPROTEIN AND WITH BOUND SATURATED AND UNSATURATED FATTY ACIDS
1MUPA:5-161PHEROMONE BINDING TO TWO RODENT URINARY PROTEINS REVEALED BY X-RAY CRYSTALLOGRAPHY
1QY0A:1-157THERMODYNAMICS OF BINDING OF 2-METHOXY-3-ISOPROPYLPYRAZINE